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D e fe ns e  m e ch a nis m s  a g a ins t v irus e s  
In healthy individuals, the immune system is able to 
limit the damag e in many viral infec tions. W hen a viral 
p artic le manag es to invade the body by c rossing  
p hysic al barriers suc h as the sk in and muc us 
membranes, it bec omes subjec t to detec tion and 
elimination by several immune effec tor c ells. A s 
viruses c annot rep lic ate on their ow n, they must infec t 
c ells in order to ex p loit the host c ell’s mac hinery for 
the p roduc tion of p rog eny and to enable further virus 
sp read.  
H ost c ell entry c an be bloc k ed by antibody-p roduc ing  
B  c ells, w hic h sp ec ific ally rec og niz e foreig n struc tures 
on the viral p artic le. T he antibodies c annot only 
steric ally hinder viral entry, but they c an also induc e 
elimination of the viral p artic les via different p athw ays. 
T hese inc lude c omp lement ac tivation, antibody-
dep endent c ell-mediated c ytotox ic ity and p hag o-
c ytosis 1 ,2 . T w o subtyp es of B  c ells arise after 
ac tivation of B  c ells, antibody p roduc ing  p lasma c ells 
and memory B  c ells. T he latter subtyp e is c ap able of 
mounting  an immediate hig h-affinity resp onse up on 
renew ed c ontac t w ith the antig en. 
O nc e virus p artic les are inside host c ells, T  c ells c ome 
into p lay. T hey c an rec og niz e foreig n antig en 
frag ments disp layed in the c ontex t of major 
histoc omp atibility c omp lex  (M H C ) molec ules at the 
c ell surfac e 3 ,4 . T here are tw o c lasses of M H C  
molec ules, w hic h differ in struc ture, ex p ression 
p attern and sourc e of antig enic  p ep tides.  
M H C  c lass I molec ules are found on all nuc leated 
c ells and mainly p resent p ep tides derived from 
endog enously synthesiz ed p roteins. C irc ulating  C D 8+
c ytotox ic  T  c ells (C T L s) insp ec t antig enic  frag ments 
disp layed by M H C  c lass I molec ules. In c ase of 
infec tion, C T L s rec og niz ing  foreig n antig ens c an, 
up on ac tivation, k ill suc h c ells.  
E x p ression of M H C  c lass II molec ules is restric ted to 
antig en-p resenting  c ells, i.e. B  c ells, mac rop hag es 
and dendritic  c ells. C lass II molec ules disp lay p ep tide 
frag ments, derived from an ex og enous sourc e of 
p roteins (e.g . viral c ap sid p roteins), for insp ec tion by 
C D 4 +T  c ells. U p on rec og nition of foreig n p ep tides, 
these T  c ells p rovide help  to C D 8+ T  c ells to elic it a 
c ytotox ic  resp onse. In addition, C D 4 + T  help er c ells 
are req uired for the maintenanc e and func tionality of 
memory C D 8+ T  c ells 5.
T he p resentation of ex og enous p ep tides is not 
c omp letely restric ted to M H C  c lass II molec ules, as 
p ep tides derived from internaliz ed p roteins c an also 
enter the M H C  c lass I p athw ay 6 ,7 . T he ability to c ross-
p resent seems to be limited to a sp ec ific  subset of 
antig en p resenting  c ells, mainly C D 8+ dendritic  c ells 8.
In addition, endog enous p roteins c an g ain ac c es to 
the M H C  c lass II p athw ay via autop hag y 9.
B esides an interac tion betw een M H C  molec ules and 
their sp ec ific  rec ep tors, a lig ation betw een ac c essory 
molec ules on the antig en p resenting  c ell and c ounter-
rec ep tors on the T  c ell (c o-stimulation) is req uired for 
T  c ell ac tivation.  
N atural k iller (N K ) c ells are also c ap able of sensing  
virally infec ted c ells, but c an only do so by virtue of 
altered ex p ression levels of c ertain native surfac e 
p roteins, inc luding  M H C  c lass I molec ules. T he 
ac tivation of N K  c ells, and the subseq uent release of 
c ytotox ins, is c ontrolled by a set of N K  c ell rec ep tors. 
D ep ending  on the typ e of rec ep tor, inhibitory or 
ac tivating  sig nals are ig nited up on binding  lig ands on 
the p otential targ et c ell. If inhibitory rec ep tor sig naling  
fails to q uenc h the effec t of eng ag ement of ac tivating  
rec ep tors, the N K  c ell w ill be trig g ered to k ill its targ et 
c ell.  
T his thesis w ill further foc us on M H C  c lass I 
molec ules and their imp lic ation as lig ands for T  and 
N K  c ell rec ep tors in the c ontex t of human c ytomeg alo-
virus infec tion.  
H um a n cy tom e g a lov irus  
H uman c ytomeg alovirus (H C M V ) is found in human 
p op ulations w orldw ide and c an infec t 6 0 – 90 % of 
individuals, dep ending  on the p op ulation studied. 
H C M V  is a member of the Herpesviridae, w hic h are 
k now n to establish a life-long relationship  w ith their 
hosts. H C M V  infec tion is usually asymp tomatic , but 
c an c ause disease in an op p ortunistic  manner. In 
immunoc omp romised individuals, suc h as A ID S  
p atients and org an transp lant rec ip ients, unc ontrolled 
H C M V  reac tivation c an c ause severe illness or death 
1 0 ,1 1 . A dditionally, H C M V  is a notorious risk  fac tor for 
c ong enital birth defec ts. In most c ases, suc h c linic al 
manifestations are found in mothers w ho underg o 
p rimary rather than rec urrent infec tions 1 2 .
In immunoc omp romised individuals, H C M V  c an 
induc e   p atholog y   in   nearly  every   org an   system.  
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In vivo, HCMV can infect endothelial cells, epithelial
cells, monocytes/macrophages, smooth muscle cells, 
stromal cells, neuronal cells, neutrophils, fibroblasts, 
and hepatocytes 13,14. In vitro, all tested vertebrate cell 
types were susceptible to HCMV infection 15. Common
HCMV-associated illnesses include retinitis (which 
may cause blindness), hepatitis, encephalitis, 
pneumonia, and bowel disease 16.
F ollowing primary infection, HCMV persists in a latent
state in cells of the myeloid lineage, with intermittent 
viral reactivation and shedding from mucosal surfaces, 
and containment by the host immune response 17.
Another potential cell type latently or persistently 
infected by HCMV are vascular endothelial cells 18.
Interestingly, HCMV infection has different effects on 
the functioning and survival of these various types of 
host cells. In macrovascular aortic endothelial cells 
HCMV infection is not lytic and results in the 
accumulation of significant amounts of extracellular, 
but not intracellular virus. In addition, the cell cycle is 
not inhibited by HCMV and cells continuously release 
infectious virus. This is in contrast with the rapid, lytic 
infection of brain microvascular endothelial cells and 
human foreskin cells 18. It also differs from HCMV 
infection in monocyte-derived macrophages, which 
results in non-lytic accumulation of intracellular virus 
and lack of extracellular virus 19.
At present, the viral and host mechanisms of HCMV 
latency and reactivation are unclear, but the virus may 
be reactivated by cellular differentiation, and hormonal 
or cytokine (TNF ) stimulation.  
HCMV particles can be found in all body fluids and 
can be transmitted by multiple means, including 
aerosol droplets, sexual contact, nursing, trans-
plantation and blood transfusion 20.
HCMV has a large double stranded DNA genome 
( 230 kb), encoding approximately 192 proteins 21.
The size of the genome varies among HCMV strains. 
Compared to low-passage clinical HCMV isolates, the 
laboratory-adapted AD169 and Towne strains lack 22 
and 19 viral genes, respectively 22.
In infected cells, viral replication occurs according to a 
cascade of three consecutive phases, called 
immediate early (IE), early (E), and late (L). The IE 
gene products play an important role in regulating the 
expression of viral E and L genes, as well as of 
cellular genes. E and L viral gene products include 
viral functions associated with viral DNA replication 
and virus packaging. The viral genome also encodes 
several proteins involved in immune evasion 
strategies, dealing with various immune effector 
mechanisms of the host. These include interference 
with MHC class I and II antigen presentation to CD8+
and CD4+ T cells, NK cell activity, cytokine and 
chemokine signalling, and apoptosis 23-37.
It is evident that these mechanisms are not exploited 
in a way that is life-threatening to the immuno-
competent host. Several studies support important 
roles for B, T and NK cells in protection against HCMV 
disease 38-44. However, these immune evasion 
strategies may prevent complete eradication of the 
virus and contribute to the ability of HCMV to cause 
lifelong persistent infections.  
Before discussing the immune escape mechanisms 
exploited by HCMV to interfere with MHC class I 
surface expression, an introduction on MHC class I 
complex formation and the different functions of the 
various MHC class I locus products will be given. 
MHC class I molecules  
MHC class I molecules consist of a 43 kDa heavy 
chain, a 12 kDa light chain ( 2-microglobulin, 2m) 
and a peptide of 8-10 amino acids in length (see 
F igure 1). The heavy chains are type 1 trans-
membrane proteins consisting of three ER -lumenal 
/surface exposed domains ( 1-3), a connecting 
peptide, transmembrane (TM) region and a 
cytoplasmic tail. The 1-3 domains bind 2m non-
covalently. The 3 domain and 2m show homology 
with immunoglobulin domains and have similar folded 
structures, whereas the 1 and 2 domains fold 
together into a single structure consisting of two 
segmented -helices lying on a sheet of eight 
antiparallel -strands. The folding of the 2 and 3
domains creates a long groove, which is the site 
where peptide antigens bind. Together with peptide, 
this highly polymorphic MHC class I region determines 
T-cell antigen recognition. A single binding site can 
bind a wide variety of peptides with high affinity, but 
there are some sequence restrictions. The peptides 
that can bind to a given MHC variant have the same 
or very similar amino acid residues at two or three 
particular positions, called anchor residues, along the 
peptide sequence. The amino acid side chains at 
these positions insert into pockets of the MHC class I 
molecule that are lined by polymorphic residues of the 
heavy chain. Additional amino acid positions within 
the peptide, called secondary anchors, can also 
influence MHC  binding. These anchor  residues differ 
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for peptides binding different alleles of MHC class I 
Figure 1. Features of MHC class I molecules. A) Schematic diagram of an MHC class I molecule showing the external domains, the
transmemb rane segment and the cy top lasmic region. T he p ep tide b inding cleft is formed b y  the memb rane distal 1  and 2  domains of class I.
B ) R ep resentation of the human class I HL A -A 2  molecule determined b y  x-ray  cry stallograp hic analy sis. T he -strands are dep icted as thick
arrows and the-helices as helical rib b ons. D isulfide b onds are rep resented as two interconnected sp heres. C) A  p lot of the v ariab ility  in the
amino acid seq uence of allelic class I molecules in humans demonstrates that the v ariab le residues are clustered in the 1  and 2  domains. D )
R ep resentation of the 1  and 2  domains as v iewed from the top  of a class I molecule, showing the cleft consisting of a b ase of anti-p arallel
b eta strands and sides of -helices. E ) E xamp les of anchor residues in nonameric p ep tides eluted from two class I MHC molecules. A nchor
residues (grey ) tend to b e hy drop hob ic amino acids and interact with the class I MHC molecule. (Adopted from J. Kuby, Immunology 4th  ed.,
W .H  F reema n) 
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for peptides binding different alleles of MHC class I 
m olecu les. A ltogeth er, th is ensu res th e display  of a 
w ide v ariety  of peptide antigens for CD 8 + T  cell 
inspection. 
MHC class I assembly and interactions with 
comp onents of MHC class I antig en p resentation 
p athway
T h e folding and assem bly  into m atu re trim eric 
com plex es inv olv es a series of ev ents and req u ires 
th e action of sev eral accessory  m olecu les (see F igu re 
2 ). A s HCMV -encoded proteins interv ene at different 
stages of th is process, th e MHC class I antigen 
presentation path w ay  w ill be discu ssed in m ore detail.  
MHC class I h eav y  ch ains encode a signal peptide, 
w h ich  directs insertion into th e E R  du ring translation. 
O nce in th e E R , th e signal seq u ence is cleav ed off by  
a signal peptidase, w h ile oligosacch ary l transferase 
eq u ips th e HC w ith  an N -link ed oligosacch aride. 
T h ese free HCs are soon fou nd in association w ith  th e 
general E R  ch aperones B iP  4 5  and m em brane bou nd 
calnex in, th e latter of w h ich  h as lectin-lik e activ ity  4 6 ,4 7 .
B iP  transiently  binds to m any  new ly  sy nth esiz ed 
proteins. Misfolded proteins and u nassem bled 
su bu nits are bou nd by  B iP  in a prolonged fash ion. 
4 8 ,4 9 . B inding of calnex in is regu lated by  glu cose 
trim m ing of nascent N -link ed oligosacch arides 5 0 .
Calnex in generally  binds proteins w ith  m ono-
glu cosy lated (G lc1 Man9 -7 G lnN A c2 ) oligosacch arides 
5 1 . Calnex in and B iP  predom inantly  associate w ith  free 
MHC class I h eav y  ch ains and th e assem bly  w ith  2 m
abolish es th e interaction of th e h eav y  ch ain w ith  th ese 
ch aperones 4 5 ,5 2 ,5 3 . B efore binding th e ligh t ch ain, 
h eav y  ch ains also interact w ith  E R p5 7 , a m em ber of 
th e protein disu lfide isom erase (P D I) fam ily , w h o are 
inv olv ed in disu lfide bond ox idation, redu ction and 
isom eriz ation reactions 5 4 -5 6 . Matu re MHC class I 
m olecu les h arbor th ree intra-m olecu lar disu lfide 
bridges, th e form ation of w h ich  is lik ely  to be m ainly  
assisted by  E R p5 7 . A fter binding 2 m , MHC class I 
m olecu les are fou nd in association w ith  anoth er, 
solu ble E R  ch aperone w ith  lectin-lik e activ ity , 
calreticu lin 5 7 ,5 8 . L ik e calnex in, calreticu lin binds to 
proteins w ith  G lc1 Man9 -7 G lnN A c2  N -link ed 
oligosacch arides 5 9 ,6 0 . MHC class I m olecu les th an 
becom e associated w ith th e peptide-loading com plex , 
w h ich  besides calreticu lin inclu des E R p5 7 , tapasin, 
and th e transporter associated w ith  antigen 
processing (T A P ). T apasin m ediates th e interaction of 
class I w ith  T A P  5 7 ,5 8 ,6 0 . T h e stru ctu re of MHC class I-
peptide com plex es su ggests th at ox idation of th e 
cy steines in th e HC 2 -dom ain is a prereq u isite for 
stable peptide binding, a process lik ely  facilitated by  
E R p5 7 6 1 . T h e peptides are generated from  
endogenou s proteins by  cy tosolic proteasom es (large 
protease com plex es, discu ssed in m ore detail in a 
later section) and m ay  be fu rth er trim m ed by  
am inopeptidases before and after translocation into 
th e E R  v ia T A P  6 2 ,6 3 . In th e E R , peptides are loaded 
onto HC- 2 m  h eterodim ers. T h ese trim eric HC- 2 m -
peptide com plex es th en dissociate from  th e loading 
com plex  and are released into th e secretory  path w ay  
6 4 .
MHC class I v ariants 
In h u m ans, a single ty pe of ligh t ch ain (B 2 m ) is fou nd 
th at is com plex ed w ith  one of m u ltiple ty pes of h eav y  
ch ains, HL A -A , B , C, E , G , of w h ich  u p to tw o different 
allelic form s can be ex pressed. T h ey  are encoded by  
separate clu sters w ith in th e MHC region of th e h u m an 
genom e, located on ch rom osom e 6 . T h is region also 
encodes oth er proteins inv olv ed in antigen 
presentation (e.g. MHC class II, T A P 1 , T A P 2 , L MP  
genes). T h e ligh t ch ain is encoded by  a gene located 
on anoth er site, on ch rom osom e 1 5 . T h e v ariou s 
ty pes of h eav y  ch ains differ from  each  oth er in sev eral 
w ay s, as w ill be discu ssed below .  
Polymorphism
O ne ou tstanding difference am ong class I h aploty pes, 
is th e degree of poly m orph ism  th at can be fou nd in 
th e w orld popu lation. T o date, 3 7 2  different alleles 
h av e been reported for HL A -A , and 6 6 1  for HL A -B . 
HL A -C sh ow s som ew h at less v ariation w ith  1 9 0  
different alleles. P oly m orph ism  of HL A -E  and HL A -G  
is v ery  lim ited, w ith  5  (HL A -E ) and 1 5  (HL A -G ) 
different alleles described to date (IMG T /HL A  
database, 6 5 .
T issu e  d istrib u tion  / su rfa c e  e x pre ssion  
T issu e distribu tion and cell su rface lev els differ for th e 
v ariou s locu s produ cts. Most h ost cells ex press HL A -
A , B , C and E  alleles, w h ereas HL A -G  ex pression is 
restricted to th e th y m u s and certain placental tissu es, 
e.g. troph oblast cells. T h e troph oblast cells at th e 
m aternal-fetal interface lack  su rface ex pression of 
HL A -A  and -B  alleles 6 6 ,6 7 . O u tside th is im m u ne-
priv ileged site, th e su rface lev els of HL A -A , -B , and -C 
alleles m ay  v ary  betw een cell ty pes 6 8 ,6 9 . S ev eral 
aspects th at influ ence MHC class I (su rface) 
ex pression lev els w ill be discu ssed below . 
R e g u la tion  of M H C  c la ss I g e n e  tra n sc ription  
HL A  class I genes h av e different constitu tiv e and 
cy tok ine-indu ced  ex pression  patterns, w h ich   can  be  
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Figure 2. M H C  c la s s  I a s s em b ly . A ) Model for folding and complex formation of MHC class I molecules and interactions with components of the 
class I antigen presentation pathway  (see text for further description). Calnexin (Cnx), calreticulin (Crt), tapasin (T pn). T he N -link ed gly can is 
mark ed “N ”. B ) N -link ed gly cans are added to proteins in the E R  as "core oligosaccharides" that hav e the structure shown. T hese are b ound to 
the poly peptide chain through an N -gly cosidic b ond with the side chain of an asparagine that is part of the A sn-X -S er/T hr consensus seq uence. 
T he three glucoses are remov ed b y  glucosidase I and II, and terminal mannoses b y  one or more different E R  mannosidases. A ssociation of 
gly copeptides with Cnx/Crt is dependent upon the presence of a single terminal glucose residue b ound to the G lcN A c2Man9 gly can precursor. 
(Adapted from ref.142 
attrib uted to differences in their promoter regions. 6 9-
7 1 . T he cy tok ines T N F - , IF N -  and IF N -  can 
increase av erage MHC class I surface lev els up to 1 0 -
fold 6 9. T he HL A -G  promoter region differs from other 
MHC class I genes, as some of the conserv ed 
regulatory  b oxes hav e b een deleted or altered, 
including the IF N  regulatory  seq uence 7 0 ,7 2. In 
addition, the cy tok ine IL 1 0  has b een reported to 
selectiv ely  upregulate HL A -G  expression 7 3 . Cell ty pe-
specific factors may  contrib ute to differential locus 
expression as well 6 8 ,6 9.
M H C  c las s  I c omplex  formation  an d s tab ility  
T he lev els of the different MHC class I molecules that 
are found at the cell surface are determined b y  
transcript lev els, as well as b y  the success of stab le 
complex formation, and turnov er rates. G enerally , 
surface lev els of HL A -C locus products are rather low, 
ab out 1 0 %  of the av erage lev el of HL A -A  and -B  
molecules 7 4 -7 6 . S ev eral explanations hav e b een 
proposed, including lower transcript lev els, lower 
assemb ly  rates for HL A -C heav y  chains with 2m, 
and an inefficient supply  of high-affinity  HL A -C-
specific peptides. 7 1 ,7 7 ,7 8 . V ariation b etween MHC 
class I molecules in b inding components of the 
peptide loading machinery , tapasin/T A P , may  also 
contrib ute to differences in MHC class I surface lev els. 
E xperiments with wild ty pe and mutant HL A -A 2 
molecules indicated that residues 1 3 2-1 3 4  in the 2
domain are important determinants for association 
with T A P . HL A -A 2 T 1 3 4 K /S 1 3 2C mutants do not 
associate with tapasin/T A P  and are released into the 
secretory  pathway  much faster (as indicated b y  
reaching E ndo H resistance) than their wild ty pe 
counterparts 7 9. T here is no seq uence v ariation in this 
particular region. R esidues 1 1 4  and 1 1 6 , which are 
poly morphic, were shown to b e responsib le for 
differences in peptide-loading complex interactions 8 0 -
8 4 . Class I molecules that associate inefficiently  with 
intracellular chaperones may  generally  demonstrate 
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lower peptide ligand binding affinities and render the 
heterotrimeric MHC class I complexes formed less 
stable. Once at the cell surface, tyrosine or di-leucine 
motifs present in most MHC class I molecules can 
function as endocytosis signals. HLA-G misses 
potential endocytosis signals and its half-life has been 
shown to be almost twice that of HLA-A2 molecules 85.
Peptide binding / repertoire 
HLA-A/B and HLA-C/G/E differ in their ligand-binding 
capabilities: HLA-A/B molecules are promiscuous, 
whereas the other class I molecules bind a limited 
number of ligands. HLA-C locus products, for 
instance, have a preference for peptides that are 
poorly transported into the ER, and that require a 10-
fold higher peptide concentration for release into the 
secretory pathway 78,86-88. HLA-G binds many self-
peptides with a defined motif and its peptide binding 
diversity is estimated to be about five fold lower than 
that of HLA-A 89,90. The most common HLA-E ligands 
are nonamers derived from signal sequences of other 
HLA class I molecules 91,92.
S pecial features / alternativ e splice v ariants 
Due to a premature stop codon in exon 6, HLA-G has 
a relatively short cytoplasmic tail (6 residues) 
compared to other HLA class I molecules (29-33 
residues) 93. Consequently, HLA-G not only lacks 
potential endocytosis signals present in other class I 
molecules, but it also gains an ER retrieval/retential 
signal with the dilysine residues positioned at -4 and -
5 from the C-terminus. This motif can mediate 
recycling of assembled HLA-G molecules between the 
ER and the cis-Golgi 94,95. High affinity peptide binding 
seems to be required to end the recycling and allow 
egress to the cell surface 85.
Primary HLA-G mRNA transcripts are differentially 
spliced, giving rise to multiple isoforms 96. Only the full 
length isoform (HLA-G1) is expressed at the cell 
surface 97. In addition to this membrane-bound 
isoform, a soluble (secreted) isoform was detected in 
placental tissues (sHLA-G1 /HLA-G5). Soluble HLA-
G1 is translated from a transcript with a retained intron 
4, which introduces a premature stopcodon after the 
1-3 domain encoding sequence. This isoform can 
associate with 2m 98,99.
L igands for T and N K  cell receptors 
MHC class I molecules can be ligands for cytotoxic T 
cell receptors, as well as for NK  cell receptors. 
Through recognition of MHC-peptide complexes, 
CD8+ T cells can kill infected target cells. HLA-A and 
B molecules are the restriction elements in the 
majority of CTL responses, although there are also 
some examples of HLA-C, -G and -E molecules 
presenting antigenic peptides to CTLs 100-103. This 
may very well explain the high degree of 
polymorphism that is particularly described for HLA-A 
and – B alleles. 
U nlike for CTLs, the distinction between self and non-
self antigens in the context of MHC class I molecules 
is not the major restriction element for triggering of NK  
cell lysis. This trigger is determined by the presence 
or absence of NK  cell receptor ligands on the surface 
of the target cell. The total input of several types of 
ligands, including MHC I molecules, and their 
engagement with both inhibitory and activating NK  
receptors controls NK  cell cytolysis 104,105. Many MHC 
class I molecules can contribute to the regulation of 
NK  cell functioning. Other NK  cell receptor ligands 
include several molecules that are distantly related to 
MHC class I molecules, e.g. MIC A/B, U L16 binding 
protein (U LBP) 1/2/3, and CD155. An overview of 
currently known NK  cell receptors and ligands is 
presented in Table 1 106,107.
A particular NK  cell clone can express up to nine 
different receptors, which together determine the 
activation status of the cell. These receptors can be 
displayed on overlapping subsets within the total NK  
cell population, and the repertoire of expressed 
receptors is heterogeneous in different individuals 
108,109. Some of these receptors are also found on 
other immune effector cell types. Variation in surface 
expression of only one type of MHC class I molecule 
can   already   make  a  difference  for   cell   survival.  
Table 1. Natural killer cell receptors and their ligands
Name of receptor Type of signal Ligand(s) 
K IR2DL1 (p58.1) inhibitory HLA-CLys80
K IR2DL2 (p58.2) inhibitory HLA-C Asn80
K IR2DL4 (p49) inhibitory HLA-G 
K IR3DL1 (p70) inhibitory HLA-Bw4 
K IR3DL2 (p140) inhibitory HLA-A3, A11 
LIR1/ILT2 inhibitory HLA-A,-B,-C,-E,-F,-G 
LIR2/ILT4 inhibitory  HLA-A,-B,-C,-E,-F,-G 
CD94/NK G2A inhibitory HLA-E 
K IR2DS1 (p50.1) activating HLA-C Lys80
K IR2DS2 (p50.2) activating HLA-C Asn80
K IR2DS4 (p50.3) activating unknown 
CD94/NK G2C activating HLA-E 
P40/LAIR1 inhibitory unknown 
p75/AIRM1 inhibitory unknown 
NK p30 (1C7/NK -A1) activating unknown 
NK p44 activating unknown 
NK p46 activating unknown 
NK p80 activating unknown 
NK G2D activating MICA/B, U LBP1-3 
2B4 activating CD48 
DNAM-1 (CD226) activating PVR; nectin-2 (CD155) 
K LRF1 (NK p80) activating unknown 
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Surface expression of HLA-E was shown to be 
sufficient to either inhibit NK cells expressing 
C D 9 4 /NKG 2 A  or to enha nce k illing by  cells 
expressing C D 9 4 /NKG 2 C  1 1 0 . L ik ew ise, H L A -G  
expression ha s been show n to protect H L A  cla ss I 
d eficient ta rgets from  NK cell m ed ia ted  ly sis, through 
enga ging inhibitory  NK cell receptors 1 1 1 ,1 1 2 . T he 
selectiv e expression of only  H L A -C , -E , a nd  – G  a lleles 
on cells a t the feta l m a terna l interfa ce m a y  help to 
protect them  from  m a terna l cy totoxic T  cell a nd  NK 
cell a tta ck . 
T cell and NK cell escape mechanisms of HCMV 
S ev era l im m une esca pe m echa nism s exploited  by  
hum a n cy tom ega lov irus seem  to focus on prev ention 
of d etection a nd  elim ina tion by  cy totoxic T  cells a nd  
NK cells.  
HCMV and escape from cytotoxic T cell killing 
D uring la tent infections, H C M V  v ira l gene expression 
is lim ited  w hich helps to a v oid  im m une surv eilla nce by  
cy totoxic T  cells. D uring a ctiv e infection, H C M V  
exploits a nother m echa nism  to a v oid  d ispla y  of v ira l 
a ntigens, tha t is by  d ow n-regula ting M H C  m olecules. 
C ell surfa ce expression of M H C  cla ss I m olecules is 
a ffected  by  the concerted  a ction of a  set of proteins 
encod ed  w ithin the uniq ue short (U S ) region of the 
H C M V  genom e tha t a re expressed  a long the d ifferent 
sta ges of v ira l infection. U S 3  is the first to be 
sy nthesiz ed  a nd  prev ents tra ffick ing of new ly  
sy nthesiz ed  M H C  cla ss I m olecules, by  entra pping 
them  in the E R  3 0 ,1 1 3 . Next, U S 2  a nd  U S 1 1  com e into 
pla y  a nd  ind uce proteoly tic d egra d a tion of M H C  cla ss 
I m olecules. Im m ed ia tely  a fter their sy nthesis a nd  
tra nsloca tion into the E R , cla ss I hea v y  cha ins a re 
tra nsported  into the cy tosol w here they  a re d epriv ed  
of their N-link ed  gly ca n a nd  subseq uently  d egra d ed  
by  protea som es 3 7 ,1 1 4 . A t ea rly  a nd  la te tim es post 
infection, U S 6  prev ents peptid e loa d ing of M H C  cla ss 
I m olecules by  block ing the T ra nsporter a ssocia ted  
w ith A ntigen P rocessing (T A P ) 2 9 ,3 3 ,1 1 5 . A nother U S -
encod ed  gene, U S 1 0 , ha s been reported  to d ela y  
m a tura tion of M H C  cla ss I m olecules 2 5 .
HCMV and N K  cell escape 
A  com plete red uction of M H C  cla ss I expression could  
ha v e serious conseq uences for the surv iv a l of the 
v irus, a s cells la ck ing M H C  cla ss I surfa ce m olecules 
a re m ore susceptible to NK-cell a tta ck  2 4 . S ev era l 
proteins encod ed  w ithin the U niq ue L ong (U L ) region 
of the H C M V  genom e (U L 1 6 , U L 1 8 , U L 4 0 ) a ppea r to 
protect infected  cells a ga inst NK-cell ly sis. T hey  either 
block  expression of liga nd s tha t a ctiv a te NK cells 
(U L 1 6 ) or a llow  expression of liga nd s tha t ca n inhibit 
NK-cell triggering (U L 1 8 , U L 4 0 ) 3 4 .
U L 1 6 , expressed  a t a n ea rly  sta ge of infection, 
interferes w ith M IC B / U L B P 1 , 2  -specific triggering of 
a ctiv a ting NK cell receptors (NKG 2 D ) by  d ow n-
regula ting their liga nd s 1 1 6 . A t the sa m e tim e, U L 4 0  
ca n prom ote surfa ce expression of H L A -E  by  
prov id ing it w ith T A P -ind epend ent peptid es, thereby  
supply ing a  liga nd  for the inhibitory  C D 9 4 /NKG 2 A  
receptor, w hich is found  on m ost NK cells 1 0 2 . A t a  la te 
sta ge of infection, H C M V  encod es a  v ira l M H C  cla ss I 
hom ologue, U L 1 8 , w hich serv es a s d ecoy  for M H C  
cla ss I a t the cell surfa ce a nd  ca n bind  the L IR 1  
inhibitory  NK cell receptor 1 1 7 . R ecently , a  new  
ea rly /la te H C M V -encod ed  gene prod uct ha s been 
id entified , U L 1 4 1 , w hich prev ents surfa ce expression 
of C D 1 5 5 , a  liga nd  for the a ctiv a ting NK cell receptor 
C D 2 2 6 3 6 . It is im porta nt to note tha t this U L 1 4 1  gene 
is present in v a rious clinica l H C M V  stra ins, w herea s it 
is lost in la bora tory  A D 1 6 9  a nd  T ow ne stra ins 2 1 ,2 2 ,3 6 .
A lterna tiv e w a y s to preserv e inhibitory  signa ls to NK 
cells could  includ e a  m ore selectiv e d ow n-regula tion 
of M H C  cla ss I surfa ce expression. If the specificity  of 
the U S  proteins w ere such tha t those M H C  cla ss I 
m olecules tha t present v ira l a ntigens (m ostly  H L A -A  
a nd  -B  a lleles) a re a ffected  pred om ina ntly , H C M V  
could  esca pe both T  cell a nd  NK cell k illing.
S electiv ity and degree of MHC class I dow n-regu lation 
b y HCMV 
T he success of im m une esca pe by  H C M V  from  both T  
cell a nd  NK cell a tta ck  through m od ula tion of M H C  
cla ss I surfa ce expression is lik ely  to be influenced  by  
the efficiency  a s w ell a s by  the specificity  of the 
d ifferent v ira l ev a sion proteins.  
T he d egree of d ow n-m od ula tion tha t ca n be 
a ccom plished  lik ely  d epend s on the ba la nce of ta rget 
M H C  cla ss I a nd  U S  protein lev els. A s m entioned  
before, M H C  cla ss I surfa ce lev els ca n be upregula ted  
by  cy tok ines. T he expression lev els of the U S  proteins 
v a ry  d uring the course of infection a nd  m a y  a lso 
d epend  on v ira l loa d  1 1 8 . A  higher a m ount of v ira l 
pa rticles ca n lea d  to a  m ore sev ere red uction in M H C  
cla ss I surfa ce expression 1 1 9 . A s m entioned  in 
prev ious sections, the tota l cellula r M H C  cla ss I pool 
is ra ther heterogeneous. B esid es contributing to a  
m ore sy nergistic effect on d ow n-regula tion of one 
pa rticula r M H C  cla ss I locus prod uct, expression of 
d ifferent U S  proteins m a y  a lso a ccount for a  broa d er 
effect on the tota l pool of M H C  cla ss I prod ucts.  
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Several laboratories have studied allelic differences 
betw een M H C  class I m olecules w ith resp ect to 
sensitivity  to U S2 , U S3 , U S6 , and U S1 1  
2 9 ,3 3 ,6 7 ,1 0 2 ,1 1 3 ,1 1 5 ,1 1 9 -1 2 6 .
O ur studies w ere focused on the sp ecificity  of M H C  
class I dow n-reg ulation by  U S2  and U S1 1 . In addition, 
w e aim ed to characteriz e the p recise reg ions in M H C  
class I alleles that determ ine sensitivity  or resistance 
to U S2  and U S1 1 . T he ap p roach for U S2  w as based 
on p revious results and on cry stal structure data from  
a soluble H L A -A 2 / 2 m /U S2  com p lex  (see F ig ure 3 ) 
p ublished by  G ew urz  et al. 1 2 3 .
Dislocation and degradation of MHC class I 
m olecu les 
In the E R , U S2  and U S1 1  bind new ly  sy nthesiz ed 
M H C  class I heavy  chains and targ et them  to the 
cy tosol for subseq uent deg radation by  p roteasom es 
3 1 ,3 7 . R etro-transp ort is a m echanism  com m only  used 
for the disp osal of im p rop erly  folded and unassem bled 
E R  lum enal p roteins, including  M H C  class I heavy  
chains. T he ex act req uirem ents for dislocation of 
these m em brane-anchored p roteins from  the E R  into 
the cy tosol are still relatively  unk now n. H ow ever, there 
are indications that certain E R  chap erones m ay  be 
involved.  
ER quality control and ER-associated degradation of 
incom p letely folded or assem b led M H C  class I 
m olecules 
W hen p rop erly  folded heterotrim eric H C - 2 m -p ep tide 
com p lex es are form ed, the M H C  class I com p lex  is 
released of all aux iliary  m olecules as it follow s the 
secretory  p athw ay . B ut until this p oint, several q uality  
control m echanism  are active to p revent surface 
ex p ression of m alfolded or unassem bled class I heavy  
chains. F or instance in the absence of one of the 
com p onents of the com p lex , e.g . in case of a defect in 
2 m  ex p ression, no M H C  class I m olecules can be 
detected at the cell surface 1 2 7 -1 3 0 . If the sup p ly  of 
p ep tides is ham p ered by  T A P  inhibition, or loading  is 
obstructed by  an im p aired interaction of T A P  and 
H C ’s in the absence of tap asin, then the surface 
ex p ression of class I m olecules is also severely  
reduced 5 7 ,1 3 1 .
In 2 m  and T A P -deficient cell lines, incom p letely  
folded and assem bled M H C  class I m olecules are 
rem oved from  the E R  and released into the cy tosol, 
w here they  are deg raded by  p roteasom es 1 3 2 . T he 
ex act m echanism  by  w hich m olecules are dislocated 
rem ains  elusive, but  there  are  indications  that  E R   
F igu re 3 . Cry stal stru ctu re of a solu b le U S 2 /HL A -A 2 /2 m /T ax  
com p lex . C ry stal structure of a soluble U S2 /H L A -A 2 /2 m /T ax  
com p lex , as determ ined by  B . G ew urz  et al. D ata for this im ag e w ere 
derived from  the P U B M E D  P rotein D ata B ase (reference 1 IM 3 ) and 
visualiz ed as solid ribbon using  W ebV iew erL ite. H L A -A 2  (lig ht g rey ), 
2 m  (dark er g rey ), U S2  (dark est g rey ) and H um an T  ly m p hotrop ic 
virus ty p e I T ax  p ep tide (L L F G Y P V Y V , black ). A m ino acid residues in 
H L A -A 2  that m ak e direct contact w ith U S2  are dep icted in dark  g rey  
and are m ark ed w ith their corresp onding  p osition num bers in the 
class I heavy  chain. 
chap erones such as B iP  and calnex in m ay  p lay  a role 
in this p rocess. B iP  retains m any  m isfolded p roteins in 
the E R , including  unassem bled H C ’s 4 5 ,1 3 3 ,1 3 4 . Studies 
involving  K ar2 p  (the y east hom olog ue of B iP ) and 
g ly cop rotein C P Y * , have link ed the A T P ase activity  of 
B iP  w ith release of m alfolded p roteins into the cy tosol 
1 3 5 . T he release from  B iP  and retro-transp ort of 
unassem bled Ig  L  chain, a soluble nong ly cosy lated 
p rotein, has been found to be tig htly  coup led w ith 
p roteasom e activity  1 3 6 . It is unclear w hether these 
effects of B iP  on dislocation are restricted to 
m alfolded soluble E R  p roteins. B esides this, B iP  has 
been im p licated to p lay  a role in the unfolded p rotein 
resp onse (U P R ), as sensor of accum ulating  m isfolded 
p roteins. U P R  directs the up reg ulation of a num ber of 
stress-related p roteins (lik ely  involved in disp osal 
p rocesses), including  B iP  1 3 7 ,1 3 8 . L ik e B iP , C alnex in 
retains incom p letely  assem bled M H C  class I H C ’s in 
the E R  by  using  its cy top lasm ic tail 5 2 ,1 3 9 . Surface 
ex p ression of M H C  class I heavy  chains in a 2 m -
deficient cell line could be restored by  introducing  
calnex in w ith a truncated tail 5 2 .
A s m entioned before, trim m ing  of the N -link ed 
p recursor olig osaccharide G lc3 M an9 G lcN A c2  in the 
E R  y ields G lc1 M an9 -7 G lnN A c2 , w hich enables 
association  w ith calnex in and calreticulin 5 1 . A   folding   
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and quality control process is then initiated that 
consists of cycles of deglucosylation by glucosidase II, 
release from the chaperone, reglucosylation by the 
folding sensor UDP-Glc:glycoprotein glucosyl-
transferase, and re-association with calnexin and 
calreticulin 140. Glycoproteins that achieve proper 
folding are no longer recognized by glucosyltranferase 
and leave this cycle. Differential mannose trimming by 
ER-mannosidases I and II has been proposed to 
signal the degradation of terminally misfolded 
glycoproteins 141-143. Inhibitors that prevent mannose 
trimming were found to inhibit degradation of many 
defective glycoproteins 141,143-147. Loss of the mannose 
residue that is the acceptor for glucosyltranferase 
leads to release from the reglucosylation cycles 
involved in the rescue of improperly folded 
glycoproteins and association to the putative mannose 
lectin EDEM 148-150. The glycoproteins are then dis-
located to the cytosol, deglycosylated and degraded 
by the proteasome 151.
Ubiquitin and proteasomal degradation 
The turnover of many cellular proteins is regulated by 
a process, which involves initial earmarking via the 
ubiquitin system and subsequent degradation by 
proteasomes (see Figure 4). This earmarking involves 
the linkage of ubiquitin, a highly conserved protein of 
~ 8.5kDa, to the substrate protein through an isopep-
tide bond between the C-terminal glycine (Gly76) of 
ubiquitin and the -NH2 group of a lysine residue in 
the target protein. Protein ubiquitination involves a 
cascade reaction with subsequent activities of three 
different types of enzymes: ubiquitin-activating 
enzyme (E1), ubiquitin-conjugating enzyme (E2) and 
ubiquitin-ligase (E3) 152,153. Polyubiquitin chains are 
formed by the attachment of additional ubiquitin 
moieties via Gly76, to Lys48 of the next ubiquitin 
moiety. Only poly-ubiquinated proteins are recognized 
as substrates for proteasomal degradation. A fourth 
type of enzyme (E4) has been postulated to function 
as multi-protein chain assembly factor 154.
Ubiquitin-mediated proteolysis is an important 
mechanism for the regulation of many cellular 
processes, as it mediates the turnover of cell cycle 
regulators, tumor suppressors and growth modulators, 
transcriptional activators and inhibitors, cell surface 
receptors, in addition to misfolded proteins. This 
requires a substrate specific mode of action for the 
E1-3 enzymes. E1 enzymes are highly conserved and 
so far only a single ubiquitin-activating enzyme (Uba1) 
has been found in yeast and humans. The ubiquitin-
conjugating (ubc) enzymes are part of a homologous 
family of proteins. To date, 13 different E2 enzymes 
have been described in yeast, and at least 18 in 
humans. Likely, E3 enzymes contribute most to the 
biological specificity of the ubiquitin system, with 
hundreds, if not thousands of often structurally 
unrelated enzymes. These include Skp/Cullin/F-box 
(SCF), SOCS-box, Anaphase Promoting Complex 
(APC), HECT family, RING finger domain, U-box, 
VBC and Parkin-like E3 ligases.  
Proteasomes, found both in the nucleus and cytosol, 
are large multi-subunit complexes, made up of a 20S 
core particle and one or two regulatory “cap” 
complexes (19S or 11S/PA28)155. The 20S barrel-
shaped core particle consists of four stacked rings: 
two identical outer -rings, and two identical inner -
rings. Each of these rings contain seven different 
subunits. The catalytic activity is provided by 3 
subunits (called X , Y and Z ) in the -rings. The 19S 
cap is composed of 17 subunits, 9 of which are part of 
a base connected to the -ring, and 8 of which are 
found in a structure referred to as the lid. This cap 
recognizes poly-ubiquitinated proteins and is believed 
to mediate entry into the narrow pore of the 20S core 
particle by unfolding the substrate and widening the 
entrance via the -ring. Immuno-modulatory cytokines 
such as IFN-  can alter the composition of the 
proteasome. IFN-  promotes expression of the 
regulatory PA28/11S complex, which reportedly 
enhances proteasome activity156,157. In addition, IFN-
induces the incorporation of LMP2, LMP7 and MECL-
1 subunits into the -rings of the 20S core particle, 
instead of the standard X , Y, and Z  subunits158-160.
Proteasomes harboring IFN-  subunits are therefore 
referred to as immunoproteasomes. Immuno-
proteasomes may enhance the specificity of the 
proteasome and promote the generation of peptides 
presented by MHC class I molecules.  
D islocation of ER-lumenal proteins and inv olv ement of 
cytosolic factors  
It is still largely unknown how dislocation of ER-
lumenal substrates is accomplished. Proteasomes 
may play an active role in the extraction of 
ubiquitinated substrates. In mammalian cells ~ 10%  of 
the proteasomes are located at the cytosolic face of 
the ER membrane, and  proteasomal activity  appear 
to be required for the extraction of several trans-
membrane proteins 161-163.
More recently, the cytosolic AAA ATPase p97-Ufd-
Npl4 complex was linked to the dislocation of ER 
proteins. This complex seems to be involved in the 
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final membrane detachment of partially dislocated 
su bstrates 1 6 4 ,1 6 5 . It is a hex americ ring  complex , that 
senses both poly-u biq u itinated as w ell as non-
u biq u itinated proteins 1 6 5 . It lik ely acts in concert w ith 
other (E R -membrane anchored) proteins ex erting  a 
more su bstrate-specific role. 
In stu dies of U S 1 1 -mediated deg radation of M H C  
class I heav y chains, D erlin1  (the mammalian 
eq u iv alent of yeast D er1 ), w as identified as an 
additional component inv olv ed in dislocation 1 6 6 -1 6 8 .
Scope of this thesis 
T he stu dies described in this thesis focu s on 
strateg ies ex ploited by hu man cytomeg alov iru s to 
escape immu ne detection by its host throu g h 
modu lation of su rface ex pression of M H C  class I 
molecu les by U S 2  and U S 1 1  (rev iew ed in C hapter 1 ). 
U S 2  and U S 1 1  can both targ et new ly synthesiz ed 
M H C  class I molecu les for proteasomal deg radation. 
T his can prohibit the display of v iral antig ens on the 
su rface of infected cells and fru strate inspection by 
cytotox ic T  cells. H ow ev er, the absence of su rface 
class I molecu les cou ld also alert N K  cells and trig g er 
cytolysis by these immu ne effector cells. 
F ig u re 4 . U b iq u itin -d epen d en t protein  d eg r a d a tion . A ) F ree u biq u itin (U b) is activ ated in an A T P -dependent manner w ith the formation of a
thiol-ester link ag e betw een E 1  and the carbox yl terminu s of u biq u itin. U biq u itin is transferred to one of a nu mber of different E 2 s. E 2 s associate
w ith E 3 s, w hich mig ht or mig ht not hav e su bstrate (S ) already bou nd. F or H E C T  domain E 3 s, u biq u itin is nex t transferred to the activ e-site
cysteine of the H E C T  domain follow ed by transfer to su bstrate (as show n) or to a su bstrate-bou nd mu lti-u biq u itin chain. F or R IN G  E 3 s, cu rrent
ev idence indicates that u biq u itin mig ht be transferred directly from the E 2  to the su bstrate. B ) A fter link ag e of a poly-u biq u itin chain onto the
su bstrate protein, the earmark ed protein can be recog niz ed by the 1 9 S  (P A 7 0 0 ) cap, w hich is composed of 1 2  non-A T P ase-lik e (R pn) and 6
A T P ase-lik e reg u latory particles (R pt). T he 1 9 S  cap is associated w ith the 2 0 S  proteasome complex , in w hich deg radation is tak ing  place. T he
2 0 S  core has a barrel-shaped stru ctu re of fou r stack ed ring s, each comprising  7  su bu nits. T he ou ter ring s harbor  su bu nits and the inner ring s 
su bu nits. T he proteolytic activ ity resides in a pair of three different  su bu nits (called X , Y  and Z ). In the presence of IF N , the composition of
proteasomes is altered. In this case IF N --indu cible su bu nits L M P 2 , L M P 7 , and M E C L 1 , replace X , Y  and Z  su bu nits. IF N - also indu ces
ex pression of the proteasome reg u lator 1 1 S  (P A 2 8 ), a hex americ complex  consisting  of 1 1 S  + . D ifferent combinations of 2 0 S  cores w ith caps
ex ist, as the 2 0 S  core particle can g o w ith tw o 1 9 S  or tw o 1 1 S  caps, or w ith a mix  of the tw o. (Adapted from A.M. Weissman, Nature Reviews
2 0 0 1
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If the specificity of the viral US2 and US11 proteins 
was such that those MHC class I molecules 
p resen tin g  v iral an tig en s (mostly  HL A -A  an d  -B  
alleles) are p referen tially  affected , these U S  p rotein s 
could  con trib ute to an  escap e of HCMV -in fected  cells 
from b oth T  cell an d  N K  cell k illin g . In  this thesis, we 
in v estig ated  whether U S 2  an d  U S 1 1  in d eed  d isp lay  
selectiv ity  in  their d own -reg ulation  of MHC class I 
locus p rod ucts (Chap ters 2 -4 ).  
A lthoug h at first sig ht the mod e of action  of U S 2  an d  
U S 1 1  seems v ery  similar, it is un lik ely  that HCMV  
en cod es two d ifferen t p rotein s with id en tical fun ction . 
W e ev aluated  if U S 2  an d  U S 1 1  could  act 
comp lemen tary  to each other. T hey  could  d o so in  
v arious way s, e.g . b y  targ etin g  d ifferen t MHC class I 
sub sets for d eg rad ation , b y  usin g  d ifferen t p athway s 
for d eg rad ation  of class I molecules, or b y  actin g  at 
d ifferen t stag es in  the fold in g  an d  assemb ly  p rocess 
of MHC class I molecules. T herefore, we ev aluated  
sev eral of these asp ects. 
F irst of all, we ex p lored  the structural req uiremen ts of 
MHC class I molecules to b ecome targ ets for U S 2  
(Chap ters 2  an d  4 ) or U S 1 1  (Chap ters 3  an d  4 ) usin g  
v arious chimeric an d  mutan t HL A  class I molecules. 
U b iq uitin  serv es as an  earmark  to targ et p rotein s for 
p roteasomal d eg rad ation  an d  it could  also p rov id e a 
han d le for p ullin g  E R  p rotein  in to the cy tosol. 
T herefore, we also assessed  the role of the ub iq uitin  
sy stem in  U S 1 1 -med iated  d islocation  of MHC class I 
molecules (Chap ter 5 ).  
F in ally , we ev aluated  whether U S 2  an d  U S 1 1  can  act 
in  early  stag es of MHC class I fold in g  an d  assemb ly , 
b y  targ etin g  un assemb led  HCs for d eg rad ation  
(Chap ter 6 ). 
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CHAPTER 2 
Amino acid composition of 1 / 2  domains 
and cy toplasmic tail of M H C  class I mole cu le s 
de te rmine  th e ir  su sce ptib ility  to 
H C M V  U S 1 1 -me diate d dow n-r e g u lation 
Eur. J. Immunol. 33: p1707-1716 (2003)
Amino acid composition of 1 / 2  domains and cy toplasmic tail of M H C class I
mole cu le s de te rmine  th e ir  su sce ptib ility  to h u man cy tome g alov ir u s U S 1 1 -me diate d 
dow nr e g u lation. 
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D u r ing  co-e v olu tion w ith  its h ost, h u man cy tome g alov ir u s h as acq u ir e d mu ltiple  de fe nse  me ch anisms to 
e scape  from immu ne  r e cog nition. In th is stu dy , w e  focu se d on U S 1 1  th at b inds to M H C  class I h e av y  
ch ains and me diate s th e ir  dislocation to th e  cy tosol and su b se q u e nt de g radation b y  prote asome s. T o 
e x amine  w h ich  domains of class I h e av y  ch ains ar e  inv olv e d in th is proce ss, w e  constr u cte d ch ime r ic 
H L A mole cu le s of U S 1 1 - se nsitiv e  and - inse nsitiv e  class I mole cu le s (H L A-A2  and H L A-G , r e spe ctiv e ly ). 
P u lse  ch ase  e x pe r ime nts w e r e  pe r forme d to e v alu ate  prote in stab ility  and inte ractions b e tw e e n class I 
h e av y  ch ains and U S 1 1 . F low  cy tome tr y  w as e mploy e d to asse ss th e  e ffe ct of U S 1 1  on su r face  
e x pr e ssion of th e  diffe r e nt ch ime ras. O u r  r e su lts indicate  th at th e  1  and 2  domains of H L A mole cu le s 
ar e  important for  th e  affinity  of U S 1 1  association. H ow e v e r , th e  de g radation e fficie ncy  se e ms to r e ly  
mostly  on cy tosolic tail r e sidu e s. W e  fou nd th at th e  nonclassical H L A-G  mole cu le  is inse nsitiv e  to U S 1 1 -
me diate d de g radation sole ly  b e cau se  it lack s e sse ntial tail r e sidu e s. A de le tion of th e  last tw o tail 
residues in full length class I already caused a severe reductio n in degradatio n efficiency. A lto gether, 
o ur data p ro vide new  insights into  the m echanism  b y w hich U S 1 1  do w nregulates M H C  class I m o lecules.
Human cytomegalovirus (HCMV) is a -h erp esvirus 
th at causes serious d isease and  h igh  mortality rates in 
immunocomp romised  p ersons, such  as A ID S  p atients 
and  organ transp lant recip ients. B esid es th is, HCMV 
is a notorious risk  factor for congenital d isord ers if th e 
moth er und ergoes p rimary infection d uring p regnancy.
In immunocomp etent h osts, HCMV infection generally 
gives b enign b ut lifelong infections.
T h e h ost immune system is elud ed  b y HCMV th rough  
a variety of d efense mech anisms th at it acq uired  w h ile 
co-evolving w ith  its h ost. A ntigen p resenting MHC 
class I molecules, w h ich  p lay a central role in 
d etection and  elimination of infected  cells b y CD 8 +  T  
cells and  N K  cells, rep resent a major target for viral 
evasion strategies. Cell surface ex p ression of MHC 
class I molecules is affected  b y th e concerted  action 
of a set of p roteins encod ed  w ith in th e uniq ue sh ort 
(U S ) region of th e HCMV genome th at are ex p ressed  
along th e d ifferent stages of viral infection. U S 3  is th e 
first to b e synth esiz ed  and  p revents traffick ing of 
new ly synth esiz ed  MHC class I molecules b y 
entrap p ing th em in th e E R  [1 ]. N ex t, U S 2  and  U S 1 1  
come into p lay and  ind uce p roteolytic d egrad ation of 
MHC class I molecules. Immed iately after th eir 
synth esis and  translocation into th e E R , class I h eavy 
ch ains are transp orted  b ack  into th e cytosol w h ere 
th ey are d ep rived  of th eir N -link ed  glycan and  
sub seq uently d egrad ed  b y p roteasomes [2 , 3 ]. A t 
early and  late times p ost infection, U S 6  p revents 
p ep tid e load ing of MHC class I molecules b y b lock ing 
th e T ransp orter associated  w ith  A ntigen P rocessing 
(T A P ) [4 , 5 ]. R ecently, anoth er U S -encod ed  gene, 
U S 1 0 , h as b een rep orted  to d elay maturation of MHC 
class I molecules [6 ].  
B y d ow nregulating surface ex p ression of MHC class I 
molecules, HCMV infected  cells may b ecome a target 
for N K  cells [7 ]. S everal mech anisms h ave b een 
d escrib ed  b y w h ich  HCMV can sid etrack  N K  cells, 
includ ing b lock ing ex p ression of ligand s th at activate 
N K  cells or allow ing ex p ression of ligand s for 
inh ib itory N K  cell recep tors. T h e uniq ue long (U L ) 
region encod ed  U L 1 6  p rotein, ex p ressed  at an early 
stage of infection, can interfere w ith  MICB / U L B P 1 ,2  -
sp ecific triggering of N K  cell recep tors [8 ]. A t th e same 
time, U L 4 0  can p romote surface ex p ression of HL A -E  
b y p rovid ing it w ith  T A P -ind ep end ent p ep tid es, 
th ereb y sup p lying a ligand  for certain inh ib itory N K  cell 
recep tors [9 ]. A t a late stage of infection, HCMV 
encod es a viral MHC class I h omologue, U L 1 8 , w h ich  
migh t serve as d ecoy for MHC class I at th e cell 
surface [1 0 ]. T h e op tions to p reserve inh ib itory signals 
to N K  cells could  b e furth er ex p loited  b y allow ing 
migration to th e cell surface for only a selected  sub set 
of MHC class I molecules. B y p reventing surface 
ex p ression of th e very p otent antigen p resenting HL A -
A  and  -B  locus p rod ucts and  allow ing ex p ression of 
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mostly nonclassical locus products that exhibit limited 
polymorphism, HCMV could escape killing by both 
CD8+ T cells and NK cells. Studies on US2 and US11 
indicated that HCMV uses such discriminating 
mechanisms. F rom experiments with murine class I 
molecules, it is known that US2 and US11 each affect 
different subsets of MHC class I molecules [11]. More 
recent studies, including pulse chase and in vitro co-
translation experiments, suggested that these viral 
gene products mainly affect HLA-A and -B allelic 
products, while HLA-C, -G  and – E are able to escape 
degradation [12, 13, 14].  
In the current study, we investigated how US11 
distinguishes between different MHC class I locus 
products. At present, the domains of the class I heavy 
chains that are important for binding to US11, or that 
determine their sensitivity to US11-mediated 
dislocation and degradation have not been 
characterized. So far, it is clear that the cytoplasmic 
region of class I molecules is essential for US11-
mediated degradation, although it does not seem to 
be essential for association with the viral protein [15].  
O ur approach to unravel the mechanism by which 
US11 distinguishes between different MHC class I 
alleles involved the use of chimeric HLA-A2/G  
molecules. HLA-A2, a classical MHC class I molecule, 
is known to bind to US11 and to be subjected to 
US11-mediated degradation [15]. F or the nonclassical 
HLA-G , association with the viral protein has never 
been observed. Moreover, US11 has no effect on its 
half-life [12]. HLA-G  molecules, which exhibit low 
polymorphism, are mainly found on trophoblast cells 
in placental tissues and could be involved in 
protecting these cells from maternal NK cell killing 
during pregnancy [16]. Although HLA-G  molecules 
share many important features with other MHC class I 
molecules, it is important to note that the cytosolic tail 
consists of only 6 residues instead of 29-33 residues 
due to a premature stop codon in exon 6 [17]. By 
expressing the chimeric HLA-A2/G  molecules in 
murine cells, we could specifically follow the fate of 
individual human class I molecules. W e then evalua-
ted the influence of US11 on their half-life and surface 
expression by pulse chase and flow cytometry. 
MATERIALS AND METHODS 
C e ll line s   
J 26 cells (H-2k murine Ltk- cells expressing human 
2m) [23] and the Phoenix amphotropic retroviral 
producer cell line (generous gift H. Spits) were 
cultured in Dulbecco’s Modified Eagle Medium (Life 
Technologies Inc.), supplemented with 10%  F CS 
(G reiner), penicillin and streptomycin.  
A ntib od ie s  
The following anti-MHC class I monoclonal antibodies 
(mAbs) were used for flow cytometry: 87G  (directed 
against 1-domain of HLA-G , kind gift of Dr. D 
G eragthy), W 6/32 (anti-human MHC I complex) [24], 
BB7.2 or MA2.1 (directed against 1-domain of HLA-
A2) [25], B9.12.1 (anti-HLA-A, B, C, G ) [26], R-Phyco-
erythrin-conjugated goat anti-mouse IgG  ((g m– PE), 
J ackson, F rance) was used as second antibody. F or 
immunoprecipitations HCA2 (against 1-domain of 
HLA-A and – E, -G ), W 6/32, US11(N2) (against the N-
terminus of US11), and H68.4 (anti-transferrin 
receptor, (Z Y MED)) Abs were used [24]. HCA2 was 
also used in western blot in combination with 
horseradish peroxidase-conjugated goat anti-mouse 
immunoglobulins (DAKO ). 
C ons tru c tion of p la s m id s  
An overview of the amino acid sequence of HLA-A2 
and – G  and of the different wild type and chimeric 
MHC class I constructs is depicted in F ig. 1. All MHC 
class I cDNA fragments were derived from either 
pcDNA-G 1 (encoding HLA-G *01011) or pLUMC9901 
(encoding HLA-A*0201) and were subcloned into the 
pcDNA3 vector (Invitrogen) [27, 24]. Chimeras CM# 1, 
CM# 2, CM# 3 and CM# 4 were constructed in a PCR 
applying the megaprimer method [28]. Amplifications 
were performed using P w o polymerase (Eurogentec, 
Belgium. The HLA-A2short construct encodes an 
HLA-A2 heavy chain with a tail (-RRKSSD) as short 
as that of HLA-G  (-RKKSSD).  Mutations in the 
cytoplasmic tail of CM# 1 were introduced with the 
Q uickChangeTM Site Directed Mutagenesis Kit 
(Stratagene). CM# 1 mutants are depicted in F igure 
3D. All constructs were fully sequenced to verify the 
absence of unwanted mutations. 
T ra ns fe c tion  
J 26 cells have been transfected with the different 
chimeric MHC class I constructs using EffecteneTM
Transfection Reagent (Q iagen). 48 h later, stable 
transfectants were selected by using 0.3 mg/ml G 418 
(G eneticin; G ibcoBRL). After a few days, cells were
sorted by flow cytometry for expression of the 
introduced cDNA with BB7.2, B9.12.1 or 87G  mAb.
P rod u c tion of re troviru s  a nd  tra ns d u c tion. 
A retroviral vector expressing both US11 and EG F P 
was constructed by ligating a US11-encoding 
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FIGURE 1. A) Schematic representation of the different domains of H L A -A 2 and H L A -G  that hav e b een ex changed to generate the C himeric 
M olecu les (C M ), c= connecting peptide, tm= transmemb rane domain. B ) A lignment of general H L A  consensu s seq u ence w ith H L A -A * 0 20 11 and 
H L A -G * 0 10 11 (w w w .eb i.ac.u k /imgt/hla/allele.html). 
fragment into the pL Z R S-IRES-E G F P  v ector [29 ]. T his 
constru ct w as u sed, together w ith the w ild ty pe E G F P  
ex pressing retrov iral v ector, to produ ce retrov iru s b y  
transfection of the amphotropic P hoenix  pack aging 
cell line w ith the calciu m phosphate method. T rans-
fected cells w ere grow n u nder pu romy cin selection (2 
g/ml). 24  h b efore harv esting the retrov iral su per-
natant, cells w ere grow n in pu romy cin-free mediu m.
C ells w ere transdu ced w ith retrov iru s u sing retronectin 
(T ak ara, J apan) coated dishes.  
V a c c in ia  v iru s  in fe c tio n s  
J 26  cells w ere infected w ith w ild ty pe or U S11-
ex pressing recomb inant v accinia v iru ses (rV V ) 
(generou s gift of D r. J .Y ew dell) at a mu ltiplicity  of 
infection of 10  P F U /cell for 4 5 -6 0  min in a small 
v olu me of seru m free cu ltu re mediu m at 3 7 C  [3 0 ]. 
M etab olic lab eling of infected cells w as performed 
approx imately  4 1/2 h after infection.  
F lo w  c y to m e try  
J 26  cells w ere sorted for ex pression of hu man M H C  
class I w ith the appropriate primary  antib odies and 
g m-P E , u sing a C ou lter E P IC S-E lite (C ou ltronics) 
flow  cy tometer. A fter cell sorting 9 5 -9 8 %  of the cells 
w ere positiv e for hu man M H C  class I ex pression. A  
F A C Scan (B ecton-D ick inson) flow  cy tometer w as 
u sed to analy z e su rface ex pression of w ild ty pe/ 
chimeric H L A  molecu les as w ell as E G F P  ex pression 
in cells transdu ced w ith retrov iru s. C ells w ere stained 
as decrib ed in K ik k ert et al [24 ]. D ata w ere analy z ed 
w ith the C ell Q u est softw are pack age (B ecton-
D ick inson).  
P rior to u se of retrov iral transdu ced cells in pu lse 
chase ex periments, cells w ere sorted for E G F P  
ex pression u sing a F A C S V antage flow  cy tometer. 
M e ta b o lic  la b e lin g , im m u n o p re c ip ita tio n  a n d  SD S-
P A G E
M etab olic lab eling, immu noprecipitations and SD S-
P A G E  w ere performed as describ ed b y  K ik k ert et al. 
[24 ]. In b rief, cells w ere starv ed in M et-C y s- mediu m at 
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37 C, labeled with 35S promix (Amersham), and 
chased in medium with excess amounts of L-cystine 
and L-methionine. Where indicated media were 
supplemented with 20mM proteasome inhibitor ZL3H.
Cells were lysed in NP40 lysis buffer containing 
leupeptin, AEBSF and ZL3H. Immunoprecipitations 
were performed  2 h on precleared samples, with 
Abs coupled to protein A/G sepharose beads. After 
washing with NET buffer, samples were taken up in 
SDS sample buffer, boiled for 5 min and run on SDS-
PAGE (10-15% gel). Gels were dried, exposed to a 
phosphor imaging screen, and analyzed by the Biorad 
Personal Molecular Imager FX  . 
Western blot 
Samples were separated by SDS-PAGE (12.5% gel) 
and transferred onto PolyScreen PVDF membrane 
(NEN) using the BioRad Trans-blot semi-dry system. 
The membrane was blocked with 0.6 % BSA in TBST 
buffer (10 mM Tris pH 8, 150 mM NaCl, 0.05 % 
Tween-20). After incubation with HCA2 and g m-
HRP, bands were visualized using Western Lightning 
chemiluminescent substrate (Perkin Elmer) and Fuji 
Super RX  film. 
RESULTS
HLA-G  becomes sensitive to US11-mediated 
degradation when its cytoplasmic tail is ex tended.
To identify the regions of MHC class I heavy chains 
that are responsible for US11-mediated down-
regulation, we constructed chimeric HLA molecules 
that contain domains of HLA-A*02011 (HLA-A2) and 
HLA-G*01011 (HLA-G), Fig. 1A. An overview of the 
amino acid sequences of HLA-A2 and –G and the 
domains that have been exchanged to generate the 
different chimeric constructs is depicted in Figure 1B. 
HLA-A2 is known to bind to US11 and to be subjected 
to US11-mediated degradation [15], whereas for HLA-
G molecules neither association nor degradation has 
been observed [12]. To avoid cross-reaction of 
antibodies with endogenous class I molecules, 
experiments were performed in murine J26 cells. This 
cell line expresses human 2m to allow proper 
complex formation with the introduced HLA class I 
heavy chains [18]. After transfection with the different 
chimeras, J26 cells were transduced with US11/ 
EGFP- or control EGFP-expressing retrovirus.  
To assess whether US11 similarly affects stability of 
HLA-A2 and HLA-G molecules in murine cells as in 
human cells, the transduced cells were metabolically 
labeled (Fig 2). In agreement with previous reports, 
HLA-G molecules remained stable over time in the 
presence of US11, while HLA-A2 molecules were 
degraded [12, 15]. The HLA-A2 signal disappeared 
over time in the absence of proteasome inhibitor, 
while in the presence of the inhibitor a deglycosylated 
degradation intermediate could be observed.  
Next, the effect of US11 on surface expression of 
chimeric HLA-A2/G molecules was analyzed. HLA-G 
has a short cytoplasmic tail, compared to other MHC 
class I molecules. To analyze the effect of the tail size 
on US11-mediated modulation of surface expression, 
we extended the HLA-G construct with cytoplasmic 
tail residues of HLA-A2 (chimeric molecule (CM) #1). 
In addition, we constructed an HLA-A2 molecule with 
a cytoplasmic tail as short as that of HLA-G (HLA-
A2short).
The different human MHC class I expressing cells 
were transduced with US11/EGFP- or control EGFP-
expressing retrovirus. Since EGFP alone had no 
effect on MHC class I cell surface expression (data 
not shown), the EGFP negative population was used 
as reference for class I expression. The influence of 
F IG URE 2 . HLA-A2  is efficiently degraded in US11-ex pressing murine J 2 6  cells, while HLA-G  remains stable. J26 cells transfected with
HLA-A2 (J26-A2) or HLA-G (J26-G) were transduced with control EGFP- or US11/EGFP expressing retrovirus. Cells were labeled (18 min) and
chased (0 or 50 min), in the absence (-) or presence (+) of proteasome inhibitor (ZL3H). HLA molecules were precipitated with HCA2 mAb. (-
CHO=  deglycosylated breakdown intermediate)
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FIGURE 3. Effect of US11 on cell surface expression of wt type and chimeric MHC class I molecules. J26 cells were transfected with 
different HLA constructs and subsequently transduced with US11/EGFP expressing retrovirus. MHC class I molecules were labeled using W6/32, 
87G (chimeras with 1 domain of HLA-G) or MA2.1 (chimeras with 1 domain of HLA-A2) mAbs followed by g m-PE (Y-axis). US11 expression 
was measured indirectly by analyzing EGFP expression (X-axis). The effect of US11 expression on surface staining of HLA molecules is 
calculated as: mean PE fluorescence of US11 positive (EGFP+) cells divided by mean PE fluorescence of US11 negative (EGFP-) cells, times 
100%. Contribution of: A) cytoplasmic tail B ) sequence variation in the cytoplasmic tail C) ER-luminal domains and transmembrane region to 
susceptibility to US11-mediated downregulation of surface expression. D) Overview of chimeras and CM#1 tail mutants showing average 
percentage (~ 3 exp.) of their surface expression in US11+ cells.  
US11 on cell surface expression of the chimeras was 
examined using flow cytometry, EGFP served as a 
marker for US11 expression (Fig. 3A).  
The tailless constructs were hardly affected by the 
presence of US11: compared to the wild type 
situation, an average of 81% of HLA-A2short and 96% 
of HLA-G molecules were still able to reach the cell 
surface. In contrast, both full length constructs were 
downregulated by US11: only 18% of wild type HLA-
A2 and 21% of CM#1 were expressed at the cell 
surface (Fig. 3A and D). Thus, the absence of most of 
the cytoplasmic tail residues is the main reason why 
this nonclassical HLA-G escapes downmodulation by 
US11.
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Influence of cytoplasmic tail residues on down-
regulation of MHC class I molecules. 
In contrast to HLA-G, HLA-C alleles possess long 
cytoplasmic tails, but they are nevertheless 
considered insensitive to US11-mediated degradation 
[12]. For HIV an immune escape mechanism has 
been described which, like HCMV, appears to affect 
only a subset of HLA alleles. Nef internalizes HLA 
molecules with tyrosine at position 321 in the 
cytoplasmic tail (HLA-A, -B), but does not affect 
surface expression of class I molecules with C321 
(HLA-C) [19]. HLA-A2 molecules with mutated Y321A 
are not affected by Nef [20]. 
To analyze the influence of amino acid composition of 
class I cytoplasmic tails on US11-mediated down-
regulation, the following constructs were generated: 
CM#1 with a substitution of tyrosine 321 for alanine 
(CM#1-Y321A), or for cysteine (CM#1-Y321C); the 
Y321A mutation combined with a deletion of the last 
lysine and valine residues (CM#1-Y321A del KV) or 
the KV deletion alone (CM#1-del KV), (Fig. 3D).  
A substitution of tyrosine 321 did not alter the 
sensitivity of class I to US11-mediated down-
regulation, as CM#1, CM#1-Y321A and CM#1–Y321C 
were all similarly affected (Fig. 3B and D). However, 
CM#1-Y321A del KV was considerably less sensitive 
to US11, with an average reduction in cell surface 
expression to 62% for CM#1-Y321A del KV as 
apposed to 21% for CM#1. This effect can be 
ascribed to the KV deletion as CM#1-del KV shows a 
similar insensitivity to US11. Clearly, the extreme end 
of the cytoplasmic tail plays an important role in the 
downmodulation mediated by US11.  
1 and 2 domains of HLA molecules contribute 
to the sensitivity to US11-mediated down-
regulation. 
Besides the cytoplasmic tail region, the 1, 2, 3 or 
transmembrane regions of HLA molecules were 
exchanged (Fig. 3C and D). Since surface expression 
of HLA-A2 and CM#1 was affected by US11 similarly, 
major differences might not be expected for these 
chimeras. No clear role could be ascribed to the 
connecting peptide or transmembrane region of MHC 
class I in this experimental set up (compare CM#1 &  
2, CM#5 &  6 and CM#8 &  9), nor to the 3 domain 
(compare CM#6 &  7). However, exchanging 1 and 
2 ER-luminal domains did alter the sensitivity to 
US11: less than 10% of CM#5, CM#6 or CM#7 
reached the cell surface in the presence of US11 
whereas around 21-34% of the other full length HLA 
molecules was able to escape US11-mediated 
downregulation. Chimeras CM#5-7 carry the HLA-A2 
1 domain and at least the HLA-G 2 domain. 
Strikingly, the tailless construct CM#3, containing the 
same 1(A2)/ 2(G)-combination, was down-
regulated by the action of US11, while HLA-A2short 
and HLA-G were not or only slightly affected (an 
average of 30% for CM#3, compared to 81% and 96% 
surface expression for HLA-A2short and HLA-G, 
respectively). By comparing flow cytometry data of 
CM#6 and CM#7 (both similarly affected with only 9% 
and 8% surface expression, respectively), we showed 
that it is the 2 domain of HLA-G that contributes to 
this increase in sensitivity. This is further supported by 
comparing data of CM#5 (10%) with CM#8 (26%) and 
CM#6 (9%) with CM#9 (34%) which only differ in their 
2 domains. Altogether, these data indicate that both 
1 and 2 domains of MHC class I molecules are 
involved in US11-mediated downregulation.  
Decrease in cell surface expression of chimeric 
HLA-G molecules with an extended cytoplasmic 
tail is due to US11-induced degradation. 
Since flow cytometry data only reflect the effect of 
US11 on cell surface expression of MHC class I 
molecules, we also evaluated its effect on their 
stability using pulse chase experiments.  
Recombinant vaccinia virus (rVV) was used to
introduce US11 into the cells. In parallel, a similar 
amount of cells were infected with wild type vaccinia 
virus. This way, a single cell line with a defined 
expression level of (chimeric) MHC class I molecules 
can be used to evaluate the effect of US11 
expression. US11-rVV infects the cells with high 
efficiency and expresses high amounts of US11 
protein after a few hours of infection [21]. Pulse chase
experiments performed with rVV infected cells are 
depicted in Figure 4. 
Class I heavy chains and murine transferrin receptor 
(mTfR) were immunoprecipitated from cell lysates, 
separated by SDS-PAGE and visualized using 
phosphor-imaging (Fig. 4A). Precipitated proteins 
were quantified and the amounts of MHC class I 
heavy chain (relative to the mTfR) are presented as a 
percentage of the wild type situation at time point zero 
(Fig. 4B). US11 expression is shown in figure 4C. 
Figure 4 shows that the reduction of cell surface 
expression measured by flow cytometry correlates 
with degradation of MHC class I molecules in US11 
positive cells. US11-mediated degradation was 
observed for HLA-G when its cytoplasmic tail was 
extended with HLA-A2 tail residues (CM#1), whereas 
a deletion of extreme tail end KV residues caused a 
severe decrease in degradation efficiency (compare 
CM#1 &  CM#1-Y321A del KV). Exchange of the HLA-
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FIGURE 4. HLA-G chimeras with an extended cytoplasmic tail are susceptible to US11-mediated degradation. J26 cells transfected with 
HLA-A2, CM#1, CM#1 Y321A del KV (CM#1*) or CM#2 were infected with wt or US11-expressing vaccinia virus. Cells were labeled (8 min.), 4½  
hours after infection, and chased for 0 or 17 min. A) Transferrin receptor (TfR) and HLA molecules were immunoprecipitated from cell lysates 
with anti-TfR (H68.4) and anti-heavy chain (HCA2) mAbs, respectively, separated by SDS-PAGE and visualized using a phosphor-image screen. 
B) Amount of precipitated HLA protein (relative to the TfR and t=0 wt VV infected sample), given as percentage. C) After immunoprecipitation of 
HLA/TfR molecules, US11 was immunoprecipitated using anti-US11(N2) Ab. 
A2 connecting peptide/transmembrane region did not 
alter class I heavy chain stability (compare CM#1 & 
CM#2).
In addition, these data provide information on 
elimination rates of HLA molecules. Whereas similar 
amounts of HLA-A2, CM#1 and CM#2 heavy chain 
were eliminated within 17 min of chase, there was a 
difference in the time course over which these 
molecules were cleared: immediately after the pulse 
(chase t=0), almost three quarters of HLA-A2 heavy 
chains was eliminated, versus half of the CM#1 & 
CM#2 material. These findings suggest that chimeras 
containing ER-luminal domains derived from HLA-G 
are somewhat less susceptible to US11-mediated 
degradation than HLA-A2 molecules. Ultimately, 
similar amounts of HLA-A2 and HLA-G molecules with 
tails as long as that of wild type HLA-A2 are degraded 
and thereby withheld from the cell surface.  
US11 causes intracellular retention of a tailless 
HLA-G chimeric molecule with the 1 domain of 
HLA-A2.
Tailless HLA-A2short and HLA-G molecules are 
relatively insensitive to US11-mediated down-
regulation (Fig. 3D). Surprisingly, the tailless HLA-G 
chimera, in which the 1 domain of HLA-G has been 
replaced with that of HLA-A2 (CM#3), proved to be 
much more sensitive to US11 (Fig. 3D). How can this 
be explained?  Is the 1 (A2) / 2 (G) combination 
advantageous for a strong association with US11 (or 
other component(s) involved in the process of US11-
mediated dislocation) and causing intracellular 
retention, or is this chimera (CM#3) being dislocated 
and degraded even though it lacks a long cytoplasmic 
tail?   
To address these questions, pulse chase analysis 
was performed with J26-CM#3 cells (Fig. 5). The 
stability of CM#3 heavy chains was hardly affected by 
US11 (Fig. 5A & B). In US11-expressing cells, some 
decrease in the amount of CM#3 heavy chains could 
be observed at 90 min of chase, but this seems to be 
US11-independent since a similar decrease is 
observed in control cells. Furthermore, CM#3 seemed 
incapable of forming normal (W6/32-reactive) 
complexes with 2m when US11 was present (Fig. 
5C). In agreement with flow cytometry data, HLA-G 
and HLA-A2short heavy chains were capable of 
forming stable complexes with 2m in the presence of 
US11 (data not shown).  
Fig. 5D shows that anti-US11 antibody, besides 
US11, also immunoprecipitated a protein with a 
mobility in SDS-PAGE similar to that of CM#3. The 
protein was identified as CM#3 by blotting the same 
anti-US11 immunoprecipitate onto PVDF-membrane,
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FIGURE 5. The tailless chimera of HLA-G with the 1 domain of HLA-A2 (CM# 3) associates with US11 and is retained intracellularly. 
J26 cells transfected with HLA-CM#3 were infected with wt or US11- expressing vaccinia virus. Cells were labeled (15 min), 4 ½ hours after 
infection and chased for 0, 45 or 90 min. Cell lysates were split in three. A) Immunoprecipitation of class I heavy chains (HCA2) and transferrin 
receptor (H68.4) B) quantified amounts of HLA (relative to TfR and t=0 wt VV infected sample). Immunoprecipitation C) of MHC I complexes 
(W6/32) or D) of US11 (anti-US11(N2)). E) Half of the anti-US11(N2) sample was run on a separate gel for a Western blot and stained with 
HCA2 and g m-HRP Abs. 
followed by staining with anti-human heavy chain 
antibody (Fig. 5E).  
Altogether, these data show that downregulation 
of CM#3 at the cell surface is not caused by 
protein degradation, but instead results from 
intracellular retention, presumably due to its 
interaction with US11.
DISCUSSION 
In this study, we explored which domains of MHC 
class I heavy chains are responsible for association 
with the HCMV-encoded US11 protein, and 
subsequent dislocation and degradation. Using a set 
of chimeric HLA molecules of US11-sensitive and 
US11-insensitive class I molecules (HLA-A2 and HLA-
G, respectively), we found that a long cytoplasmic tail 
was required for efficient US11-induced degradation 
of both classical HLA-A2 as well as nonclassical HLA-
G heavy chains. In addition, we demonstrated that the 
lysine and valine residues at the extreme end of the 
cytoplasmic tail, together with the amino acid 
composition of both 1 and 2 ER-luminal domains 
play an important role in US11-mediated MHC class I 
downregulation. 
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US11 exclusively degrades HLA-A2 molecules with 
long cytoplasmic tails [19]. Using an HLA-G/A2 
chimera with a long cytoplasmic tail (CM#1), we 
demonstrated that HLA-G is insensitive to US11-
induced degradation solely because it lacks essential 
cytoplasmic tail residues. We then tested whether 
alterations in the amino acid composition of the tail 
influenced the efficiency of downmodulation. We 
found that a substitution of tyrosine residue 321, a 
critical residue for selective HIV Nef-mediated 
internalization of MHC class I molecules, had no 
influence. Interestingly, a deletion of only two residues 
(lysine and valine) at the extreme end of the 
cytoplasmic tail made class I molecules a lot less 
susceptible to US11-mediated downregulation. We 
are currently investigating the exact role of these 
residues with respect to selectivity of the US11-
mediated dislocation and degradation process.  
Our data also indicate that the amino-acid 
composition of both 1 and 2  lu m inal do m ains  
influ e nc e s  U S 11-m e diate d M H C  c las s  I do w n-
re g u latio n. P u ls e -c h as e  e x p e rim e nts  w ith  w ild ty p e  
H L A -A 2  and c h im e ric  H L A -G /A 2  m o le c u le s  w ith  lo ng  
c y to p las m ic  tails  s h o w e d th at E R -lu m inal do m ains  
de te rm ine  th e  e ffic ie nc y  o f th e  de g radatio n p ro c e s s : 
w ild ty p e  H L A -A 2  m o le c u le s  w e re  de g rade d fas te r 
th an th e  c h im e ric  H L A  m o le c u le s  in w h ic h  E R -lu m inal 
do m ains  c o ns is te d o f H L A -G  re s idu e s  (C M # 1, C M # 2 ). 
N o te  th at alth o u g h  U S 11 ne e de d m o re  tim e  to  indu c e  
de g radatio n o f th e s e  c h im e ras , e v e ntu ally  s im ilar 
am o u nts  o f w ild ty p e  H L A -A 2 , C M # 1 and C M # 2  w e re  
e lim inate d and th e re fo re  w ith h e ld fro m  th e  c e ll 
s u rfac e .  
O u r flo w  c y to m e try  e x p e rim e nts  s h o w e d th at th e  1
and 2  E R -lu m inal do m ains  p re do m inantly  de te rm ine  
do w nre g u latio n, rath e r th an th e  3  do m ain. T h e  
c o m b inatio n o f th e  H L A -A 2  1 do m ain w ith  at le as t 
th e 2  do m ain o f H L A -G  in diffe re nt lo ng  taile d 
c h im e ras  re s u lte d in an e v e n m o re  e ffic ie nt 
do w nre g u latio n th an th at o f w ild ty p e  H L A -A 2  c e ll 
s u rfac e  e x p re s s io n. U ne x p e c te dly , th is  s am e  
c o m b inatio n e v e n le d to  a m ajo r do w nre g u latio n o f a 
taille s s  c h im e ra (C M # 3 ), w h e re as  s u rfac e  e x p re s s io n 
o f H L A -G  and H L A -A 2 s h o rt w e re  no t o r o nly  s lig h tly  
affe c te d. P u ls e  c h as e  e x p e rim e nts  indic ate d th at 
U S 11 is  inc ap ab le  o f m e diating  de g radatio n o f th is  
taille s s  c h im e ra, p re s u m ab ly  b e c au s e  it lac k s  
e s s e ntial c y to p las m ic  tail re s idu e s . T h e  o b s e rv e d 
re du c tio n in s u rfac e  e x p re s s io n is  m o re  lik e ly  du e  to  
intrac e llu lar re te ntio n b y  U S 11. In ag re e m e nt w ith  th is  
h y p o th e s is , c o m p le x e s  o f U S 11 and c las s  I h e av y  
c h ains  c o u ld b e  de te c te d. In additio n, fo rm atio n o f 
W 6 /3 2  re ac tiv e  m o le c u le s  w as  s tro ng ly  re du c e d in th e  
p re s e nc e  o f U S 11. U S 11 m ay  th e re fo re  inte rfe re  w ith  
th e  fo lding  o f c las s  I h e av y  c h ains  and/o r th e ir 
as s o c iatio n w ith  2 m , alth o u g h  it c anno t b e  e x c lu de d 
th at U S 11 b inding  b lo c k s  th e  W 6 /3 2  e p ito p e .  
B as e d o n o u r data, w e  p ro p o s e  th e  fo llo w ing  m o de l: 
U S 11 c o u ld firs t as s o c iate  w ith  ne w ly  s y nth e s iz e d 
M H C  c las s  I h e av y  c h ains  v ia th e ir 1/ 2  do m ains . 
T h e  affinity  o r as s o c iatio n/dis s o c iatio n rate s  m ig h t 
de p e nd o n th e  am ino  ac id c o m p o s itio n o f th e s e  
lu m inal do m ains  w h ile  th e  am ino -ac id c o m p o s itio n o f 
th e  c y to p las m ic  tail w o u ld b e  c ritic al fo r e ffic ie nt 
dis lo c atio n to  th e  c y to s o l and s u b s e q u e nt de g radatio n 
b y  th e  p ro te as o m e . A c c o rding  to  th is  m o de l, th e  
u ne x p e c te d do w nre g u latio n o f th e  taille s s  c h im e ric  
H L A -G  m o le c u le  in w h ic h  th e  1 do m ain h as  b e e n 
re p lac e d w ith  th at o f H L A -A 2  (C M # 3 ) c o u ld b e  
e x p laine d b y  a h ig h  affinity  inte rac tio n, b u t s lo w  
dis s o c iatio n rate  b e tw e e n U S 11 and C M # 3 . T h e  
inte rac tio n b e tw e e n U S 11 and H L A -G  c o u ld b e  s o  
b rie f th at it do e s  no t affe c t c e ll s u rfac e  e x p re s s io n. 
T h e  as s o c iatio n w ith  H L A -A 2 s h o rt c o u ld b e  s o m e w h at 
lo ng e r as  U S 11 do e s  h av e  a s lig h t e ffe c t o n s u rfac e  
e x p re s s io n o f th is  taille s s  m o le c u le  (re du c tio n to  8 1%  
c e ll s u rfac e  e x p re s s io n). T h e  inte rac tio n w ith  H L A -G  
and H L A -A 2  is  ne v e rth e le s s  lo ng  e no u g h  to  indu c e  
th e ir dis lo c atio n and de g radatio n if th e y  p o s s e s s  th e  
e s s e ntial tail re s idu e s . T h e  am ino  ac id c o m p o s itio n o f 
th e  c y to p las m ic  tail th e n de te rm ine s  th e  e ffic ie nc y  w ith  
w h ic h  th is  dis lo c atio n/de g radatio n p ro c e s s  tak e s  
p lac e .  
O u r data s e e m  to  b e  in c o ntras t w ith  a p re v io u s  re p o rt 
[12 ]. B as e d o n in vitro e x p e rim e nts  in w h ic h  diffe re nt 
M H C  c las s  I h e av y  c h ains  (H L A -A 2 , -C , -G ) w e re  c o -
trans late d w ith  e ith e r U S 2  o r U S 11, S c h u s t e t al. 
s u g g e s te d th at th e s e  v iral p ro te ins  c o u ld o nly  
as s o c iate  w ith  H L A -A 2  and th at th e  s tab ility  o f H L A -C  
and H L A -G  w as  du e  to  a lac k  o f as s o c iatio n. It is  
p o s s ib le  th at an inte rac tio n o f H L A -G  w ith  U S 11 c o u ld 
no t b e  de te c te d in th e s e  e x p e rim e nts  as  th e  
inte rac tio n m ig h t b e  v e ry  trans ie nt and diffic u lt to  
de te c t u nde r th e  c o nditio ns  u s e d. H o w e v e r, w e  do  
b e lie v e  th at th is  inte rac tio n tak e s  p lac e  as  taille s s  
c las s  I m o le c u le s  c an as s o c iate  w ith  U S 11 and th e  
C M # 1 m o le c u le  (H L A -G  w ith  an e x te nde d c y to p las m ic  
tail) c an b e  de g rade d. 
L ik e  U S 11, U S 2  is  c ap ab le  o f indu c ing  de g radatio n o f 
M H C  c las s  I m o le c u le s . O u r data indic ate  th at th e s e  
tw o  v iral p ro te ins  inte rac t w ith  dis tinc t E R -lu m inal 
do m ains  o f c las s  I h e av y  c h ains . W e  s h o w e d th at 
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binding to US11 involves the 1/ 2 domains of class 
I molecules. Experiments performed with US2 and this 
same set of chimeras did not reveal involvement of 
the combination 1/ 2, but pointed towards a 
combination of 2/ 3, as both wt HLA-A2 and CM#5  
were downregulated around 5  fold more efficiently 
than CM#7  (unpublished results). These data are in 
agreement with the previously published crystal 
structure of a soluble HLA-A2/US2 complex, which 
demonstrated association of US2 with ER-luminal 
2/ 3 domains [22]. Association of US2 and US11 
with distinct domains of class I molecules may 
contribute to a broader defense of HCMV , as US2 and 
US11 together could attack a wider variety of MHC I 
molecules.  
Altogether, our data provide new insights in the 
mechanism by which US11 downregulates MHC class 
I molecules. It will help unraveling the criteria for 
selective modulation of different MHC class I subsets 
involved in NK  and T cell recognition. 
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HCMV-encoded US2 differentially affects surface expression of MHC class I locus 
products and targ ets m em b rane b ound, b ut not solub le HL A -G 1  for deg radation
Martine T. Barel,* Maaike Ressing,* Nathalie Pizzato,† Daphne van Leeuwen,* Philippe Le Bouteiller,† 
F ranc oise Lenfant,† E m m anuel J .H .J  W iertz* 
*Department of Medical Microbiology, Leiden University Medical Center, P.O. box 9600, 2300 RC Leiden, The 
N etherlands. † Inserm U5 63, CPTP, H ô pital Pu rpan, 31 05 9 Tou lou se cedex 3, F rance. 
Hum an cytom eg alov irus (HCMV) can elude cytotoxic T  lym ph ocytes as w ell as N K  cells b y m odulating  
surface expression of MHC class I m olecules. T h is strateg y w ould b e m ost efficient if th e v irus w ould 
selectiv ely dow n-reg ulate v iral antig en- presenting  alleles, w h ile at th e sam e tim e preserv ing  oth er 
alleles to act as inh ib itors of N K  cell activ ation. W e focussed on HCMV-encoded US2, w h ich  b inds to 
new ly synth esiz ed MHC class I h eav y ch ains and supports th eir dislocation to th e cytosol for 
sub seq uent deg radation b y proteasom es. W e studied th e effect of US2 on surface expression of 
indiv idual class I locus products using  flow  cytom etry. O ur results w ere com b ined w ith  crystal structure 
data of com plexed US2/HL A -A 2/ 2m and alignments of 948 HLA class I database sequences of the ER 
lumenal region inp licated in U S 2 binding. T his study  suggests that surface ex p ression of all HLA-A, -G  
and most -B  alleles w ill be affected by  U S 2. S ev eral HLA-B  alleles and all HLA-C  and -E alleles are lik ely  
to be insensitiv e to U S 2-mediated degradation. W e also found that the M HC  class I ER-lumenal domain 
alone is not sufficient for  degradation by  U S 2, as illustrated by  the stability  of soluble HLA-G 1  in the 
p resence of U S 2. F ur thermore, w e show ed that the membrane bound HLA-G 1  isoform, but also tailless 
HLA-A2, are targeted for  degradation. T his indicates that the cy top lasmic tail of the M HC  class I heav y  
chain is not required for  its dislocation to the cy tosol by  U S 2. 
A large proportion of the world population is carrier of 
hum an cy tom egalov irus (H C M V ), which usually  giv es 
rise to asy m ptom atic b ut lifelong infections. In 
im m uno-com prom ised indiv iduals, howev er, H C M V  
contrib utes to high m orb idity  and m ortality  rates. 
B esides this, H C M V  is a notorious risk  factor for 
congenital disorders if the m other undergoes prim ary  
infection during pregnancy  1.
T he host im m une sy stem  is eluded b y  H C M V  through 
a v ariety  of defense m echanism s that it acq uired while 
co-ev olv ing with its host. S urface ex pression of 
antigen presenting M H C  class I m olecules, which play  
a central role in detection and elim ination of infected 
cells, is affected b y  the concerted action of a set of 
H C M V  uniq ue short (U S ) region- encoded proteins 
(U S 2 , U S 3 , U S 6 , U S 11) ex pressed along different 
stages of v iral infection 2 -6 . L ik e U S 11, U S 2  induces 
proteoly tic degradation of M H C  class I m olecules: 
im m ediately  after their sy nthesis and translocation into 
the E R  lum en, M H C  class I heav y  chains are 
transported b ack  into the cy tosol where they  are 
depriv ed of their N -link ed gly can and sub seq uently  
degraded b y  proteasom es 2 ;6 ;7 . W hen dev oid of M H C  
class I surface ex pression, cells m ay  b ecom e a target 
for N K  cell ly sis 8. S ev eral m echanism s hav e b een 
describ ed b y  which H C M V  can sidetrack  N K  cells, 
either b y  b lock ing ex pression of ligands that activ ate 
N K  cells or allowing ex pression of ligands that inhib it 
N K  cell triggering. S ev eral proteins encoded within the 
U L  region of the H C M V  genom e (U L 16 , U L 18, U L 4 0 ) 
could protect from  N K  cell ly sis 9. In addition, inhib itory  
signals to N K  cells could b e preserv ed b y  allowing 
selectiv e surface ex pression of those M H C  class I that 
are less efficient in v iral antigen presentation 10 .
M ost host cells ex press H L A-A, -B , -C  and -E  alleles. 
H L A-A and – B  alleles are lik ely  m ost powerful in the 
presentation of v iral antigens, which is supported b y  a 
v ery  high degree of poly m orphism  in the world 
population for these alleles 11. T he contrib ution of 
H L A-C  to im m une control b y  cy totox ic T  cells is not 
entirely  clear. H L A-C  alleles are less poly m orphic and 
surface ex pression is generally  lower then that 
ob serv ed for H L A-A and -B  alleles, b ut H IV  peptides 
display ed in the contex t of H L A-C  hav e b een reported 
12 ;13 . H L A-E  is low poly m orphic, m ainly  presents 
peptides deriv ed from  signal seq uences of M H C  class 
I m olecules, and is ex pressed in low am ounts at the 
cell surface 10 . H L A-E  has also b een reported to 
present peptides to specific T  cell receptors on C D 8+  
T  cells or N K  C D 8+  cells 14 15 . H L A-E  and H L A-C  
could also serv e im portant functions as inhib itory  N K  
cell receptor ligands 16 ;17 .
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HLA-G is found primarily on extravillous cyto-
trophoblast cells at the fetal-maternal interface and on 
a subpopulation of thymic epithelial cells 18. These 
trophoblast cells express no HLA-A and -B alleles on 
their cell surface, only HLA-C, -E and -G. Different 
HLA-G isoforms have been described, of which only 
one, called HLA-G1, is expressed at the cell surface 
19. HLA-G1 has a unique feature: it has a relatively 
short cytoplasmic tail of 6 amino acids. Another 
isoform, soluble HLA-G1, has all domains required for 
stable complex formation with 2m and peptide and is 
secreted 20. Membrane bound and soluble HLA-G 
both present viral peptides to CD8+ T cells 21-23. The 
soluble isoform also induces apoptosis of activated 
CD8+ T cells and inhibits CD4+ T cell proliferation 24-
26. It is unknown to what extent this potential T cell 
function is exploited, because only few macrophages 
and T and B immune cells are found at the 
implantation site. The population of lymphoid cells at 
this site predominantly consists of NK cells 27. Like 
other HLA class I molecules, HLA-G could also be an 
important modulator of cytokine production by NK 
cells. Interactions with activating NK receptors and 
stimulation of cytokine secretion by uterine NK cells 
could play a role in the placentation process. HLA-G 
could also serve as ligand for inhibitory NK receptors 
to prevent trophoblast lysis 27.
F or efficient immune escape, HCMV should prevent 
the display of viral antigens by MHC class I molecules 
to cytotoxic T cells and at the same time preserve a 
substantial amount of ligands that can modulate NK 
cell activation. It would be beneficial to selectively 
down-regulate those MHC class I molecules that are 
most important for viral antigen presentation and keep 
other locus products as inhibitor of NK cell activation.  
In general, HLA-A and -B alleles are believed to be 
down-regulated by HCMV, but detailed information is 
scarce. P ulse chase experiments suggested that US2 
does not affect the stability of HLA-C, -G, and -E 
alleles 28;29.
In the present study, we evaluated the sensitivity of 
different MHC class I locus products to US2-mediated 
down-regulation using flow cytometry. F low cyto-
metrical analysis of MHC class I surface expression is 
most relevant with respect to T and NK cell 
interactions. Besides this, it can be a valuable 
complementation of pulse chase data as it could 
unravel or exclude other mechanisms than 
degradation that cause reduced surface expression.  
We introduced different HLA class I alleles into a 
murine cell line, which also expresses human 2m, 
and monitored the effect of US2 on surface 
expression of these molecules. To verify that our 
results were not species or cell type specific, we 
included experiments with human cell lines. We 
further investigated structural requirements for US2-
induced HLA class I heavy chain degradation, making 
use of membrane-bound HLA-G1, which lacks most 
cytoplasmic tail residues, and soluble HLA-G1, which 
consists of ER-lumenal domains only. O r data will also 
show that US2 and US11employ different strategies to 
target class I heavy chains for degradation. 
MATERIALS AND METHODS 
Cell lines  
J 26 cells (H-2k murine Ltk- cells expressing human 
2m) 30, the P hoenix amphotropic retroviral producer 
cell line and J EG-3 cells (both from the American 
Type Culture Collection, ATCC) were cultured in 
DMEM (Life Technologies Inc). J 26 cells expressing 
HLA-B7 (B*070201), B27 (B*270502) and Cw3 
(Cw*030401) were described previously 31;32. U373-
MG cells (ATCC) were cultured in RP MI 1640 medium 
(Life Technologies Inc.). All media were supplemented 
with 10%  F CS (Greiner), 100 U/ml penicillin and 100 
g/ml streptomycin and G418 (GibcoBRL).  
A ntib o d ies 
The following anti-MHC class I mAbs were used for 
flow cytometry: 87G (HLA-G) 23, W6/32 (general HLA 
class I) 33, MA2.1 (HLA-A2) 34, MEM-E/06 (HLA-E; 
EX BIO  P raha, Cz ech Republic), B1.23.2 (HLA-
C)35and Y -3 (murine MHC class I; ATCC). P E-
conjugated goat anti-mouse (g m), IgG (J ackson 
Immuno Research laboratories) was used as second 
Ab. The polyclonal antisera MR24 (directed against 
the 3 domain of HLA-A*0201 and generated in 
rabbits using synthetic tetanus toxoid conjugated 
peptide P KTHMTHHAVSDHEA) and US2-N2 
(directed against the N-terminus of US2 and 
generated in rabbits using synthetic tetanus toxoid 
conjugated peptide GITKAGEDALRP WKSTAK), as 
well as mAbs HCA2 (HLA-A, -G) 36, MEM-G/01 (HLA-
G; EX BIO  P raha, Cz ech Republic) and H68.4 
(transferrin receptor; Z ymed), were used for 
immunoprecipitations.  
Co nstru c tio n o f p la sm id s 
P lasmid pLUMC9901 (encoding HLA-A*0201) 37, was 
used as template for the construction of short-tailed 
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HLA-A2 constructs containing 4 or 6 amino acid tails 
(-RRKS or -RRKSSD respectively). A cDNA fragment 
obtained from an HLA-Cw4 typed individual was used 
for subcloning into pcDNA3.1/V5/His-TOPO to 
generate the plasmid pCw*0304 (generous gift of B. 
van den Eynde). The HLA-Cw4 fragment was fully 
sequenced to determine the HLA-Cw*0304 allelic 
subtype. Plasmid pCw*0304 and pLUMC9901 were 
used for the construction of HLA-Cw3/HLA-A2 
chimeras. For HLA-Cw3/tail A2, the HLA-Cw3 
cytoplasmic tail was replaced with the corresponding 
HLA-A2 tail region (aa 310-342). The reverse was 
done for the construction of HLA-A2/tail Cw3. These 
constructs were generated applying the megaprimer 
method 38 and were subcloned into pcDNA3 
(Invitrogen). Plasmid pcHLA-A/E was generated by 
replacing the leader sequence of the HLA-E*01033-
Gly107 gene derived from cosmid 3.14 39 with the 
leader sequence of HLA-A2 and subcloning this into 
pcDNA3. Plasmid pcDNA-G1 (encoding HLA-
G*01011) and soluble HLA-G1 cDNA have been 
described previously 40;41. Amplifications were 
performed using DNA polymerase Pwo (Eurogentec, 
Seraing, Belgium). All constructs were fully 
sequenced to verify the absence of unwanted 
mutations. 
T ransfection  
J26 and U373 cells were transfected with the different 
MHC class I constructs using EffecteneTM
Transfection Reagent (Q iagen). After 48 hours, stable 
transfectants were selected by adding 0.3 mg/ml 
G418 (GibcoBRL). Cells were sorted by flow 
cytometry for expression of the introduced cDNA as 
described 40.
Production of retrov irus and transduction 
A retroviral vector expressing both US2 and EGFP 
was constructed by ligating a US2-encoding cDNA 
fragment into the pLZRS-IR E S -EGFP vector 42. Wild 
type or US2-IR E S -EGFP constructs were transfected 
into the amphotropic Phoenix packaging cell line for 
the production of retrovirus, as described 40. Cells 
were transduced with retrovirus using retronectin 
(Takara, Japan) coated dishes.  
V accinia v irus infections 
Cells were infected with wild type or US2-expressing 
recombinant vaccinia virus (generous gift of Dr. 
J.Yewdell) at a multiplicity of infection of 10 PFU/cell 
for 45-60 min in a small volume (~ 1.5 ml) of serum 
free culture medium at 37 C 43. After infection, a mix 
of conditioned and fresh culture medium was added. 
Metabolic labeling of the infected cells was performed 
approximately 4½  h after infection.  
F low cy tometry  
Cell surface expression of MHC class I molecules as 
well as EGFP expression in cells transduced with 
retrovirus were analyzed using flow cytometry as 
described 40. J26-HLA-E and JEG-3 cells were stained 
in 3 steps to intensify the MHC class I staining: first 
with specific anti-MHC class I antibody, then with 
biotinylated-g m and finally with streptavidin-
conjugated PE. Absence of MEM-E/06 binding to wild 
type J26 cells in flow cytometry (data not shown) 
excluded any possible cross reactivity with murine 
MHC class I. Data are collected from at least two 
independent experiments of which one representative 
experiment is shown. Independent measurements for 
MHC class I (PE) staining in EGFP positive cells 
differed with an average of 5%. 
M etabolic labeling , immunoprecipitation and S D S -
PAG E
Metabolic labeling, immunoprecipitations and SDS-
PAGE were performed as described 37. In brief, cells 
were starved in Met-Cys- medium at 37 C, labeled 
with 35S promix (Amersham), and chased in medium 
with excess amounts of L-cystine and L-methionine. 
Where indicated, media were supplemented with 
proteasome inhibitor ZL3H. Cells were lysed in a small 
volume of Nonidet-P40 lysis buffer, containing 
protease inhibitors leupeptin, AEBSF and ZL3H, for 30 
min at 4 C After centrifugation to remove cell debris, 
supernatant was transferred to a new tube to which 
1/10 volume of 10% SDS and 1/10 volume of 0.1 M 
DTT was added. Samples were boiled for 5 min to 
further denature proteins. Next, the volume was 
increased 10 times with non-denaturing buffer (1% 
Triton X-100, 50 mM Tris HCl pH 7.4, 300 mM EDTA, 
0.02%NaN3) supplemented with protease inhibitors 
(leupeptin, AEBSF, ZL3H) and 10 mM iodoacetic acid. 
Immunoprecipitations were performed  2 h on 
precleared samples, with Abs pre-coupled to protein 
A/G sepharose beads. Samples were separated by 
SDS-PAGE and displayed via phosphor imaging (Bio-
Rad Personal Molecular Imager FX). 
RESULTS
Allelic differences in US2-mediated down-
regulation of MHC class I surface expression.  
We first investigated if US2 differentially affects 
surface expression of various MHC class I alleles.  
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Since alterations in surface display of MHC class I can 
directly affect the incidence of T and NK cell receptor 
interactions, we used flow cytometry for our 
investigation. The available crystal structure data on a 
soluble complex of US2/HLA-A2/ 2m provided a 
starting point for the selection of representative locus 
products for our study 44. By aligning HLA class I 
sequences from the IMGT/HLA sequence database 45
to the region of US2-interaction described for HLA-A2 
and looking at conserved residues, we found HLA-A2, 
-B7, -B27, -Cw3, -G and -E alleles to be good 
candidates (see Figure 1). These alleles all have an 
amino acid composition for the region implicated in 
US2 binding that is conserved within their locus 
(sub)group. HLA class I constructs were transfected 
into murine J26 cells to enable specific monitoring of 
introduced alleles by flow cytometry. J26 cells co-
express human 2m to allow proper HLA class I 
complex formation. Cells were then transduced with 
retrovirus expressing US2-IRES-EGFP. Figure 2 
shows that surface expression of HLA-A2, -B27 and -
G was reduced by US2, to 12%, 39% and 7% respec-
tively, compared to US2-negative cells. In contrast, 
HLA-B7, -Cw3 and -E are not or only slightly affected 
by US2 with 110%, 85% and 98% surface expression, 
respectively. Endogenously expressed H-2k molecules 
were not downmodulated by US2. Control EGFP-
expressing retrovirus had no effect on MHC class I 
cell surface expression, as shown here for HLA-A2. 
Cytoplasmic tail of MHC class I heavy chains is 
not essential for US2-mediated down-regulation 
We previously showed that residues at the extreme 
end of the cytoplasmic tail of class I heavy chains can 
FIGURE 1. Overview of sequence variation within the US2 binding region of MHC class I locus products. Depicted is the region of HLA-A2
with residues directly involved in interaction with US2 marked in grey (according to crystal structure data from PUBMED Protein Data Base
reference: 1IM3, deposited by Gewurz et al.44. The US2 binding site of HLA-A2 has been aligned with corresponding regions of other alleles, and
their locus (sub)group consensus sequences (cons) obtained from the IMGT/HLA Sequence Database 45.
FIGURE 2. Selective US2-mediated down-regulation of HLA class I. Murine J26 cells, transfected with different plasmids encoding HLA class
I and transduced with US2-IRES-EGFP encoding retrovirus, were analyzed using flow cytometry. The following MoAbs were used to stain the
different HLA class I molecules: HLA-A2 (MA2.1), HLA-B7, -B27, and -Cw3 (W6/32), HLA-E (MEM-E/06), HLA-G (87G) or endogenously
expressed H-2k (Y-3), followed by PE-conjugated goat anti-mouse Ab (Y-axis). US2 positive cells are marked by EGFP expression (X-axis). The
effect of US2 on surface staining of MHC class I was calculated by comparing mean PE fluorescence of EGFP negative (defined as 100%) and
positive cells. As a control, J26-HLA-A2 cells were transduced with EGFP-expressing retrovirus to show that EGFP alone, does not affect MHC
class I surface expression.
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determine their sensitivity to down-regulation by US11 
40. Others reported that a reduction of the tail to 4 
amino acids ensures stability of HLA-A2 in the 
presence of either US11 or US2 46. HLA-G has a 
relatively short cytoplasmic tail of 6 amino acids 47,
due to a premature stopcodon in exon 6, and was 
found to be insensitive to US2-mediated degradation 
28. We decided to evaluate the contribution of the tail 
of class I heavy chains to US2-mediated down-
regulation in more detail (Figure 3). By exchanging 
cytoplasmic tail regions of US2-sensitive (HLA-A2) 
and US2-insensitive (HLA-Cw3) class I molecules 
(see Figure 3A), we evaluated if the tail region could 
account for differences in sensitivity among locus 
products. Figure 3B shows that HLA-A2 with the tail of 
HLA-Cw3 was down-regulated as efficiently as HLA-
A2 wt (both 12% surface expression in the presence 
of US2), while HLA-Cw3 with the tail of HLA-A2 and 
wild type HLA-Cw3 were almost equally resistant (with 
75% and 85% surface expression). In parallel, we 
evaluated the effect of tail length on US2-sensitivity by 
reducing the size of the tail of HLA-A2 molecules (see 
Figure 3A) to 6 amino acids (similar in length to HLA-
G) or 4 amino acids (identical to the construct tested 
previously 46). Figure 3B shows that both short-tailed 
HLA-A2 molecules were efficiently downmodulated by 
US2.
These data indicate that the tail of MHC class I heavy 
chains is not essential for US2-mediated down-
regulation of cell surface expression. 
HLA-G and short-tailed HLA-A2 are efficiently 
targeted for degradation by US2. 
Downregulation of MHC class I surface expression 
can be accomplished by degradation, but also by 
retention in an intracellular compartment, as has been 
shown for US11 40. We investigated the underlying 
mechanism for down-regulation of short-tailed MHC 
class I molecules by US2. Since the tail region of the 
class I heavy chain is exposed to the cytosol it might 
serve an important function in the retrograde transport 
to the cytosol for subsequent proteasomal degra-
dation. We investigated whether US2 affects the 
stability of HLA-G1 and short-tailed HLA-A2 (6 aa tail) 
in a pulse chase experiment (Figure 4). Recombinant 
vaccinia virus was used to introduce US2 into the 
cells. In parallel, a similar amount of cells was infected 
with wild type vaccinia virus. Immunoprecipitations 
were performed on denatured cell lysates to evaluate 
the effect of US2 on total amounts of HLA class I 
heavy chains, irrespective of their folding state.  
We observed a destabilizing effect of US2 on wt HLA-
A2 as well as on HLA-G1 and short-tailed HLA-A2 
(upper panel Figure 4). In the presence of proteasome 
inhibitor ZL3H (lower panel) deglycosylated degrada-
tion intermediates could be observed in US2 
expressing cells for all three HLA class I molecules.  
Thus, HLA-G1 and short-tailed HLA-A2 are efficiently 
destabilized in US2+ cells, indicating that the cytosolic 
tail of MHC class I heavy chains is not required for 
US2-dependent dislocation and degradation. 
FIGURE 3 . Cytoplasmic tail of MHC class I is not essential for US2-mediated down-regulation. A) Overview of  amino acid sequences of 
the cytoplasmic tail regions that are exchanged in the HLA-A2/Cw3 chimeras and shortened for the HLA-A2 tail mutants. As a comparison, the 
HLA-G tail region is depicted. B) J26 cells were transfected with chimeras or tail mutants, transduced with US2-IRES-EGFP encoding retrovirus 
and analyzed using flow cytometry. MHC class I molecules are stained with W6/32 (chimeras) or MA2.1 (HLA-A2short), followed by goat anti-
mouse-PE conjugate (Y-axis). US2 positive cells are marked by EGFP expression (X-axis).
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Evaluation of US2-mediated down-regulation of 
HLA-G in cell lines of human origin. 
To ensure that our observation on HLA-G was not 
species or cell type specific, we included experiments 
in different cell lines of human origin (Figure 5).  
First, U373 astrocytoma cells (expressing HLA-A2, -
B18 and -Cw5), transfected with HLA-G and 
transduced with control or US2-IRES-EGFP encoding 
retrovirus, were analyzed by flow cytometry (Figure 
5A). Comparable HLA-G surface expression was 
observed in control EGFP expressing cells and non-
transduced cells, as determined with 87G (upper left 
histogram). This antibody is specific for HLA-G and 
does not cross-react with endogenous HLA class I, as 
wild type U373 cells remained PE negative when 
stained with this antibody (Figure 5A, lower left 
histogram). A reduction of HLA-G surface expression 
was seen in US2/EGFP expressing cells (to 45%). 
Down-regulation of HLA-G by US2 seems to be even 
more efficient than that of endogenous HLA-A2, 
stained by antibody MA2.1 (to 63%). This antibody 
preferentially recognizes HLA-A2 molecules and not 
HLA-B18 or -Cw5 in these U373 cells 34. MA2.1 did 
not cross-react with HLA-G in HLA-G1 expressing J26 
cells (data not shown). 
Note that wild type U373 cells expressing US2 
demonstrated a stronger down-regulation of 
endogenous HLA-A2 molecules stained with MA2.1 
(to 15%). This indicates that the transfection of an 
additional US2-sensitive class I heavy chain into cells 
affects the efficiency of down-modulation of the total 
pool of MHC class I. It is unlikely that the lower 
efficiency of MHC class I down-regulation in the U373-
HLA-G cells is due to a lower level of US2 expression. 
The mean fluorescence value for EGFP, as a marker 
for US2 expression (not shown in figure 5A) was even 
higher in these cells (255) than in wild type U373 cells 
(194).  
Secondly we tested the effect of US2 on HLA-G in the 
physiologically more relevant trophoblast cell line 
JEG-3 (Figure 5B). These cells naturally express 
HLA-G1, HLA-Cw4 and likely also low amounts of 
HLA-E, but lack HLA-A and HLA-B molecules at their 
cell surface. In cells transduced with US2 retrovirus, 
HLA-G surface expression was severely reduced (to 
9%) whereas HLA-Cw4 surface expression remained 
stable. In this case, severity of HLA-G down-
modulation was comparable to that observed for J26 
cells transfected with HLA-G (to 7%, see Figure 2). 
FIGURE 4. HLA-G and short-tailed HLA-A2 are efficiently degraded in US2 expressing cells.  J26 cells expressing wt HLA-A2, HLA-A2short
(6aa tail) or HLA-G were infected with wt or US2-encoding vaccinia virus. At 4½ hours post-infection, cells were metabolically labeled for 10
minutes and chased for 0, 20 or 40 minutes in the absence (upper panel) or presence (lower panel) of proteasome inhibitor ZL3H.
Immunoprecipitations were performed on denatured cell lysates using the following antisera: MR24 (HLA-A2 wt, -A2short), HCA2 (HLA-G), H68.4
(transferrin receptor [TfR]) or US2-N2 (US2) Abs. Deglycosylated degradation intermediates are marked by an asterisk. The 20 min chase
sample (+ZL3H, +US2) for HLA-A2short was lost during the procedure for this representative experiment. Molecular weight markers are given in
kilo Daltons.
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Note that both cell lines expressed no other US2-
sensitive MHC class I molecules besides HLA-G.  
Together, these results show that down-regulation of 
short-tailed MHC class I molecules can be observed 
in different cell lines of human origin. These data 
further indicate that efficiency of down-regulation is 
influenced by amounts of US2-susceptible class I 
heavy chains present in the cells.  
Soluble HLA-G1 is resistant to US2-mediated 
degradation 
Interaction between US2 and class I heavy chains 
does not require transmembrane regions, as soluble 
trimeric HLA-A2/US2/ 2m complexes could be 
crystallized 44. Binding of MHC class I molecules to a 
soluble form of US2 is not sufficient for their 
degradation 48. We investigated if interaction of US2 
with a soluble form of MHC class I could induce its 
degradation. This is of clinical relevance, as 
membrane-bound and soluble isoforms are generated 
by differential splicing of primary HLA-G mRNA 
transcripts 20. One of these isoforms is soluble due to 
retention of intron 4, which introduces a premature 
stopcodon (Figure 6A). This isoform possesses the 
ER-lumenal 1-3 domains required for interaction 
with US2. We compared its sensitivity to US2-
mediated degradation to that of the membrane bound 
HLA-G isoform in pulse chase experiments (Figure 
6B). In the absence of proteasome inhibitor, a 
progressive loss of membrane bound HLA-G1 and 
endogenous MHC class I molecules was observed in 
US2-expressing cells (upper panel). In contrast, 
soluble HLA-G1 remained stable throughout the 
chase (lower panel). In the presence of proteasome 
inhibitor, a deglycosylated degradation intermediate 
could be observed for both endogenous HLA 
molecules and membrane bound HLA-G1, but not for 
soluble HLA-G1.  
FIGURE 5 . US2-mediated down-regulation of HLA-G in human cell lines. A) Wild type human U373 astrocytoma cells (HLA-A2, -B18, -Cw5),
or U373 cells transfected with HLA-G were transduced with retrovirus (EGFP- or US2-IRES-EGFP) and analyzed by flow cytometry. Cells were
stained with either 87G (HLA-G), MA2.1 (HLA-A2), or W6/32 (general anti-MHC class I) MoAbs, followed by goat anti-mouse PE conjugate.
Shown are histograms representing transduced (thick grey line) and non-transduced (thin black line) cells. Surface expression is given as
percentage of mean PE fluorescence in transduced cells compared to non-transduced cells. B) Similarly, JEG-3 cells expressing HLA-G1, -Cw4 (
and likely also HLA-E) were transduced with retrovirus (US2-IRES-EGFP), stained with 87G (anti-HLA-G) or B1.23.2 (anti-HLA-C) and analyzed
using flow cytometry. 
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Evidently, soluble HLA-G1 can escape US2-mediated 
degradation although it possesses all ER-lumenal 1-
3 domains required for binding US2. 
DISCUSSION
HCMV encodes several proteins that interfere with 
cross talk between host cells and immune effector 
cells through modulation of surface expression of 
MHC class I molecules. The various MHC class I 
locus products can serve different immune functions. 
Some are more important for the presentation of viral 
antigens, while others may mainly act as ligands for 
inhibitory NK receptors. The success of immune 
escape by HCMV through modulation of MHC class I 
surface expression is likely to be influenced by MHC 
class I allele specificity of the different HCMV US 
proteins. In this paper we focused on modulation of 
MHC class I expression by HMCV US2. 
We first evaluated allelic differences in US2-mediated 
down-regulation of MHC class I cell surface 
expression. Previous studies on US2 mainly focused 
on the mechanism of interference with antigen 
presentation 2;7;46;48;49. With the cell lines and 
FIGURE 6 . Soluble HLA-G1 is stable in US2-expressing cells. A) Depicted are two isoforms of HLA-G: membrane bound and soluble HLA-
G1. HLA-G1 has a premature stopcodon (*) in exon 6 which allows translation of only 6 amino acids of the cytoplasmic tail (CT) region. Soluble
HLA-G1 contains a premature stopcodon due to retention of intron 4, allowing translation of only ER-lumenal 1-3 domains. L= leader sequence,
TM= transmembrane region B) U373 cells transfected with membrane bound or soluble HLA-G1 were infected with wt or US2-encoding vaccinia
virus. At 4½ hours post-infection, cells were labeled for 10 minutes and chased for 0 or 40 minutes in the absence or presence of proteasome
inhibitor ZL3H. Immuno-precipitations were performed on denatured cell lysates with MR24 (endogenous HLA class I), MEM G/1 (HLA-G), H68.4
(TfR) or US2-N2 (US2) Abs. Deglycosylated degradation intermediates are marked by an asterisk.
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antibodies used in these studies it is difficult to deduce 
effects on individual MHC class I locus products. In 
general, HLA-A and -B alleles are believed to be 
down-regulated, but detailed information is scarce. 
Binding studies indicate that US2 associates with 
HLA-A2 and -Aw68, but no interaction could be 
detected with HLA-B7, -B27, -Cw4, or -E 50. Pulse 
chase experiments show that US2 does not affect the 
stability of HLA-C, -G, and -E alleles 28;29. It is, 
however, also important to specifically evaluate the 
effect on surface expression of MHC class I 
molecules, as this is most relevant with respect to T 
and NK cell interactions. MHC class I molecules that 
appear to be stable in pulse chase experiments can 
nevertheless be withheld from the cell surface via 
other mechanisms than degradation. US11, for 
example, can cause ER-retention of MHC class I 
molecules that can not be targeted for degradation 40.
Flow cytometrical analysis of surface expression 
therefore is a valuable complementation of pulse 
chase data.  
The available crystal structure of a soluble complex of 
US2/HLA-A2/ 2m 44 provided us with a good starting 
point for the selection of representative class I locus 
products (Figure 1). We found that US2 down-
regulates HLA-A2, -B27, and -G, but not HLA -B7, -
Cw3, and -E alleles of this selection (Figure 2). 
Sequence variation in the region implicated in US2 
binding (residues 101-110 and 171-190) was 
evaluated for those alleles present in the IMGT/HLA 
sequence database 45 that are fully sequenced for this 
region. Of the residues directly involved in interaction 
with US2, the residue at position 105 is either S or P, 
and both are found in US2 sensitive alleles. Out of 
947 alleles, 946 have K176. Residues at position 105 
and 176 are therefore unlikely to account for 
sensitivity differences between locus products. Among 
locus products that differ in sensitivity for US2, 
residues found at positions 180, 181 or 183 also differ. 
All 274 HLA-A and most of the 519 HLA-B alleles 
have residues Q180, R181 and D183 that are present 
in US2-sensitive HLA-A2 and HLA-B27. In contrast, 
US2-insensitive HLA-B7 has E180 instead of Q180, 
which is also found in other HLA-B alleles. Two other 
US2-insensitive locus products, HLA-Cw3 and HLA-E, 
have E183 instead of D183. This E183 is also found in 
132 out of 133 HLA-C alleles and in all 6 HLA-E 
alleles. In addition, HLA-E alleles differ from US2-
sensitive alleles at position 180 and 181, with their 
L180 and H181 residues. Among the residues that are 
not directly involved in US2 binding, but that are 
located around US2 binding residues, only little 
sequence variation is found. Moreover, most of the 
sequence variation that is found here is unlikely to 
account for allelic differences, as they are found in 
both US2-sensitive and -insensitive alleles. 
Altogether, our findings suggest that US2 down-
regulates all HLA-A, -G and most -B alleles and no 
HLA-C, or-E. In addition to HLA-B7 several other 
HLA-B isotypes, including HLA -B8, -B40, -B41, -B42, 
and -B48 are likely to be US2-resistant. These HLA-B 
isotypes are relatively common, as they are found in 
25-30% of the Caucasion population (Frans Claas, 
personal communication). Since HLA-B alleles are 
very important for presentation of viral peptides to 
cytotoxic T cells, it might be advantageous for the host 
to possess such HLA-B alleles.  
The finding that US2 down-regulates cell surface 
expression of HLA-G, which has a relatively short tail, 
is novel. A previous report claimed that HLA-G 
remains stable in the presence of US2 28. Resistance 
to US2-mediated down-regulation has been ascribed 
to absence of a full-length tail, as tailless HLA-A2 
molecules were reported insensitive to US2-mediated 
degradation 46. When looking at the residues required 
for interaction with US2, the HLA-G locus product 
closely resembles HLA-A2 (see Figure 1A). The most 
striking difference between HLA-G and -A locus 
products is found in their cytosolic domains, as HLA-G 
alleles lack most cytosolic tail residues due to a 
premature stop codon in exon 6. Our flow cytometry 
experiments with murine cells showed that both HLA-
G1 and tailless HLA-A2 molecules were withheld from 
the cell surface by US2 (Figures 2 and 3). When we 
investigated the mechanism underlying this reduction 
in cell surface expression, it became evident that 
HLA-G1 and tailless HLA-A2 molecules are targeted 
for degradation by US2 (Figure 4). These data reveal 
that the cytosolic tail is not required for US2-mediated 
dislocation and subsequent degradation. To exclude 
that cell- or species-specific factors account for our 
observations in the murine cell line, we also 
performed experiments in human JEG-3 trophoblast 
and U373 cell lines, with similar results (Figures 5 and 
6). The observation that tailless HLA class I molecules 
are sensitive to US2-mediated degradation may have 
been missed in earlier reports as a result of a different 
experimental set up; The experiments shown by 
Schust et al. 28 are performed with porcine endothelial 
cells transfected with HLA-G. However, HLA-G 
expression in these cells was too poor to allow firm 
conclusions on possible stability changes as a result 
of US2 expression 28. Furthermore, our experiments 
with U373 cells (the same cell line used by Story et al. 
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46) indicate that expression of multiple, US2-sensitive 
class I products results in reduced efficiency of US2-
mediated MHC class I down-regulation (Fig. 5). Down-
regulation of HLA-G was more pronounced in murine 
J26 cells transfected with HLA-G or in naturally HLA-
G expressing JEG-3 trophoblast cells. In contrast to 
the U373 cell line transfected with HLA-G, these cell 
lines express no other US2-sensitive MHC class I 
molecules than HLA-G. The effectiveness of down-
modulation of HLA products likely also depends on 
expression levels of US2, which may vary between 
expression systems. US2-mediated degradation of 
tailless HLA-A2 molecules might have been revealed 
in previous experiments 46 if the experiments had 
been performed in the presence of proteasome 
inhibitor. In case of a suboptimal degradation 
efficiency, a small amount of deglycosylated 
degradation intermediate already serves as 
indisputable evidence.  
We also investigated if US2 could induce degradation 
of the soluble HLA-G1 isoform. This isoform consists 
of ER-lumenal 1-3 domains only. It is known that 
interaction between US2 and HLA class I does not 
require transmembrane regions, as soluble US2/HLA-
A2/ 2m complexes could be crystallized 44. We have 
shown here that ER-lumenal domains of HLA class I 
alone are nevertheless insufficient to allow US2-
mediated degradation, as soluble HLA-G1 remained 
stable in the presence of US2 (Figure 6). 
The observation that viruses use different proteins for 
interference with MHC class I expression is likely to 
improve the effectiveness of immune escape. 
Together they can affect a wider range of class I locus 
products. They may also act synergistically to reach a 
more dramatic down-regulation of a single locus 
product. The use of different strategies may also help 
to avoid saturation of a particular cellular pathway 
used by the virus to effectuate evasion. HCMV 
encodes several proteins that affect MHC class I 
surface expression during the course of infection, and 
they act through different mechanisms: a) by retaining 
MHC class I molecules in the ER (US3) 3, b) by 
blocking the Transporter associated with Antigen 
Processing (TAP)(US6) 4;5 c) by delaying MHC class I 
maturation (US10) 51, and d) by dislocating newly 
synthesized class I heavy chains to the cytosol for 
subsequent degradation by proteasomes (US2 and 
US11) 2;6. When looking at the different mechanisms 
employed, US2 and US11 seem to act very similarly. 
Our data contribute to the understanding of the need 
of two proteins with, at first sight, similar functions. 
Previous studies have already shown that US2 and 
US11 each interact with different sites on ER-lumenal 
regions of the HLA class I heavy chain 40;44. We 
showed here that they also differ in their requirements 
for cytosolic tail residues, as HLA-G1 and tailless 
HLA-A2 are efficiently targeted for degradation by 
US2. As shown before, this is not the case for US11 
28;40;46. Interestingly, the requirement for cytosolic tail 
residues appears to be the reverse for the viral 
proteins themselves. Where tailless US11 can still 
target newly synthesized class I heavy chains for 
degradation, this is not the case for US2 48;52. Since 
US2 and US11 approach their target MHC class I 
molecules differently, they may affect different subsets 
of locus products. The difference in cytosolic tail 
requirements may also be accompanied by usage of 
different accessory proteins involved in the dislocation 
and degradation process.  
Trophoblast membrane-bound and soluble HLA-G1 
are believed to serve important immunological 
functions at the fetal-maternal interface. Our finding 
that membrane-bound, but not soluble HLA-G1, is 
sensitive to US2-mediated degradation may be of 
relevance in the context of HCMV infection during 
pregnancy.  
It is unknown if viral antigen presentation could be 
effective at the fetal-maternal interface. Only few 
maternal CTLs are found here and during HCMV 
infection, T cell recognition of infected trophoblast 
cells will largely be prohibited due to absence or 
reduction of surface expression of antigen presenting 
MHC class I molecules: HLA-A and -B molecules are 
lacking in these cells and surface expression of HLA-
G is reduced by both US2 (this paper), US3 53 and 
US6 54. In addition, HLA-C can be down-regulated by 
US3, US6 53 and US11 55 ,(our own unpublished 
results). HLA-E surface expression is not affected by 
US2 (this paper), US6 54 and US11 (our own 
unpublished results). We are unaware of data 
describing the effect of US3 on HLA-E expression.  
NK cells are the predominant population of immune 
effector cells at the maternal-fetal interface and they 
serve several important functions at this site. By 
down-regulating most HLA class I locus products, 
many ligands for inhibitory receptors on NK cells will 
also be lost. Expression of HLA-E and UL16, UL18 
and UL40 is not likely to fully compensate for the lack 
of inhibitory NK cell ligands 8. It is unclear if HCMV-
infected trophoblast cells are at risk for NK cell attack 
in vivo, as the degree of protection from NK cell lysis 
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was shown to differ significantly between lab strains 
and clinical isolates 56. HLA-G down-regulation by 
HCMV could also prevent interaction with activating 
NK cell receptors and prohibit uterine NK cell cytokine 
secretion, which is necessary for the placentation 
process. 
We also demonstrated that soluble HLA-G1 is 
resistant to US2-mediated degradation. In a previous 
paper we showed that US11 has no effect on surface 
expression of membrane-bound HLA-G1 40, which 
makes it unlikely that US11 will prohibit secretion of 
the soluble HLA-G1 isoform. It remains to be 
established to what extent other US proteins could 
affect its secretion. Soluble HLA-G1 can induce apop-
tosis of activated T cells 24. Cells secreting this HLA-
G1 isoform could also modulate NK cell triggering.  
Together, our results suggest that surface expression 
of all HLA-A, and -G, and most -B alleles will be down-
regulated in the presence of US2. Several HLA-B 
alleles and all HLA-C and -E alleles will be resistant 
against US2-mediated degradation. Using HLA-G and 
tailless HLA-A2 we demonstrated that US2 does not 
require the cytosolic tail of class I heavy chains to 
initiate dislocation and degradation of these 
molecules. The MHC class I ER-lumenal domain 
alone is not sufficient for US2-mediated degradation, 
as illustrated by the stability of soluble HLA-G in the 
presence of US2. Our data shed new light on the 
modulation of MHC class I expression on cells at the 
fetal-maternal interface in the context of HCMV 
infection. More research will be needed to evaluate 
the immunological consequences of these virus-
induced changes in MHC expression. 
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CHAPTER 4
Subtle sequence variation  
am ong  M H C  class I locus p rod ucts
g reatly  influences sensitivity
to H C M V  U S2 -and  U S1 1 -m ed iated  d eg rad ation 
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Subtle sequence variation among MHC class I locus products greatly influences 
sensitiv ity to H C M V  U S 2 -and U S 1 1 -m ediated degradation. 
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H um an cytom egalov irus (H C M V ) interferes w ith  cellular im m une responses b y m odulating surface 
ex pression of M H C  class I m olecules. H ere, w e focused on H C M V -encoded U S 2  and U S 1 1 , w h ich  b ind 
new ly synth esiz ed M H C  class I h eav y ch ains and support th eir dislocation into th e cytosol for 
sub seq uent degradation b y proteasom es. N ot all M H C  class I locus products are eq ually sensitiv e to th is 
dow n-m odulation. T h e aim  of th is study w as to identify w h ich  dom ains, and ultim ately w h ich  residues, 
are responsib le for th e resistance or sensitiv ity of M H C  class I m olecules to U S 2 - and U S 1 1 -m ediated 
dow n-regulation. W e sh ow  th at, b esides E R -lum enal regions, th e C -term inus of class I m olecules 
represents an im portant determ inant for allele specificity in U S 1 1 -m ediated degradation. H L A -E  b ecom es 
sensitiv e to U S 1 1 -m ediated dow n-regulation w h en its cytoplasm ic tail is ex tended. Interestingly, th is 
only req uires tw o additional residues, lysine and v aline, at its C -term inus. F or U S 2 , th e M H C  class I allele 
specificity is largely determ ined b y a sm all region at th e junction of th e 2 / 3  dom ain of th e h eav y 
ch ain. It is q uite rem ark ab le th at m inor ch anges, in only 4  residues, can com pletely rev ert th e sensitiv ity 
of naturally U S 2 -resistant H L A -E  m olecules. W ith  th is study w e prov ide b etter insigh ts into th e features 
underlying th e selectiv ity in M H C  class I dow n-regulation b y U S 2  and U S 1 1 . 
H u m an c y to m eg alo v iru s  (H C MV ) es tab lis h es  p ers is -
tent infec tio ns  in h u m an p o p u latio ns  w o rld w id e and  
c an g iv e ris e to  s erio u s  d is eas e in im m u no -
c o m p ro m is ed  ind iv id u als . H C MV  u s es  v ario u s  
d efens e m ec h anis m s  to  elu d e th e h o s t im m u ne 
s y s tem . E lim inatio n o f infec ted  c ells  b y  C D 8 +  T c ells  
c an b e p rev ented  b y  d o w n-reg u latio n o f v iral antig en-
p res enting  MH C  c las s  I m o lec u les . In th e c o u rs e o f 
H C MV  infec tio n, MH C  c las s  I s u rfac e ex p res s io n is  
affec ted  b y  s ev eral H C MV  U niq u e S h o rt (U S ) reg io n-
enc o d ed  p ro teins , w h ic h  ac t at d ifferent lev els  o f th e 
antig en p ro c es s ing  and  p res entatio n p ath w ay  (1-5 ). 
A ntig en p res entatio n is  p rev ented  b y  b lo c k ing  th e 
s u p p ly  o f p ep tid es  th ro u g h  TA P  inh ib itio n (U S 6 ), b y  
retaining  new ly  s y nth es iz ed  MH C  c las s  I m o lec u les  in 
th e E R  c o m p artm ent (U S 3 ) o r b y  d is lo c ating  c las s  I 
h eav y  c h ains  b ac k  into  th e c y to s o l fo r s u b s eq u ent 
d eg rad atio n b y  p ro teas o m es  (U S 2 and  U S 11). 
E ffic ient d o w n-reg u latio n m ay  v ery  w ell req u ire th e 
c o nc erted  ac tio n o f s ev eral o f th es e U S  p ro teins . 
A  c o m p lete red u c tio n o f MH C  c las s  I ex p res s io n c o u ld  
h av e s erio u s  c o ns eq u enc es  fo r th e s u rv iv al o f th e 
v iru s , as  c ells  lac k ing  MH C  c las s  I s u rfac e m o lec u les  
are m o re s u s c ep tib le to  an N K -c ell attac k  (6 ). S ev eral 
p ro teins  enc o d ed  w ith in th e U niq u e L o ng  (U L ) reg io n 
o f th e H C MV  g eno m e (U L 16 , U L 18 , U L 4 0 , U L 14 1) 
ap p ear to  p ro tec t infec ted  c ells  ag ains t N K -c ell ly s is . 
Th ey  eith er b lo c k  ex p res s io n o f lig and s  th at ac tiv ate 
N K  c ells  (U L 16 , U L 14 1) o r allo w  ex p res s io n o f lig and s  
th at c an inh ib it N K -c ell trig g ering  (U L 18 , U L 4 0 ) (7 ,8 ).  
In g eneral, h o s t c ells  ex p res s  H L A -A , -B, -C  and  -E  
alleles . Th e (s u rfac e) ex p res s io n lev els  o f th e v ario u s  
lo c u s  p ro d u c ts  is  d ifferentially  reg u lated  (9 ,10 ). H L A -A  
and  -B are g enerally  m o s t ab u nd ant at th e c ell 
s u rfac e. Betw een th e v ario u s  MH C  c las s  I lo c u s  
p ro d u c ts , m o s t s eq u enc e v ariatio n is  fo u nd  in th e 
reg io n enc o m p as s ing  th e antig en-b ind ing  g ro o v e (11). 
Th is  g enerates  d ifferent res tric tio ns  fo r p ep tid e 
b ind ing  as  w ell as  fo r th e v ariety  o f p ep tid e d is p lay  fo r 
eac h  allele. MH C  c las s  I m o lec u les  c an s erv e a d u al 
ro le, as  a lig and  fo r b o th  T and  N K  c ell rec ep to rs , b u t 
th eir k ey  tas k  m ay  b e b ias ed . H L A -A  and  – B alleles  
are p ro b ab ly  m o s t p o w erfu l in th e p res entatio n o f 
fo reig n p ep tid es . Th is  is  s u p p o rted  b y  a h ig h  d eg ree 
o f p o ly m o rp h is m  in th e w o rld  p o p u latio n fo r th es e 
alleles , w ith  3 25  d ifferent H L A -A , and  5 9 2 d ifferent 
H L A -B alleles  rep o rted  to  th e IMG T/H L A  d atab as e 
s o far. N ex t c o m es  H L A -C  (17 5  alleles ) and  th e lo w es t 
p o ly m o rp h ic  is  H L A -E  (5  alleles ) (11). A lth o u g h  th ere 
are rep o rts  s h o w ing  th at H L A -C  and  H L A -E  c an 
p res ent fo reig n antig ens  to  T c ell rec ep to rs , th ey  m ay  
p rim arily  s erv e as  interac tio n p artners  fo r N K  c ell 
rec ep to rs  (7 ,12-17 ).  
Tak ing  into  ac c o u nt th e fu nc tio ns  o f th e d ifferent MH C  
c las s  I lo c u s  p ro d u c ts , it is  im p o rtant to  k no w  w h ic h  
alleles  are affec ted  in H C MV  infec ted  c ells . D ata fro m  
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several laboratories have shown that there are allelic 
differences between MHC class I molecules with 
respect to sensitivity to US2, US3, US6 and US11, but 
the picture is still far from complete (18-23). In this 
study we aimed to characterize the precise regions in 
MHC class I alleles that determine sensitivity or 
resistance to these US proteins. This knowledge will 
also help to predict the down-modulatory effect of US2 
and US11 for a broader range of MHC class I alleles.  
MATERIALS AND METHODS 
Cell lines  
J26 cells (H-2k murine Ltk- cells expressing human 
2m) (24) and the Phoenix amphotropic retroviral 
producer cell line (American Type Culture Collection, 
Manassas, VA) were cultured in DMEM (Invitrogen, 
Breda, The Netherlands), supplemented with 10%  
FCS (Greiner bv, Alphen aan den Rijn, The 
Netherlands), 100 U/ml penicillin and 100 g/ml 
streptomycin and G418 (Invitrogen, Cergy-Pontoise, 
France). J26 cells expressing HLA-A2 (A*0201), HLA-
B7 (B*070201), HLA-B27 (B*270502), HLA-Cw3 
(Cw*0304, gift from B. van den Eynde, Brussels, 
Belgium), HLA-G (G*01011), and HLA-E (E*01033, 
gift from E. Weiss, Munchen, Germany) were all 
described previously (19,25). 
Antibodies 
The following anti-MHC class I mAbs were used for 
flow cytometry: W6/32 (anti-human MHC I complex) 
(26), BB7.2, MA2.1 (both anti-HLA-A2) (27), MEM-
E/06 (anti-HLA-E; EX BIO  Praha, Czech Republic), 
B1.23.2 (anti-HLA-B and -C) (28), BB7.1 (anti-HLA-B, 
ATCC), Y -3 (murine MHC class I; ATCC). In most 
cases, primary mAbs were used in combination with 
PE-conjugated goat anti-mouse (g m), IgG (Jackson 
ImmunoResearch Laboratories, West Grove, PA). In 
some experiments biotinylated-g m Ig was used as 
second Ab, in combination with streptavidin-
conjugated PE as third Ab (PharMingen, Europe). The 
mAbs MEM-E/02 (denatured HLA-E; EX BIO  Praha, 
Czech Republic), H68.4 (transferrin receptor; Z ymed 
Laboratories, San Francisco, CA) and polyclonal 
antisera US2-N2 (US2) (19) and US11-N2 (US11) 
(29) were used for immuno-precipitations. A control 
experiment was performed with MEM-E/02 to exclude 
possible cross-reactivity with murine MHC class I. 
MEM-E/02 only precipitated MHC class I heavy chains 
in J26 cells transfected with HLA-E and no MHC class 
I in wild type J26 cells (data not shown).  
Construction of plasmids 
Plasmid pLUMC9901 (encoding HLA-A*0201 cDNA) 
(29) was used as template for the construction of 
HLA-A2delCKV (HLA-A2 with a deletion of residues 
340-342). pLUMC9901 and pcDNA-E(sigA2) 
(encoding cDNA of HLA-E*01033 with signal 
sequence of HLA-A2; kind gift of E. Weiss, Munchen, 
Germany) (30) were used as template to construct 
HLA-A2/E chimeras HLA-A2 1-184/E (residues 1-184 of 
HLA-A2 and rest of HLA-E) and its reverse HLA-E 1-
184/A2, HLA-E( 3+c A2) (HLA-E with 3 domain and 
connecting peptide region of HLA-A2) HLA-E(TM A2) 
(HLA-E with transmembrane domain of HLA-A2), 
HLA-E(tail A2) (HLA-E with cytoplasmic tail of HLA-
A2) and HLA-A2(tail E) (HLA-A2 with cytoplasmic tail 
of HLA-E). pcDNA-E (sigA2) was also used to 
construct the mutants HLA-E Q RTD (HLA-E with 
residues 180-183, LHLE, replaced by Q RTD), HLA-
E+KV and HLA-E+ACKV (HLA-E with tail extended 
with KV or ACKV residues, respectively). pCR-B7 
(HLA-B*070201 in vector pCR3.1 (Invitrogen); kind gift 
of M. Heemskerk, Leiden, The Netherlands) was used 
as template to construct HLA-B7 ETLQ (HLA-B7 with 
residues 177, 178, 180, DK-E, replaced by ET-Q , 
resulting in the sequence ETLQ  at position 177-180). 
Amplifications were performed using Isis polymerase 
(Q .BIO gene, Illkirch, France). Mutations were 
introduced using the Q uickChange X L Site-directed 
mutagenesis kit and/or protocol (Stratagene, La Jolla, 
USA) and chimeric constructs were generated 
applying the megaprimer method (31). All constructs 
were fully sequenced to verify the absence of 
unwanted mutations. 
Transfection  
J26 cells were transfected with the different MHC 
class I constructs using EffecteneTM Transfection 
Reagent (Q iagen, Courtaboeuf, France). After 48 
hours, stable transfectants were selected by adding 
0.4 mg/ml G418 (Invitrogen). Cells were sorted by 
flow cytometry for expression of the introduced cDNA 
using MEM-E/06, W6/32, B1.23.2 or BB7.1 mAbs.  
Production of retrovirus and transduction 
US2 and US11 cDNA fragments were subcloned into 
the pLZ RS-IRE S -EGFP vector (19,32,33) and used 
for transfection of amphotropic Phoenix packaging 
cells to produce retrovirus, as described (19). Cells 
were transduced with retrovirus using Retronectin 
(Takara Shuzo, O tsu, Japan)-coated dishes.  
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Flow cytometry 
Cell surface expression of MHC class I molecules as 
w ell as E G F P  expression in cells transd uced  w ith  
retrov irus w ere analy z ed  using  flow  cy tometry  as 
d escrib ed  (1 9 ). In cells expressing  low  lev els of 
h uman MHC class I (e.g . HL A -E ) and /or w h en 
ind icated , cells w ere stained  in 3 steps to intensify  th e 
MHC class I (P E ) staining  (first w ith  specific anti-MHC 
class I antib od y , th en w ith  b iotiny lated -g m and  finally  
w ith  streptav id in-conjug ated  P E ). D ata are collected  
from sev eral experiments (g enerally  3), of w h ich  one 
representativ e experiment is sh ow n. 
M eta b olic la b elin g , immu n op recip ita tion  a n d  S D S -
P A G E
Metab olic lab eling , immunoprecipitations on 
d enatured  samples and  S D S -P A G E  w ere performed  
as d escrib ed  (2 9 ). In b rief, cells w ere starv ed  in 
med ium w ith out meth ionine (Met) or cy steine (Cy s) for 
~ 1  h our, lab eled  w ith  promix (35 S  Met and  Cy s), and  
ch ased  in med ium w ith  excess amounts of cold  Met 
and  Cy s. W h ere ind icated , med ia w ere supplemented  
w ith  proteasome inh ib itor carb oxy b enz y l-leucy l-leucy l-
leucinal (Z L 3H). Cells w ere ly sed  in a small v olume of 
N onid et-P 4 0  ly sis b uffer, containing  protease inh ib i-
tors. Cell d eb ris w as remov ed  b y  centrifug ation and  
th e supernatant w as transferred  to a new  tub e to 
w h ich  1 /1 0  v olume of 1 0 %  S D S  and  1 /1 0  v olume of 
0 .1  M D T T  w as ad d ed . S amples w ere b oiled  for 5  min 
to furth er d enature th e proteins. N ext, th e v olume w as 
increased  1 0  times w ith  non-d enaturing  b uffer, 
supplemented  w ith  protease inh ib itors and  w ith  1 0  
mM iod oacetic acid . Immunoprecipitations w ere 
performed   2  h  on precleared  samples, w ith  A b s pre-
coupled  to protein A  seph arose b ead s. S amples w ere 
separated  b y  S D S -P A G E  and  d isplay ed  v ia ph osph or 
imag ing . 
RESULTS
Se le c tiv ity  o f US2  a n d  US1 1  fo r  M H C  c la s s  I lo c u s  
p r o d u c ts
U S 2  and  U S 1 1  can targ et specific MHC class I locus 
prod ucts for d eg rad ation w h ile preserv ing  surface 
expression of oth ers (1 9 ,2 1 ,2 3,34 ). In th is stud y  w e 
aim to find  more information on MHC class I allele 
specificity  of U S 2  and  U S 1 1 .  
P rev iously , w e h av e found  th at HL A -A 2 , HL A -B 2 7 , 
and  HL A -G  w ere d ow n-mod ulated  b y  U S 2 , w h ile 
surface expression of HL A -B 7 , HL A -Cw 3 and  HL A -E  
w as unaffected  (32 ). F or U S 1 1  it h as b een sh ow n th at 
it can d ow n-mod ulate HL A -A 2  and  HL A -C molecules, 
b ut not HL A -G  or HL A -E  (1 9 ,2 1 ,2 3). A lth oug h  HL A -B  
locus prod ucts are g enerally  b eliev ed  to b e d ow n-
reg ulated  b y  U S 1 1 , as sug g ested  b y  a d estab iliz ing  
effect of U S 1 1  on g eneral pools of MHC class I, 
formal proof is still lack ing . T o ev aluate th e stab ility  of 
ind iv id ual HL A -B  locus prod ucts, w e used  murine J 2 6  
cells expressing  one particular h uman MHC class I 
h eav y  ch ain construct and  transd uced  th ese cells w ith  
a retrov iral v ector encod ing  b oth  U S 1 1  and  E G F P . 
T h e E G F P  expression is used  as a mark er for trans-
d uction (i.e. U S 1 1  positiv e cells). T h ese J 2 6  cells co-
express h uman 2 m to allow  proper MHC class I 
complex formation. F ig ure 1 A  sh ow s th e effect of 
U S 1 1  (E G F P +  cells) on surface expression of HL A -
B 7 , and  -B 2 7  compared  to th e nontransd uced  (E G F P  
– ) cell population, as analy z ed  b y  flow  cy tometry . It 
also includ es d ata on HL A -C, -E , and  murine alleles to 
prov id e a more complete ov erv iew  in th is experimen-
tal sy stem. In th e U S 1 1 -expressing  cells, surface 
expression of HL A -B 7 , HL A -B 2 7 , HL A -Cw 3 and  
end og enous murine MHC class I molecules w ere 
red uced  compared  to th e non-transd uced  cells, w h ile 
HL A -E  expression remained  unaffected . Control w t-
E G F P -expressing  retrov irus h ad  no effect on MHC 
class I cell surface expression (d ata not sh ow n). 
F ig ure 1 B  sh ow s an ov erv iew  of th e sensitiv ity  to U S 2  
and  U S 1 1  for all th e d ifferent MHC class I alleles th at 
h av e b een tested  in th is experimental sy stem. 
R epresentativ e d ot-plot d ata not sh ow n h ere, h av e 
b een presented  in our prev ious stud ies (refs. 1 8 , 31 ). 
T h is ov erv iew  sh ow s th at th ere are clear specificity  
d ifferences b etw een U S 2  and  U S 1 1 . U S 2  affects 
HL A -A 2 , -B 2 7 , and  – G  and  not HL A -B 7 , -Cw 3, -E , or 
end og enous H-2 k , w h ile U S 1 1  affects all of th ese 
alleles except HL A -E  and  – G . HL A -E  is th e only  allele 
th at is not affected  b y  eith er one of th ese tw o U S  
proteins. 
Re s id u e s  a r o u n d  th e  ju n c tio n  o f th e  2 / 3
d o m a in s  o f M H C  c la s s  I a lle le s  a r e  c r itic a l fo r  US2 -
m e d ia te d  d o w n -r e g u la tio n . 
T h e summary  in F ig ure 1 B  clearly  sh ow s th at 
ind iv id ual h uman locus prod ucts d iffer in th eir 
sensitiv ity  to U S 2 -med iated  d ow n-reg ulation. Cry stal 
structure d ata of a solub le HL A -A 2 /U S 2 / 2 m complex 
h av e sh ow n th at at least a reg ion in th e 2 / 3
d omain of HL A -A 2  is inv olv ed  in th e interaction w ith  
U S 2  (F ig ure 2 A ) (35 ). T h ese d ata cannot exclud e th e 
possib ility  th at ad d itional interactions w ith  trans-
memb rane or cy toplasmic tail reg ions contrib ute to 
sensitiv ity  d ifferences b etw een alleles. S o, b efore 
exploring  th e effect of seq uence v ariation in th is E R -
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lumenal region, we first addressed this question using 
chimeras consisting of US2-insensitive HLA-E and 
US2-sensitive HLA-A2 alleles. We tested the 
sensitivity of a chimeric molecule in which the ER-
lumenal part comprising residues 1-184, is derived 
from HLA-A2, and the remainder from HLA-E (HLA-
A21-184/E). This construct contains all the HLA-A2 
residues that are implicated in US2-binding according 
to the crystal structure data. We also included a 
reciprocal version of this construct (HLA-E1-184/A2). 
Figure 2B shows that HLA-A21-184/E was almost 
equally sensitive to US2 as wild type HLA-A2. 
Likewise, HLA-E1-184/A2 was as insensitive as wild 
type HLA-E. This shows that the sensitivity differences 
of HLA-A2 and HLA-E are determined by something 
located between amino acids 1-184 of the ER-lumenal 
region.  
A concordance can be found between US2-insensitive 
class I alleles (HLA-B7, HLA-E) and variation in the 
region that for HLA-A2 was shown to be involved in 
binding to US2 (E177, T178, Q 180, R181, T182, 
D183). To test if sequence variation in this region can 
indeed account for the observed allelic sensitivity 
differences, mutants of US2-insensitive HLA-B7 and 
HLA-E were constructed that resemble their US2-
sensitive allelic counterparts (see Figure 2A). 
Residues at positions 177, 178 and 180 of HLA-B7 
were replaced with the corresponding residues E, T 
and Q  of US2-sensitive HLA-B27. Figure 2B shows 
that this HLA-B7 ET(L)Q  mutant had a reduced surface 
expression in the presence of US2 similar to that 
observed for HLA-B27, while wild type HLA-B7 
remained unaffected. Likewise, a clear sensitivity 
conversion was observed for an HLA-E mutant with 
residues 180-183 replaced by Q RTD. Whereas wild 
type HLA-E surface expression was unaffected in US2 
expressing cells, surface expression of the mutant 
HLA-E was clearly reduced. The sensitivity shift was 
less dramatic, but still clearly visible, when only one 
mutation, H181R, was introduced into HLA-E.  
These flow cytometry data mainly provide information 
on alterations in surface expression levels in the 
presence of US2. To exclude the possibility of 
retention, rather than degradation, being the under-
lying mechanism for a reduced surface expression, 
we also evaluated the effect of US2 on the stability of 
the HLA-E Q RTD mutant by pulse chase analysis 
(Figure 2C). Like US11, US2 can mediate the retro-
translocation of newly synthesized class I heavy 
chains to the cytosol where they are first deprived of 
their N-linked glycan through the action of an N-
glycanase and subsequently degraded by the 
proteasome (4,5). This is a very rapid process, taking 
place from the start of pulse labeling. Figure 2C (left 
FIGURE 1. Selective down-regulation of HLA class I molecules by US2 and US11. (A) Murine J26 cells, transfected with different plasmids
encoding HLA class I and transduced with US11-IRES-EGFP encoding retrovirus, were analyzed using flow cytometry. The following mAbs were
used to stain the different human MHC class I molecules with PE in a 2- or 3-step staining protocol (Y -axis): HLA-B7, -B27, and -Cw3 (W6/32),
HLA-E (MEM-E/06, 3-steps) or endogenous H-2k (Y -3). US11 positive cells are marked by EGFP expression (X -axis). (B) O verview of sensitivity
of different MHC class I locus products to US2- and US11-mediated down-regulation, as evaluated in the same experimental system in this and
in our previous studies (19,32). The effect of US11 on surface staining of MHC class I was calculated by comparing mean PE fluorescence of
EGFP negative (defined as 100%) and EGFP positive cells. The averages of calculations of at least two independent experiments are shown,
with error bars. 
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panel) shows that, in the absence of proteasome 
inhibitors, US2 has a strong destabilizing effect on 
HLA-E QRTD; only a small amount of HLA-E QRTD heavy 
chains could be immunoprecipitated in US2+ cells at 
the beginning of the chase and no heavy chains can 
be recovered after a 30 minute chase, while HLA-E 
QRTD remained stable in the absence of US2. Equal 
amounts of transferrin receptor could be recovered 
over the chase course in US2+/- samples. In the 
presence of proteasome inhibitor (+ZL3H, middle and 
right panel), deglycosylated degradation intermediates 
could be recovered for HLA-E QRTD, which are absent 
in US2 negative cells and in the US2 positive cells 
expressing wild type HLA-E. It has to be noted that, in 
the presence of proteasome inhibitor, dislocated 
heavy chains remain targets for other cytosolic 
proteases. 
Altogether, these results show that subtle changes in 
a small region around the junction of the 2/ 3
FIGURE 2. Alterations in the 2/ 3 domain of MHC class I alleles affect sensitivity to US2-mediated downregu-lation. (A) Depicted is
HLA-A2 showing ER-lumenal regions ( 1- 3 and connec-ting peptide (c)), transmembrane domain (TM) and cytoplasmic tail, as well as an
enlargment of the boxed regions (aa 101-110, 171-190) of HLA-A2 with residues directly involved in interaction with US2 marked in grey
(according to crystal structure data from Gewurz et al.((35)). The US2 binding site of HLA-A2 has been aligned with corresponding regions of
other alleles, and their locus (sub)group consensus sequences (cons) obtained from the IMGT/HLA Sequence Database (11). (B). J26 cells
were transfected with different HLA class I mutants, transduced with US2-IRES-EGFP encoding retrovirus and analyzed using flow cytometry.
The following mAbs were used to stain the different human MHC class I molecules with PE, in a 3-step staining protocol (Y-axis): HLA-A2, -
A21-184/E (BB7.2), HLA-B, HLA-E1-184/A2 (W6/32), HLA-E (MEM-E/06). US2 positive cells are marked by EGFP expression (X-axis).(C) J26
cells expressing wt HLA-E or HLA-E QRTD or cells co-expressing US2 were meta-bolically labeled for 10 minutes and chased for 0 or 30
minutes in the absence or presence of proteasome inhibitor ZL3H. Immuno-precipitations were performed on denatured cell lysates using the
following antisera: H68.4 (transferrin receptor [TfR]), MEM/02 (HLA-E) or US2-N2 (US2) Abs. Deglycosylated degradation inter-mediates are
marked by an asterisk. 
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domains of MHC class I can greatly affect their 
sensitivity to US2-mediated degradation. 
In contrast to US2, US11 can discriminate between 
MHC class I locus products on the basis of their 
cytoplasmic tail seq uences.  
For US11 it is still rather unclear which regions of 
MHC class I molecules determine allelic sensitivity 
differences to US11-mediated down-regulation. 
Chimeric HLA-A2/G molecules, consisting of US11-
sensitive HLA-A2 and US11-resistant HLA-G alleles, 
showed that the length of the cytoplasmic tail was the 
most important determinant for the insensitivity of 
HLA-G (19). An extension of the short (6 amino acids) 
HLA-G tail with residues matching the relatively long 
(33 amino acids) tail of HLA-A2 made it very sensitive 
to US11-mediated degradation. However, this 
information cannot directly explain the insensitivity to 
US11-mediated down-regulation for HLA-E, which has 
a relatively long cytoplasmic tail of 29 residues. 
Chimeras of HLA-E and HLA-A2 were constructed to 
test which regions determine resistance or sensitivity 
to US11 (see Figure 2A). Like for US2, we first 
evaluated the effect of US11 on surface expression of 
the HLA-A21-184/E and HLA-E1-184/A2 chimeras. Figure 
3B shows that the HLA-A2/E chimera consisting of 
residues 1-184 of HLA-A2 was somewhat down-
regulated in US11 positive cells. This chimera was 
more sensitive to US11 compared to wild type HLA-E, 
but less sensitive than wild type HLA-A2. HLA-E1-
184/A2 on the other hand, was as sensitive to US11 as 
wild type HLA-A2, with an almost complete reduction 
FIGURE 3. Ex change of ER-lumenal domains or ex tension of the cytoplasmic tail of HLA-E by two residues alter their sensitivity to
US11-mediated degradation. (A) Overview of HLA-A2/E chimeras showing regions that are exchanged. (B) J26 cells transfected with the
HLA class I chimeras shown in (A) and transduced with US11-IRES-EGFP encoding retrovirus were analyzed using flow cytometry. HLA
class I molecules were stained with PE in a 3-step staining protocol (Y-axis) using MEM-E/06 mAb, except for HLA-A2, -A21-184/E (BB7.2),
and HLA-E1-184/A2, -E- 3+c A2 which were stained with W6/32 mAb. US11 positive cells are marked by EGFP expression (X-axis). (C) J26
cells expressing wt HLA-E or HLA-E+K V  or cells co-expressing US11 were metabolically labeled for 10 minutes and chased for 0 or 30
minutes in the absence or presence of proteasome inhibitor ZL3H. Immuno-precipitations were performed on denatured cell lysates using the
following antisera: H68.4 (transferrin receptor [TfR]), MEM/02 (HLA-E) or US11-N2 (US11) mAbs. 
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of surface expression. We then tested what region of 
HLA-A2 was responsible for this down-regulation of 
HLA-E1-184/A2. Replacement of the 3 domain and 
connecting peptide region with the corresponding 
domains of HLA-A2 (HLA-E( 3+c A2)) caused a slight 
reduction in surface expression, observed in the 
highest EGFP (and US11)-expressing population only. 
Replacement of the transmembrane region (HLA-
E(TM A2)) showed no effect. Exchanging the 
cytoplasmic tail (HLA-E(tail A2)) however, resulted in 
a remarkable increase in sensitivity to US11. This 
indicated once again that the cytoplasmic tail can be 
an important determinant for US11-mediated down-
regulation.  
A more detailed analysis was performed to determine 
which element of the HLA-A2 tail made the HLA-E(tail 
A2) chimera sensitive to US11. In a previous report, 
we have shown that MHC class I heavy chains are 
less sensitive to US11-mediated down-regulation 
when the cytosolic tail lacks the lysine and valine 
residues at the extreme end (19). HLA-E molecules 
have a slightly shorter tail than HLA-A2 as they lack 
C-terminal –ACKV residues. We tested whether 
addition of these residues could increase the 
sensitivity of HLA-E to US11-mediated down-
regulation. Figure 3B shows that an extension of the 
cytoplasmic tail with–ACKV or –KV residues markedly 
reduced surface expression of these HLA-E mutants 
in US11 expressing cells.  
We also evaluated the effect of US11 on the stability 
of HLA-E+KV in pulse chase experiments (Figure 3C). 
In the absence of proteasome inhibitor (left panel), 
HLA-E+KV heavy chains remained stable over time in 
US11 negative cells, but were clearly unstable in the 
presence of US11. This effect of US11 is specific for 
class I HC’s, as the amount of transferrin receptor in 
these cells was not reduced. In the presence of 
proteasome inhibitor (middle and right panel), a 
deglycosylated breakdown intermediate was observed 
only in cells expressing US11 and only for HLA-E with 
the –KV extension, but not for wild type HLA-E. 
From these results we can conclude that HLA-E, like 
HLA-G, becomes sensitive to US11-mediated 
degradation when its tail is extended with HLA-A2 tail 
residues. This indicates that the cytoplasmic tail can 
be an important determinant for sensitivity to US11. 
Interestingly, it only required two extra residues at its 
C-terminus for HLA-E to become completely sensitive 
to US11. Clearly, the tail is not the only determinant, 
as the 1/ 2 region and to a lesser extent the 
3/connecting peptide region also contribute to the 
efficiency of US11-mediated down-regulation of MHC 
class I molecules.  
C-terminal lysine and valine residues influence 
efficiency, but are not essential for US11-mediated 
down-regulation of MHC class I molecules.  
When looking at the cytoplasmic tail sequences of 
MHC class I locus products, it becomes evident that 
other class I molecules besides HLA-G and HLA-E 
(e.g. HLA-B molecules), lack lysine and valine 
FIGURE 4 . Cytoplasmic tail residues of MHC class I molecules determine efficiency of US11-mediated down-regulation. (A) Alignment of
amino acid sequences of the cytoplasmic tail region of different MHC class I locus products consensus sequences, obtained from the IMGT/HLA
Sequence Database (11). (B) J26 cells expressing wt HLA-A2, HLA-A2delCKV, or HLA-A2(tailE) were transduced with US11-IRES-EGFP encoding
retrovirus and analyzed using flow cytometry. HLA class I molecules were stained with PE in a three step staining protocol using BB7.2 as first mAb
(Y-axis). US11 positive cells are marked by EGFP expression (X-axis). 
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residues at their C-terminal tail (Figure 4A). Figure 3 
already showed that ER-lumenal regions influence the 
efficiency of down-modulation by US11. To evaluate if 
this region could also be sufficient for down-
modulation of HLA-A2 molecules in the absence of 
lysine and valine residues, we tested two different 
HLA-A2 mutants. One mutant (HLA-A2delCKV) lacks 
the last three C-terminal residues, as do HLA-B 
alleles, and the other mutant has the same tail as 
HLA-E molecules (HLA-A2(tailE)). Figure 4B shows 
that other regions than the cytoplasmic tail KV 
residues can mediate sufficient interactions for a 
US11-mediated reduction in surface expression, as 
HLA-A2 mutants without these residues were also 
down-regulated. Interestingly, the efficiency of down-
regulation of class I molecules lacking (A)CKV 
residues seems to be somewhat lower than of those 
with these residues at the extreme end of the tail. In 
general, the level of down-modulation is lower in the 
low EGFP positive cells and increases with rising 
EGFP (i.e. US11) levels. In cells expressing highly 
sensitive wild type HLA-A2, effective reduction in 
surface expression can also be observed in cells 
expressing relatively low levels of EGFP.  
These results show that the C-terminal KV residues 
do not necessarily function as strong determinants for 
sensitivity to US11 for all locus products. As opposed 
to the crucial role of KV residues in US11-mediated 
down-regulation of HLA-E molecules, they are less 
important for down-regulation of other MHC class I 
locus products. This is shown for HLA-A2 molecules, 
where the (C)KV tail residues could be removed 
without completely loosing sensitivity to US11. It can 
also explain the observed down-regulation of HLA-B 
molecules (Figure 1A), which naturally lack CKV 
residues. However, the presence or absence of these 
KV residues can nevertheless influence the efficiency 
of down-modulation by US11, and can determine the 
levels of US11 that are required for sufficient 
modulation of antigen presentation by MHC class I. 
DISCUSSION
HCMV encodes several proteins that interfere with 
cross talk between infected host cells and host 
immune effector cells through modulation of surface 
expression of MHC class I molecules. The success of 
immune escape by HCMV through modulation of 
MHC class I surface expression is likely to be 
influenced by the efficiency, as well as by the 
specificity of this down-modulation by the different US 
proteins. US3 mainly affects surface expression of 
tapasin-dependent MHC class I alleles (20). By 
blocking TAP, US6 prevents peptide transport into the 
ER and subsequent peptide loading. This affects 
surface expression of all MHC class I alleles (2,3). In 
spite of this, surface expression of HLA-E molecules 
is preserved by supplying it with a TAP-independent 
peptide source (30,36). In this study we focused on 
US2 and US11, which both target different sets of 
newly synthesized MHC class I molecules for 
degradation. In this study we further clarify how, and 
to what extend, US2 and US11 can contribute to the 
efficiency and specificity of MHC class I down-
regulation.  
We and others have found that US2 differentially 
affects surface levels of individual human MHC class I 
locus products (23,32,34). Based on crystal structure 
data of HLA-A2/ 2m/US2 and sequence alignments 
for the region of class I implicated in US2 binding, we 
hypothesized that allelic variation in the 2/ 3 ER-
lumenal region could form an explanation for the 
resistance of HLA-B7, HLA-Cw3 and HLA-E (35). In 
the present study, we tested this hypothesis to see if 
this would result in a more reliable prediction of US2 
sensitivity of, as of yet, untested MHC class I alleles. 
Using chimeras derived from US2-sensitive (HLA-A2) 
and –insensitive (HLA-E) alleles, we found that there 
are no other regions in HLA molecules, outside the 
ER-lumenal region implicated in US2-binding, that 
contribute to US2-mediated down-regulation. 
Sequence alignments of HLA-B27 and HLA-B7 also 
point to a role of the ER-lumenal region in selective 
down-regulation of only HLA-B27 and not HLA-B7, as 
there are no differences in the amino acid sequence 
outside the ER-lumenal region between these two 
alleles.  
We then investigated if we could convert the 
resistance of HLA-B7 and HLA-E by replacing those 
residues that are assumed to prohibit an interaction 
with US2, with the corresponding residues found in 
US2-sensitive alleles (as described in figure 2A). The 
HLA-B7 ET(L)Q and HLA-E QRTD mutants showed that 
residues in this region are indeed important sensitivity 
determinants, as this alteration of only 3 or 4 residues 
clearly affected the surface expression of these 
mutants in the presence of US2. We showed for HLA-
E QRTD that it is targeted for degradation, thereby 
excluding the possibility that retention is the 
underlying mechanism for the observed down-
modulation. 
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We also tried to find an explanation for the resistance 
of H L A -C w 3  alleles to U S 2 -m ediated dow n-reg u lation. 
T he presence of particu lar residu es at positions 1 8 3  
(E ) and 1 8 4  (D ) appeared not to b e responsib le for its 
resistance. T his is su pported b y  recent data show ing  
that H L A -C  m olecu les (H L A -C w 7  and – C w 2 ), w hich 
all hav e E 1 8 3  and D 1 8 4 , can nev ertheless b e dow n-
reg u lated b y  U S 2  ((3 4 ); ou r ow n u npu b lished resu lts). 
N onetheless, seq u ence v ariation at this site m ay  still 
affect the efficiency  of dow n-m odu lation, as U S 2 -
resistant H L A -C w 3  alleles b ecam e som ew hat m ore 
sensitiv e w hen E 1 8 3 D , H 1 8 4 P  m u tations w ere 
introdu ced (u npu b lished resu lts). H ow ev er, the 
presence of a positiv ely  charg ed ly sine residu e at 
position 1 7 3  is the m ost lik ely  explanation for the 
resistance to U S 2 -m ediated dow n-reg u lation of H L A -
C w 3 , since U S 2 -sensitiv e alleles, inclu ding  the 
m ajority  of H L A -C  alleles, hav e a neg ativ ely  charg ed 
g lu tam ic acid at position 1 7 3 . 
F or U S 1 1 , the only  M H C  class I locu s produ cts 
com pletely  insensitiv e to dow n-m odu lation w ere H L A -
G  and H L A -E  (F ig u re 1 ). Interesting ly , all that is 
req u ired to confer sensitiv ity  to these tw o M H C  class I 
locu s produ cts, is an extension of their cy toplasm ic 
tail. P rev iou s stu dies hav e show n that the leng th of 
the class I cy toplasm ic tail is v ery  im portant. T ailless 
H L A -A 2  m olecu les (w ith a tail shortened to either 4  or 
6  am ino acids) cou ld no long er b e targ eted for 
deg radation b y  U S 1 1  (1 9 ,3 7 ). C onv ersely , H L A -G  
m olecu les natu rally  hav e a tail of 6  residu es and an 
extension of this tail w ith 2 7  H L A -A 2  tail residu es 
resu lted in a v ery  efficient deg radation of these 
m u tants in U S 1 1  positiv e cells (1 9 ). Interesting ly , an 
extension of the tail of H L A -G  w ith 2 5  H L A -A 2  tail 
residu es did not g iv e this resu lt. A pparently , the C -
term inal ly sine and v aline residu es w ere essential for 
deg radation. H L A -E  has a cy toplasm ic tail that lack s 
only  4  residu es com pared to H L A -A  m olecu les (see 
F ig u re 4 A ). Interesting ly , H L A -E  req u ired only  2  extra 
residu es (ly sine and v aline) to b ecom e sensitiv e to 
U S 1 1 . T his indicates that the leng th of the tail can b e 
an im portant determ inant for sensitiv ity  differences 
am ong  M H C  class I locu s produ cts. H L A -B  m olecu les, 
on the other hand, also lack  the ly sine and v aline 
residu es at their C -term inu s, b u t are nev ertheless 
dow n-m odu lated b y  U S 1 1 . We show ed in fig u re 4  that 
the ly sine and v aline residu es are not essential for 
dow n-reg u lation of all haploty pes, as H L A -A 2  w ith a 
tail as long  as that of H L A -B  m olecu les (H L A -
A 2 delC K V ) or w ith the H L A -E  tail cou ld still b e dow n-
m odu lated b y  U S 1 1 . T hese residu es can, how ev er, 
determ ine the effectiv eness or threshold for dow n-
reg u lation, as H L A -A 2 delC K V  and H L A -A 2 (tail E ) 
seem ed to req u ire hig her lev els of U S 1 1  than w ild 
ty pe H L A -A 2  for a sim ilar dow n-reg u latory  effect. A t 
the sam e tim e, these data show  that E R -lu m enal 
residu es also influ ence sensitiv ity  to U S 1 1 . T his is 
fu rther su pported b y  ou r finding s that the exchang e of 
1 / 2  dom ains or of the 3  dom ain of H L A -E  w ith 
those of H L A -A 2  cou ld, to som e extent, also chang e 
the efficiency  of dow n-m odu lation b y  U S 1 1 .  
Whereas specificity  of U S 2 -m ediated dow n-
m odu lation seem s to rely  m ostly  on a reg ion at the 
ju nction of the 2 / 3  dom ain, these data indicate that 
the conditions are different and m ore com plicated for 
U S 1 1 . A lthou g h E R -lu m enal residu es do play  a role, 
replacem ent of residu es L H L E  in H L A -E  b y  Q R T D  did 
not affect its sensitiv ity  to U S 1 1  (u npu b lished resu lts). 
A lso, U S 2  does not req u ire M H C  class I tail residu es, 
b u t U S 1 1 -m ediated dow n-m odu lation depends larg ely  
on this reg ion. In principal, all M H C  class I 
cy toplasm ic dom ains, w ith the exception of H L A -G , 
b ear the essential residu es necessary  for U S 1 1  to 
targ et them  for deg radation. O u r data indicate that a 
m inim u m  of 2 9  class I tail residu es has to g o w ith 
either a fav orab le E R -lu m enal reg ion, or w ith ly sine 
and v aline tail residu es in order to see su fficient dow n-
m odu lation. A  fav orab le E R -lu m enal reg ion m ay  
b y pass the fu nction of the K V  residu es throu g h a 
prolong ed and/or strong er interaction w ith U S 1 1 , 
thereb y  increasing  the chances of dislocation and 
su b seq u ent deg radation. 
T he fu nction of the K V , as w ell as of the other tail 
residu es is still u nclear. E nhancem ent of dow n-
reg u lation b y  the K V  residu es m ay  rely  on the ly sine, 
fu nctioning  as a potential u b iq u itination site. It is 
k now n that u b iq u itination is essential for U S 1 1 -
m ediated targ eting  for dislocation and su b seq u ent 
deg radation of M H C  class I m olecu les (2 9 ,3 8 ). 
A lthou g h a stu dy  b y  S ham u  et al. show ed that ly sine 
residu es in the tail of H L A -A 2  are not essential for 
U S 1 1 -m ediated deg radation, elim ination of H L A -A 2  
w ithou t ly sine residu es in the tail seem ed to b e 
retarded com pared to w ild ty pe H L A -A 2  (3 9 ). 
A lternativ ely , the K V  residu es m ay  m erely  facilitate 
access of com ponents of the dislocation/deg radation 
m achinery  to essential residu es residing  w ithin 
another reg ion of the tail. P hosphory lation can b e an 
im portant sig nal for dock ing  of E 3  lig ases, w hich in 
tu rn can u b iq u itinate their su b strates (4 0 ). T he tail of 
M H C  class I m olecu les encodes sev eral potential 
phosphory lations sites, one of w hich, S 3 3 5 , is a 
k now n phosphory lation site that can b e fou nd in all 
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class I locus products (41,42). We have mutated this 
residue S335 in HLA-A2, as well as two other 
potential phosphorylation sites close by (S328, S332) 
and replaced them with alanine. However, these 
mutants did not behave any differently from wild type 
HLA-A2, in the presence of US11 (unpublished 
results). More research will be required to unravel why 
the tail is essential for US11 to mark MHC class I 
molecules as substrate for the ubiquitination 
machinery. 
All in all, we showed here that sequence variation 
around the region comprising residues 176-183 
accounts for sensitivity differences of MHC class I 
locus products to US2-mediated degradation. This 
knowledge provides a valuable tool to predict the 
effect of US2 on a broader range of HLA class I 
molecules. For US11, we showed that not only ER-
lumenal regions, but also cytosolic tail residues are 
important determinants for the outcome of the down-
modulatory effect of US11 on different class I locus 
products. The length of the tail can explain the 
insensitivity of HLA-G and HLA-E, and may also 
determine the efficiency by which other HLA class I 
molecules are down-modulated. More research is still 
required to define which regions in the 1, 2 and 3
domains of MHC class I molecules are also playing a 
role.
It is remarkable that the difference between complete 
resistance and full sensitivity of HLA-E alleles to US2 
and US11-mediated degradation relies on as few as 
2-4 residues. It is known that a preserved surface 
expression of HLA-E supports immune escape from 
NK cell attack of HCMV infected cells (34,36,43). 
From this point of view, it would be beneficial for the 
host to reduce its HLA-E surface levels in HCMV 
infected cells. As mentioned before, it requires only 
small modifications within HLA-E to render this 
molecule sensitive to US2 or US11. Despite a long co-
evolution of virus and host, HLA-E demonstrates 
limited polymorphism. This may imply that the 
residues determining resistance to these viral proteins 
are essential for interactions of HLA-E with 
components of the antigen presentation pathway 
and/or its biological function.  
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CHAPTER 5
Ubiquitination is essential for human
c y tomeg alov irus US 1 1 -med iated   
d isloc ation of M H C  c lass I molec ules  
from the end op lasmic  retic ulum to the c y tosol 
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H uman cytomegalovirus encodes tw o glycop roteins, US2  and US11, w hich cause rap id degradation of 
M H C  class I molecules, thus p reventing recognition of virus-infected cells by the immune system. T his 
degradation p rocess involves retrograde transp ort or 'dislocation' of M H C  class I molecules from the 
endop lasmic reticulum (E R ) to the cytosol, w here they are deglycosylated by an N -glycanase and 
degraded by the p roteasome. A t p resent it is unk now n w hether ubiquitination is required for US2 - and 
US11-mediated dislocation and degradation of M H C  class I molecules. H ere, w e show  that in E 3 6 ts2 0  
hamster cells, w hich contain a temp erature-sensitive mutation in the E 1 ubiquitin-activating enz yme, 
US11-mediated degradation of M H C  class I molecules is strongly imp aired at the non-p ermissive 
temp erature, indicating the necessity for ubiquitination in this p rocess. W e nex t addressed the question 
of w hether ubiquitination is a condition for the retrograde movement of M H C  class I molecules from the 
E R  to the cytosol, or w hether ubiquitination is merely required for recognition of dislocated M H C  class I 
molecules by the p roteasome. In the absence of a functional ubiquitin system, comp lex es of US11 and 
M H C  class I molecules accumulate in the E R . In this state the membrane top ology of M H C  class I 
molecules does not significantly change, as judged from p roteinase K  digestions. T hus the results 
indicate that a functional ubiquitin system is essential for dislocation of M H C  class I molecules from the 
E R  to the cytosol. 
T he p roteasome mediates deg radation not only  of 
cy tosolic and nuclear p roteins [1 ,2 ], b ut also of 
p roteins that reside in the ER  [3 ,4 ]. T his discovery  
imp lied that ER  p roteins destined for deg radation must 
b e transp orted, or “dislocated”, b ack to the cy tosol for 
them to access the deg radation machinery . 
D islocation and sub seq uent deg radation b y  the 
p roteasome has b een ob served for an increasing  
numb er of ER  p roteins in several different org anisms 
(review ed in [2 -5 ]). O f p articular interest is the 
deg radation of MHC class I molecules, w hich are 
neither misfolded, nor destined for deg radation b y  
cellular sig nals like most know n sub strates, b ut w hich 
are targ eted for deg radation b y  either of tw o human 
cy tomeg alovirus (HCMV )-encoded g ly cop roteins, U S 2  
or U S 1 1  [6 ,7 ].
P roteasomes w ere imp licated in this deg radation 
p rocess b ased on the use of p roteasome inhib itors, 
w hich caused accumulation of deg ly cosy lated MHC 
class I b reakdow n intermediates in the cy tosol [6 ,7 ]. 
S uch cy tosolic deg ly cosy lated intermediates w ere also 
found in the course of deg radation of T -cell recep tor 
(T CR )α-chains transiently expressed in non-T cells, 
u sing  proteasom e inhib itors [8 ,9 ]. B ased on co-
precipitation of deg lycosylated M H C  class I heav y 
chain interm ediates w ith sec6 1 ß  [7 ], the translocon is 
prob ab ly inv olv ed in b oth anterog rade and retrog rade 
transport of proteins across the E R  m em b rane. 
E xperim ents inv olv ing  sec6 1 p m u tants in yeast 
su pport this notion [1 0 -1 2 ].  
C ov alent attachm ent of u b iq u itin chains to lysine 
residu es is the m ain m ode of targ eting  proteins to 
proteasom es. U b iq u itinated proteins are recog niz ed 
b y su b u nits of the 1 9 S  cap of the 2 6 S  proteasom e 
[2 ,4 ]. Inv olv em ent of u b iq u itination in deg radation of 
E R  proteins b y the proteasom e w ou ld therefore b e 
anticipated, and indeed u b iq u itination w as show n to 
b e essential for deg radation of sev eral E R  su b strates 
[1 3 -1 8 ]. S om e su b strates, how ev er, are deg raded b y 
the proteasom e in a u b iq u itin-independent m anner 
[1 9 -2 1 ].
A t present, it is u nk now n w hether u b iq u itination is 
req u ired for U S 2 - and U S 1 1 -m ediated dislocation and 
deg radation of M H C  class I m olecu les. S ham u  and co-
w ork ers show ed that a proportion of the M H C  class I 
heav y chains are u b iq u itinated in U S 1 1 -expressing  
cells, b u t their resu lts failed to show  w hether 
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ubiquitination is a condition for dislocation or whether 
it is merely a consequence of dislocation to the cytosol 
[22].
The attachment of multiple ubiquitin molecules to 
proteins involves the action of three enzymes, the 
ubiquitin-activating enzyme, designated E1, a 
ubiquitin-conjugating/carrier enzyme or E2, and a 
ubiquitin ligase or E3 [2]. W e used the E36-ts20 
hamster cell line, which contains a temperature-
sensitive mutation in the E1 ubiquitin-activating 
enzyme, to monitor the effects of a disrupted ubiquitin 
system on US11-mediated degradation of MHC class I 
molecules. The results indicate that the early step of 
dislocation of MHC class I molecules from the ER to 
the cytosol is blocked when the ubiquitin system is not 
functional. This suggests dual ubiquitin dependence, 
since it is anticipated that ubiquitination is also needed 
for recognition of the degradation substrate by the 
proteasome at a later stage of the degradation 
pathway. 
MATERIALS AND METHODS 
Materials 
The hamster cell lines E36 and E36ts20 (the latter 
referred to as ts20 throughout the rest of the article) 
[23] were maintained at 33° C under an air/ CO 2 (19:1)
atmosphere in minimal essential medium (MEMα;
G ibco BRL ) supplemented with 10%  (v/v) foetal calf 
serum (G reiner), penicillin (100 units/ml) and 
streptomycin (100 µ g/ml) (G ibco BRL ). 
A polyclonal antiserum against the cytoplasmic tail of 
HL A-A2 was produced in rabbits using the synthetic 
peptide K G G SY SQ AASSD SAQ G SD . P olyclonal 
antiserum against US11 was raised in rabbits using 
the synthetic peptide L SL TL F D EP P P L V ETEP L , 
derived from the cytoplasmic tail of US11. P olyclonal 
rabbit serum specific for unfolded MHC class I heavy 
chains has been described [24], as well as W 6/32 
monoclonal antiserum, specific for assembled MHC 
class I heavy chain-β2m complexes [25 ], and 
monoclonal antiserum HCA2 against the lumenal 
domain of HL A-A2 heavy chains [26]. 
The proteasome inhibitors carboxybenzyl-leucyl-
leucyl-leucinal (Z L 3H) and carboxyl benzyl-leucyl-
leucyl-leucyl vinylsulfone (Z L V S) were from P eptide 
Institute, Inc. (J apan) and used in a final concentration 
of 20 µ M.
A pcD N A3 derivative, encoding HL A-A0201 under 
control of the CMV  promoter, was constructed as 
follows. The plasmid pSRα1N eo-HL A-A2, provided by 
D r J . Alejandro Madrigal (The Anthony N olan 
Research Centre, The Royal F ree Hospital, L onden, 
UK ), was digested with X hoII, after which the fragment 
encompassing the HL A-A2 coding region was 
rendered blunt by digestion of the 5 ' protruding ends. 
The blunt-ended fragment was digested with HindIII 
and ligated with the large EcoRV -HindIII fragment of 
pSP 72 (P romega). The HL A coding region was then 
re-isolated as a BglII-X hoI fragment and cloned into 
BamHI-X hoI digested pcD N A3 (Invitrogen). The 
resulting plasmid was designated pL UMC9901.  
The plasmid containing US11 and the puromycin 
resistance gene (pIE-puro US11) has been described 
[27].
S tab le tran sfec tio n  o f H L A -A 2  an d  U S 1 1  in to  E 3 6  an d  
ts2 0  c ell lin es 
The plasmids containing HL A-A2 and US11 were 
transfected separately or together into ts20 and E36 
cells, which were both kept at 30-33ºC, using F ugene 
(Roche) according to the manufacturer’s directions. 
After 48 hours, G 418 (G eneticin; G ibco BRL ) or 
puromycin (ICN ) was added to the transfected cells at 
amounts that killed untransfected cells within a few 
days. Clones were tested for expression of the genes 
of interest by radiolabelling and immunoprecipitation 
(see below). 
P re-in c u b atio n  o f c ells at d ifferen t tem p eratu res 
P rior to pulse-chase analysis cells were pre-incubated 
at 40ºC (the non-permissive temperature) or other 
temperatures as indicated in the figures. Culture flasks 
containing cells were transferred from the stove to a 
closed waterbath at the chosen temperature, in which 
they were incubated for 2 hrs. Starvation and pulse-
chase incubations were all performed at the same 
temperature.
P u lse-c h ase an aly sis, im m u n o p rec ip itatio n  an d  S D S / 
P A G E
After trypsinization, suspended cells were starved in 
RP MI 1640 medium (BioW hittaker) without methionine 
and cysteine for approx. 1 h at either 33ºC or 40ºC. 
The proteasome inhibitor Z L 3H was added where 
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indicated. The cells were metabolically labelled with 
250 µCi 35S-labelled Redivue Promix (a mixture of L-
[35S ]methionine and L-[35S]cysteine; Amersham) per 
107 cells in starvation medium (pulse). For chase 
samples radioactive medium was replaced with RPMI 
1640 medium supplemented with 1mM methionine 
and 0.1mM cysteine. Pulsed and chased cells were 
lysed in Nonidet P-40 (NP40) containing lysis buffer as 
described in [24]. 
Before immunoprecipitation, two subsequent preclears 
were performed using normal rabbit and normal 
mouse sera pre-coupled with mixed (1:1) Protein A-
Sepharose and Protein G-Sepharose beads. 
Immunoprecipitation was performed on the precleared 
lysate for 2-4 hours at 4ºC using specific antiserum 
pre-coupled to Protein A/G-Sepharose beads. Beads 
were washed with NET-buffer [50 mM Tris/HCl, pH 
7.4/ 150 mM NaCl/ 5 mM EDTA/ 0.5% (v/v) NP-40] 
supplemented with 0.1 % SDS and subsequently 
boiled in sample buffer [40 mM Tris/HCl, pH8.0/ 4 mM 
EDTA/ 8% (w/v) SDS/ 40% (v/v) glycerol/ 0.1% 
Bromophenol Blue] for 5-10 min. Samples were 
loaded on SDS/polyacrylamide gels and run overnight. 
Gels were dried and exposed to a storage 
PhosphorImaging screen, which was scanned in a 
Personal Molecular Imager FX and analysed with 
Quantity One software (BioRad). 
FACS analysis of cell surface expression of MHC 
class I molecules 
FACS analysis of cell surface expression of HLA-A2 
was performed as described by Ressing et al. [28] 
using W6/32 antiserum and goat-anti-mouse-FITC 
conjugate (Jackson, WA, USA).  
Infection w ith v accinia v irus  
Infection with vaccinia virus was performed as 
described previously [29]. Briefly, E36 and ts20 were 
infected simultaneously with recombinant vaccinia 
viruses expressing HLA-A2 (vvA2) and HCMV US11 
(vvUS11), respectively. Cells (106/ml in RPMI without 
serum) were infected with virus at a multiplicity of 
infection of 1 for vvA2 and 1.5 for vvUS11. After 1 h of 
infection, complete medium was added to the infected 
cells. Cells were subsequently incubated at 40ºC for 3 
h followed by a 1 h starvation period in media lacking 
methionine and cysteine in the presence of 
proteasome inhibitor where indicated. Pulse-chase 
experiments were performed as described above.  
Subcellular fractionation 
Fractionation of cells was performed essentially as 
described by Wiertz et al. [6]. In brief, about 107 cells 
were starved and labelled for 30 minutes with 35S
Redivue Promix as described above. Cells were 
washed and resuspended in 1 ml of homogenization 
buffer [0.25 M sucrose/ 10 mM triethanolamine/ 10 
mM potassium acetate/ 1 mM EDTA, pH 7.6], 
supplemented with protease inhibitors leupeptin (0.1 
mM) and AEBSF (10 mM)). Cells were placed on ice 
and homogenized in a Dounce homogenizer (50 
strokes) with a tight-fitting pestle. The homogenate 
was spun for 10 minutes at 4ºC and 1000 g in an 
Eppendorf centrifuge. The pellet was saved and the 
supernatant was spun for 30 minutes at 4ºC and 
10,000 g. Again the pellet was saved and the 
supernatant was spun for 1h at 4ºC and 100,000 g.
The latter two centrifugations were performed in a TLA 
120.2 fixed-angle rotor, operated in a Beckman 
Optima® TLX ultracentrifuge. All pellets were 
resuspended in NP-40 lysis buffer. HLA-A2 and US11 
were immunoprecipitated simultaneously from the 
solubilized pellets and the 100,000 g supernatant by 
immunoprecipitation and separated by SDS-PAGE. 
PhosphorImaging was performed as described above. 
Proteinase K  digestions 
After pre-incubation at 30ºC or 40ºC, cells were 
labelled with 35S-Redivue Promix as described above 
and subsequently resuspended in 200 µl of cold 
permeabilization buffer (containing 25 mM HEPES pH 
7.2, 115 mM potassium acetate, 5 mM sodium 
acetate, 2.5 mM MgCl2, and 0.5 mM EGTA). 
Proteinase K (Life Technologies) was added in 
concentrations as indicated and digitonin 
(Calbiochem) was added in concentrations that were 
always 100 times higher than the proteinase K 
concentrations used. The cells were incubated with 
the digestion mix at 4ºC for 20 minutes. Proteolysis 
was stopped by centrifuging cells at 14000 g for 10 
minutes and resuspending the pellets in 1 ml NP-40 
lysis buffer containing 2mM PMSF. For denaturing 
immunoprecipitations pellets were resuspended in 150 
µl lysis buffer containing 2 mM PMSF and 1% (w/v) 
SDS and boiled for 5 min., after which 800 µl lysis 
buffer was added. Immuno-precipitations, SDS/PAGE 




Re c o n s titu tio n  o f US1 1  m e d ia te d  b r e a k d o w n  o f 
HLA-A2  in  h a m s te r  c e lls
The hamster cell line ts20, containing a temperature-
sensitive mutation in the E1 ubiquitin-activating 
enzyme, and the parental cell line E36 [23] were 
stably transfected with human HLA-A2, HCMV US11, 
or both genes together (see Materials and Methods).  
HLA-A2 transfected into ts20 cells is stable at the 
permissive temperature of 33ºC (Figure 1), and 
matures from free heavy chains detected by rabbit 
anti-heavy-chain serum (Figure 1, lanes 1 and 2) to 
mature, fully assembled molecules as detected by the 
conformation-dependent antibody W6/32 (Figure 1, 
lanes 3-5). For HLA-A2, W6/32 reactivity not only 
requires association with β2m but also binding of 
antigenic peptide [25]. W6/32 reactive MHC class I 
molecules obtained after 90 minutes of chase are 
endoglycanase H (EndoH)-resistant (Figure 1, lane 6), 
indicating their transport to the Golgi apparatus. Cell 
surface expression of transfected HLA-A2 molecules 
was analysed using flow cytometry (Figure 2). Figure 
2 (B) shows that ts20 cells transfected with HLA-A2 
express these molecules on their surface. Taken 
together the data indicate that HLA-A2 is stably 
expressed in hamster cells, associates with hamster 
β2m, acquires antigenic peptides and is transported to 
the cell surface at 33ºC. 
When US11 was co-transfected together with HLA-A2 
into ts20 cells, the MHC class I molecules were 
degraded at the permissive temperature of 33ºC, as 
assessed by immunoprecipitations with either 
polyclonal rabbit anti-(MHC class I heavy chain) serum 
(Figure 1, lanes 7 and 8) or the conformation 
dependent antibody W6/32 (Figure 1, lanes 9-12). The 
amount of surface-expressed HLA-A2 was 
dramatically lower in the cells that express HLA-A2 
and US11 (Figure 2C), which is attributed to efficient 
degradation of HLA-A2 at the permissive temperature. 
Very similar results were obtained with E36 cells 
transfected with HLA-A2 and/or US11 (see below). 
Pulse-chase analysis of ts20 cells transfected with 
US11 alone showed that endogenous hamster MHC 
class I molecules are not degraded (results not 
shown). 
In h ib itio n  o f th e  p r o te a s o m e  in te r fe r e s  w ith  
d is lo c a tio n  a n d  d e g r a d a tio n  o f HLA-A2  
Treatment of E36 HLA+ US11 cells (Figure 3) and ts20 
HLA+ US11 cells (results not shown) with the 
proteasome inhibitor ZL3H delays US11 mediated 
degradation of MHC class I molecules and causes a 
F ig u r e  1 . US1 1  m e d ia te d  d e g r a d a tio n  o f HLA-A2  in  ts 2 0  h a m s te r  c e lls . ts20 cells stably transfected with HLA-A2 alone (ts20 HLA), or both 
HLA-A2 and US11 (ts20 HLA+ US11) were pulse-labelled with [35S]methionine/ [35S]cysteine as described in Materials and Methods for 8 min and 
chased for the periods indicated at 33°C. Lysates were split and subjected to immunoprecipitation with polyclonal antiserum against the unfolded 
MHC class I heavy chain (αHC), or conformation dependent antiserum (W6/32), which recognizes the complex of MHC class I heavy chain with 
ß2m and peptide. Samples in lanes 6 and 12 were treated with endoglycosydase H (endoH). The immunoprecipitates were separated on an 
SDS/polyacrylamide (10%) gel. The experiment was repeated twice with very similar results, the data shown here are from one of these 
experiments.
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Figure 2. HLA-A2 surface ex pression is down-regulated in ts20 
cells ex pressing US11. A FACS experiment was performed to assess 
the cell surface expression of HLA-A2 in different cell lines. At least 105
cells were sorted per measurement. The x axes represent fluorescence 
intensity (arbitrary units) and y axes represent cell counts. Cells grown 
at 33°C were incubated with W6/32 antiserum and subsequently with 
goat-anti-mouse-FITC respectively (black lines). As a control, cells 
were incubated with goat anti-mouse-FITC alone (dotted lines); (A) Wild 
type ts20 cells; (B) ts20 cells transfected with HLA-A2; (C) ts20 cells 
transfected with HLA-A2 and US11.
Figure 3 . Effect of proteasome inhibitor on US11 mediated 
degradation of HLA-A2 in E3 6  cells. E36 HLA+US11 cells were 
pulse-labelled (10 min) with [35S]methionine/ [35S]cysteine as described
in Materials and Methods and chased for 0, 10, 30, and 90 min at 33°C,
with or without the proteasome inhibitor ZL3H. HLA-A2 molecules were 
immunoprecipitated with antiserum against the cytoplasmic tail of MHC 
class I molecules and separated on an SDS/polyacrylamide (10%) gel. 
In the graph, relative volumes of bands representing HLA-A2 molecules 
with carbohydrate (HLA+CHO) were plotted (measured in arbritary 
units, counts/mm2). The experiment was performed twice with similar 
results; this figure represents one such experiment.
deglycosylated intermediate to accumulate in the 
cytosol. In the experiment shown in Figure 3 an 
antiserum against the cytoplasmic tail of HLA-A2 was 
used for immunoprecipitation, which recognizes both 
folded and unfolded molecules.  
In the graph on Figure 3 the relative amounts of 
glycosylated HLA molecules only are represented. 
The disappearance of glycosylated HLA molecules is 
a measure of the dislocation of HLA molecules to the 
cytosol, where they are degraded (in the absence of 
ZL3H) or accumulate as deglycosylated breakdown 
intermediates (in the presence of ZL3H). The graph 
indicates that inhibition of the proteolytic activity of the 
proteasome also inhibits the dislocation process.  
At later timepoints in the chase (>  30 minutes) the 
deglycosylated HLA molecules also begin to 
disappear (Figure 3, lane 8). It is not very likely that 
this dis-appearance is related to the concentrations of 
proteasome inhibitor being too low. Degradation of the 
deglycosylated breakdown intermediate has also been 
observed in other cell lines, at higher concentrations of 
proteasome inhibitor (unpublished observations). 
Rather, at later time points cytosolic deglycosylated 
HLA molecules may be degraded by other proteases, 
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which may form a by-pass for the inhibited 
proteasome. 
A defective ubiquitination system results in 
stabiliz ation of HLA-A2 molecules and causes 
HLA-A2-US11 complexes to accumulate 
US11-mediated degradation of HLA-A2 was observed 
in ts20 cells at any temperature below the non-
permissive temperature of 40°C (Figure 4A, lanes 1-
9). When the experiment was performed at 40°C, the 
temperature at which the ubiquitin-activating enzyme 
E1 is inactive, HLA-A2 molecules were stabilized 
(Figure 4A, lanes 10-12). This result indicates that the 
ubiquitin system plays an essential role in US11-
dependent degradation of HLA-A2. A considerable 
amount of US11 co-precipitated with stabilized HLA-
A2 at 40°C (Figure 4A, lanes 10-12), while at the 
same time HLA-A2 co-precipitated with US11 (Figure 
Figure 4 . Ubiquitination is required for US11 mediated degradation of MHC class I heavy chains. (A) ts20 HLA+US11 cells were pre-
incubated at the indicated temperatures for 2 h and subsequently starved, pulse-labelled for 8 min with [35S]methionine/ [35S]cysteine as described
in Materials and Methods, and chased for 0, 30 and 90 min at the same temperature, as shown. Immunoprecipitations were performed sequentially 
with antiserum against the cytoplasmic tail of MHC class I molecules (lanes 1-12) and anti-US11 serum (lanes 13-24), respectively. Samples were 
separated by SDS/PAGE (10% gel) and a PhosphorImage was generated. The panel shows one experiment that was performed five times in a 
comparable fashion, all with similar results. (B) Pulse-chase analysis of E36 HLA+US11 cells (10 min pulse labelling, chase times as indicated) at 
33°C and 40°C using antiserum against the cytoplasmic tail of MHC class I molecules (lanes 1-8) and anti-US11 serum respectively (lanes 9-12). 
Samples were separated by SDS/PAGE (10% gel) and a PhosphorImage was generated. The experiment was performed twice, with similar 
results; this figure represents one such experiment. For (A) and (B), in the graphs relative volumes of HLA-A2 bands, from lanes (A) 1-12 and (B)
1-8, were plotted (measured in arbritary units, counts/mm2) (C) E36 and ts20 cells were infected with vaccinia viruses expressing HLA-A2 (lanes 1 
and 2), or simultaneously with vaccinia viruses expressing HLA-A2 and US11 (lanes 3-8) as indicated in the Materials and Methods section. After 4 
h of incubation the cells were pulsed for 10 min and chased for 30 min. All incubations were performed at 40°C. Proteasome inhibitor ZLVS was 
included where indicated. HLA-A2 and US11 were immunoprecipitated sequentially, the precipitates were analysed by SDS/PAGE and 
PhosphorImages were generated. Bands representing HLA-A2 molecules with (HLA+CHO) or without (HLA-CHO) carbohydrate are indicated.
(See next page for Figure 4 B/C)
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4A, lanes 22-24). The identity of the co-precipitating 
molecules was confirmed in re-immunoprecipitation 
experiments (results not shown). Thus whereas 
binding of US11 to HLA-A2 at the permissive 
temperature is quickly lost due to the degradation of 
HLA-A2, the interaction of US11 and HLA-A2 is 
stabilized when ubiquitination is prohibited. In the 
course of the chase the mobility of US11 and HLA-A2 
altered slightly, probably owing to a post-translational 
modification, which was not pursued further at this 
stage. 
Figure 4. For legend see previous page. 
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In the E36 parental cells US11 mediated degradation 
of HLA-A2 was as efficient at 33°C as it was at 40°C 
(Figure 4B). The stabilization of HLA-A2 in ts20 cells 
observed at the non-permissive temperature is 
therefore solely due to paralysis of the ubiquitin 
system. In E36 cells not expressing US11, HLA-A2 
was stable (Figure 4C, lanes 1 and 2). The MHC class 
I breakdown intermediate was observed in E36 cells 
expressing HLA-A2 and US11, but not in ts20 cells 
expressing HLA-A2 and US11, incubated at 40oC in 
the presence of proteasome inhibitor ZLVS (Figure 
4C, lanes 5-8). Note that in the experiment shown in 
Figure 4C HLA-A2 and US11 were expressed using 
recombinant vaccinia viruses. During later stages of 
vaccinia virus infection host protein synthesis is shut 
off, and expression of viral (trans-)genes is generally 
high. To avoid artefacts due to loss of stoichiometry, 
cells were monitored for expression of HLA and US11 
only 4 h after infection. The ratio between US11 and 
HLA was influenced by using M.O.I. 1.5 for vvUS11 
and of 1 for vvA2, to ensure sufficient US11 to 
degrade HLA-A2 at the permissive temperature. 
Degradation and stabilization of MHC class I 
molecules occurred in a similar fashion in stably 
transfected and vaccinia virus-infected cells. 
HLA-A2-US11 complexes accumulate in the 
membrane fraction at 40° C 
Is ubiquitination required only for targeting of 
dislocated MHC class I molecules to proteasomes, or 
is ubiquitination also a prerequisite for the actual 
dislocation of these molecules?  To distinguish 
between these possibilities, a cell fractionation 
experiment was carried out (Figure 5). ts20 cells 
expressing HLA-A2 and US11 or HLA-A2 only were 
metabolically labelled for 30 min in the presence of a 
proteasome inhibitor. At 33°C in the double 
transfectant, US11 and all of the glycosylated MHC 
class I resided exclusively in the membrane fraction 
(Figure 5, 1000 g and 10 000 g pellets, lanes 1 and 2). 
In contrast, the deglycosylated intermediate was found 
predominantly in the cytosolic fraction (Figure 5, 100 
000 g supernatant, lane 4). This pattern reflects 
dislocation to the cytosol and deglycosylation of MHC 
class I heavy chains, similar to what was shown 
earlier for endogenous MHC class I molecules in 
US11 transfected U373 cells [6]. When a similar 
experiment was performed on cells that were pre-
incubated at 40°C, a deglycosylated intermediate was 
not detected. Instead, all of the HLA-A2 material was 
found in the membrane fraction along with US11 
(Figure 5, lanes 5-8). EndoH digestion experiments 
showed that the HLA-A2 population rescued at 40°C 
Figure 5 . In the absence of ubiquitination HLA-A2 accumulates in the membrane fraction. Ts20 HLA+US11 and ts20 HLA cells were labelled 
with 35S[methionine]/ 35S[cysteine] as described in Experimental for 30 minutes in the presence of ZL3H either at 33°C or 40°C, as indicated. The 
cells were homogenized with a Dounce homogenizer and subjected to repeated centrifugations at the indicated g forces (see also Materials and 
Methods section). HLA-A2 and US11 were immunoprecipitated simultaneously from each fraction using antisera against the cytoplasmic tails of 
MHC class I and US11. Samples were separated on a 10% SDS polyacrylamide gel. A phosphor-image was generated using a BioRad Personal 
Molecular Imager FX and analysed using Quantity One software.
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is endoH sensitive (results not shown). Together, 
these da ta  suggest tha t, when the ub iq uitin sy stem  is 
disrup ted, HL A-A2  m olec ules a re not disloc a ted to the 
c y tosol, b ut rem a in a ssoc ia ted with a  p re-G olgi 
c om p a rtm ent, m ost lik ely  the E R . HL A-A2  from  c ells 
tha t do not ex p ress U S 1 1  resided in the m em b ra ne 
fra c tions, (F igure 5 , la nes 9 -1 2 ), a s ex p ec ted, sinc e 
these m olec ules a re sta b le during the 3 0  m in la b elling 
p eriod.
At 40ºC, membrane insertion of MHC class I 
molecu les is not altered  
W e nex t a sk ed the q uestion: does the m em b ra ne 
top ology  of HL A-A2  m olec ules c ha nge while they  
a c c um ula te in the E R  in the a b senc e of ub iq uitina tion?  
P revious ex p erim ents ha ve indic a ted tha t ly sines in 
the c y tosolic  ta il of HL A-A2  hea vy  c ha in c a n b e 
sub stituted without a ffec ting disloc a tion a nd 
degra da tion [2 2 ]. The c y tosolic  ta il is therefore not 
lik ely  to b e the p rim a ry  ta rget for ub iq uitina tion. 
Assum ing tha t disloc a tion involves ub iq uitina tion of 
M HC  c la ss I m olec ules them selves, this would then 
req uire E R  lum ena l dom a ins to b ec om e ex p osed to 
the c y tosolic  ub iq uitin sy stem . S uc h c onform a tiona l 
c ha nges would ta k e p la c e b efore a tta c hm ent of 
ub iq uitin, they  m a y  b e indep endent of the ub iq uitin 
m a c hinery , a nd they  m a y  p ossib ly  b e induc ed b y  the 
b inding of U S 1 1  to the M HC  c la ss I m olec ules. 
P roteina se K  digestion of M HC  c la ss I m olec ules in 
sem i-p erm ea b iliz ed ts2 0  HL A+ U S 1 1  c ells, k ep t a t 
3 0 º C , results in p roduc ts tha t la c k  their c y tosolic  C -
term ina l ta il (F igure 6  la nes 1 -4 ). At 4 0 º C , M HC  c la ss I 
m olec ules a c c um ula te in the E R  m em b ra ne, a s wa s 
shown a b ove. F igure 6  (la nes 6 -9 ) shows tha t this 
sta te does not involve dra m a tic  c ha nges in the 
m em b ra ne insertion of M HC  c la ss I m olec ules, suc h 
a s p a rtia l disloc a tion to the c y tosol, sinc e p roteina se K  
digestion a ga in resulted in rem ova l of the c y tosolic  ta il 
only . 
D IS CU S S IO N
The results desc rib ed here indic a te tha t disloc a tion of 
the M HC  c la ss I m olec ules a c ross the E R  m em b ra ne 
is fully  dep endent on a  func tiona l ub iq uitin sy stem . 
O b viously , not only  disloc a tion req uires ub iq uitin, b ut 
sub seq uent p rotea som a l degra da tion is lik ely  to 
req uire ub iq uitina tion a s well, sinc e p roteins a re 
usua lly  ta rgeted to the p rotea som e via  the a tta c hm ent 
of a t lea st four ub iq uitin m olec ules [1 ,2 ,3 0 ]. It is not 
c lea r whether a  single ub iq uitina tion event a c c ounts 
for b oth a sp ec ts of the degra da tion p roc ess, or 
whether severa l distinc t ub iq uitina tion events would b e 
req uired.
The degra da tion p roc ess m edia ted b y  U S 2  a nd U S 1 1  
now evidently  inc ludes intera c tion of the M HC  c la ss I 
m olec ule with the tra nsloc on c ha nnel (shown for U S 2  
m edia ted degra da tion [7 ]), involvem ent of the ub iq uitin 
sy stem  ([2 2 ]; a nd this study ), disloc a tion to the c y tosol 
a nd de-gly c osy la tion [6 ] a nd degra da tion b y  the 
p rotea som e [6 ,7 ].  
E ffects of d isru p tion of th e u biq u itin sy stem 
O ur ex p erim ents indic a te tha t c om p lex es of U S 1 1  a nd 
HL A-A2  a re reta ined in the E R  m em b ra ne when 
ub iq uitin c onjuga tion is b loc k ed. S im ila r E R  retention 
wa s ob served for p roteins tha t a re degra ded via  
endogenously  initia ted, q ua lity  c ontrol a ssoc ia ted, 
disloc a tion. F or ex a m p le, the TC R   c ha in [1 7 ] a nd 
R I3 2 2 , a  trunc a ted E R  lum ena l form  of rib op horin A 
[3 1 ], a re a lso not disloc a ted when ub iq uitina tion is 
F ig u re 6 . HL A-A2  molecu les th at accu mu late at 40ºC d o not h av e an altered  membrane insertion. ts2 0  HL A a nd ts2 0  HL A+ U S 1 1  c ells
were p re-inc ub a ted a t the tem p era tures indic a ted a nd la b elled with 3 5 S [m ethionine]/ 3 5 S [c y steine] for 1 0  m in a t the sa m e tem p era ture. The c ells
were sem i-p erm ea b iliz ed a nd digested with p roteina se K  a t 0 º C  a s wa s desc rib ed in the M a teria ls a nd M ethods sec tion a t c onc entra tions
indic a ted. Im m unop rec ip ita tions were p erform ed using a ntib odies a ga inst the E R  lum ena l dom a in of HL A-A2  hea vy  c ha ins (m onoc lona l a ntib ody
HC A2 ). S a m p les in la ne 5  a nd 1 0  were trea ted with 1 %  (v/v) triton X -1 0 0  p rior to p roteina se K  digestion. S a m p les were sep a ra ted on a  1 0 %  S D S
p oly a c ry la m ide gel. A p hosp hor-im a ge wa s genera ted using a  B ioR a d P ersona l M olec ula r Im a ger F X  a nd a na ly sed using Q ua ntity  O ne softwa re.
The ex p erim ent wa s rep ea ted twic e with sim ila r results. The da ta  shown in this figure a re from  one suc h ex p erim ent. 
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prevented. Mutation of the E2 ubiquitin carrier 
enzymes involved in the degradation pathway of a 
soluble misfolded yeast protein CPY *  similarly caused 
the accumulation of the substrate in the ER [13]. 
Together, these results indicate that the ubiquitin 
system plays an important role in both endogenously 
and exogenously triggered dislocation of proteins 
across the ER membrane.  
Possible mechanisms of ubiquitin dependent 
dislocation of MHC class I molecules 
Although the cytoplasmic tail of the MHC class I heavy 
chain obviously is the part most accessible to the 
ubiquitination machinery, it is unlikely to be the 
primary target for ubiquitination, as removal of the 
lysine residues from the cytoplasmic tail of HLA-A2 
neither prohibits its dislocation and degradation, nor its 
ubiquitination [22]. Interestingly, removal of all lysines 
from the  subunit of the T cell receptor neither affects 
its dislocation nor its degradation, while a functional 
ubiquitination system is still required for dislocation of 
the mutant  chain [17,32]. These results can be 
explained by assuming that not the degradation 
substrate itself, but an interacting protein is 
ubiquitinated, leading to in trans ubiquitin-mediated 
dislocation of the substrate. In the case of 1-
antitrypsin Z  it was shown that the chaperone calnexin 
is ubiquitinated in trans, leading to degradation of 1-
antitrypsin Z . In the course of the process calnexin is 
released from the substrate and is neither dislocated 
nor degraded itself [33].  
Since for MHC class I molecules not all of the lysines 
were removed, it is still a possibility that ubiquitination 
within ER lumenal domains of the MHC class I heavy 
chains mediates dislocation. Apart from lysine 
residues within a protein, the N -terminus can serve as 
a target for ubiquitination. Exclusive N -terminal 
ubiquitination was found for the short-lived cytosolic 
protein MyoD and the Epstein-Barr virus membrane 
protein LMP1 [34,35]. Thus, if MHC class I molecules 
would be ubiquitinated while still in the ER membrane, 
this would either involve lumenal lysine residues, or 
the N -terminus, which then would have to be exposed 
to the cytosol prior to attachment of ubiquitin. 
Proteinase K digestion experiments (Fig. 6) suggest 
that in the absence of a functional ubiquitin system the 
membrane topology of HLA-A2 does not drastically 
change. Assuming that MHC class I molecules are 
ubiquitinated themselves prior to dislocation, the 
conformational change may involve only minor 
exposure of HLA-A2 lumenal sequences to the 
cytosol, which can not be observed after proteinase K 
digestion. Alternatively, the topological change may 
not take place at the non-permissive temperature, 
because this by itself already requires the action of the 
ubiquitination machinery. Binding of MHC class I 
molecules to US11, which occurs without 
ubiquitination, apparently does not induce obvious 
topological changes of the MHC class I molecules.  
The molecular basis of the dislocation reaction still 
remains obscure. It has been proposed that cytosolic 
chaperones such as Hsp70 and Hsp90 facilitate the 
actual dislocation [36,37]. The important role of 
ubiquitin in the dislocation process supports the 
suggestion that the proteasome provides the pulling 
force that extracts proteins from the ER membrane 
[38 ,39].
T he role of US2 and US1 1  
Inhibition of ubiquitination did not only cause a 
dramatic stabilization of HLA-A2, but also revealed 
strong binding of US11 to HLA-A2 (Figure 4A). This 
obviously confirms that the binding of US11 to MHC 
class I molecules precedes ubiquitination and that 
MHC class I heavy chain is not released from US11 
when ubiquitination is prevented. Since US11 is not 
degraded and has never been found in the cytosol 
along with MHC class I molecules ([6] and Figure 5), 
the release from US11 must take place before MHC 
class I heavy chain is dislocated to the cytosol.  
Although rather extensive research has been done on 
the US2 and US11 mediated degradation of MHC 
class I molecules, the exact functions of US2 and 
US11 in the dislocation process have remained 
elusive. Binding of US2 and US11 to MHC class I 
could alter the conformation of the latter such that it is 
recognized by the ER quality control machinery and is 
degraded via the constitutive dislocation pathway. 
US2 and US11 could also mimic components of the 
quality control machinery, which normally target 
misfolded cellular proteins for destruction. Although to 
date no sequence similarities have been found 
between US11 or US2 and any cellular protein, one 
could speculate that US2 and US11 themselves 
function as E3 enzymes, which specifically catalyse 
ubiquitination of MHC class I molecules, thus inducing 
their dislocation and degradation.  
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CHAPTER 6
Human cytomegalovirus-encoded US2 and US11 
 target unassemb led M HC  class I
h eavy ch ains for degradation. 
Mol. Immunol. : in press (2005) 
Human cytomegalovirus-encoded US2 and US11 target unassembled MHC class I 
h eavy ch ains for degradation. 
Martine T. Barel, Gerco C. Hassink, Sjaak van Voorden, Emmanuel J.H.J Wiertz. 
Department of Medical Microbiology, Leiden University Medical Center, P.O. box 9600, 2300 RC Leiden, The 
N etherlands. 
Surface MHC class I molecules serve imp ortant immune functions as ligands for both  T  and N K  cell 
recep tors for th e elimination of infected and malignant cells. In order to reach  th e cell surface, MHC 
class I molecules h ave to fold p rop erly and form trimers consisting of a h eavy ch ain (HC), a 2-
microglobulin ligh t ch ain and an 8  to 10 -mer p ep tide. A  p anel of E R  ch ap erones facilitates th e folding 
and assembly p rocess. Incorrectly assembled or folded MHC class I HCs are detected by th e E R  q uality 
control system and transp orted to th e cytosol for degradation by p roteasomes. In h uman 
cytomegalovirus-infected cells tw o viral p roteins are synth esiz ed, US2 and US11, w h ich  target MHC 
class I HCs for p roteasomal degradation. It is unk now n at w h ich  stage of MHC class I folding and 
comp lex  formation US2 and US11 come into p lay. In addition, it is unclear if th e disp osal tak es p lace via 
th e same p ath w ay th rough  w h ich  p roteins are removed th at fail to p ass E R  q uality control. In th is study, 
w e sh ow  w ith  a 2m-deficient cell line th at US2 and US11 both  target unassembled HCs for degradation. 
T h is suggests th at US2 and US11 both  act at an early stage of MHC class I comp lex  formation. In 
addition, our data indicate th at US11-mediated degradation involves mech anisms th at are similar to 
th ose normally used to remove terminally misfolded HCs.  
MHC class I molecules are imp ortant rep orters for th e 
immune sy stem. Th ey  disp lay  small frag ments of th e 
total cellular p rotein p ool at th e cell surface for 
insp ection b y  cy tox ic T cells 1. In th is w ay  th ey  reveal 
th e p resence of ab normal p roteins ex p ressed b y  
malig nant or infected cells. In addition, th e ab sence or 
p resence of MHC class I molecules can b e sensed b y  
N K  cells and reg ulate th eir activation 2.
In order to reach  th e cell surface, MHC class I 
molecules h ave to fold p rop erly  and form a trimeric 
comp lex  th at consists of a h eavy  ch ain (HC; ~ 4 3 kD a), 
2-microg lob ulin ( 2m; 12 kD a) and an 8 to 10 -mer 
p ep tide. Th e folding  and assemb ly  p rocess occurs in 
an orderly  fash ion and is facilitated b y  several ER  
ch ap erones.  
MHC class I HCs encode a sig nal p ep tide, w h ich  
directs insertion into th e ER  during  translation. O nce 
in th e ER , th e sig nal seq uence is cleaved off b y  a 
sig nal p ep tidase. A n olig osacch ary l transferase 
eq uip s th e HC w ith  an N -linked olig osacch aride at 
residue N 86 . A t th is stag e, free HCs are found in 
association w ith  th e g eneral ER  ch ap erones 
immunog lob ulin b inding  p rotein (BiP ) 3 and calnex in 
(CN X ), th e latter of w h ich  is a memb rane b ound 
p rotein w ith  lectin-like activity  4 ,5 . Bip  b inds transiently  
to many  new ly  sy nth esized p roteins and for p rolong ed 
times to misfolded p roteins or unassemb led sub units 
6 ,7 . Binding  of CN X  is reg ulated b y  g lucose trimming  of 
nascent N -linked olig osacch arides 8. CN X  g enerally  
b inds p roteins w ith  monog lucosy lated (Glc1Man9-
7 GlnN A c2) olig osacch arides 9. CN X  and BiP  
p redominantly  associate w ith  free MHC class I HCs 
and th e assemb ly  w ith  2m ab olish es th e interaction 
of th e HC w ith  th ese ch ap erones 10 -12. Before b inding  
th e lig h t ch ain, HCs also interact w ith  ER p 5 7 , a 
memb er of th e p rotein disulfide isomerase (P D I) 
family , involved in disulfide b ond ox idation, reduction 
and isomerization reactions 13-15 . Mature MHC class I 
molecules h arb or th ree intra-molecular disulfide 
b ridg es, th e formation of w h ich  is likely  to b e mainly  
assisted b y  ER p 5 7 .  
A fter b inding  2m, MHC class I molecules are found 
in association w ith  anoth er, solub le ER  ch ap erone 
w ith  lectin-like activity , calreticulin (CR T) 16 ,17 . L ike 
CN X , CR T b inds to p roteins w ith  Glc1Man9-
7 GlnN A c2 N -linked olig osacch arides 18,19. Th ese MHC 
class I molecules b ecome associated w ith th e p ep tide 
loading  comp lex , w h ich  b esides CR T includes ER p 5 7 , 
tap asin, and th e transp orter associated w ith  antig en 
p rocessing  (TA P ) sub units, TA P 1 and TA P 2. Tap asin 
mediates th e interaction of HCs w ith  th e TA P  comp lex  
20 -22. P ep tides g enerated from endog enous p roteins 
b y  p roteasomal deg radation are transp orted from th e 
cy tosol into th e ER  via th e TA P  comp lex , w h ere th ey  
can b e trimmed furth er b y  amino-p ep tidases b efore 
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loading onto HC- 2m dimers 23,24. Trimeric HC- 2m-
peptide complexes dissociate from the loading 
complex and are released into the secretory pathway 
25. In contrast, incompletely assembled MHC class I 
HCs are recognized by the ER quality control system 
and are targeted for degradation 26.
During the course of HCMV infection, several viral 
proteins are synthesized which prevent MHC class I 
surface expression. These immune evasion proteins 
can obstruct different steps of the folding and 
assembly pathway of MHC class I molecules. The 
unique-short region 3 (U S3) gene product retains 
MHC class I molecules in the ER and specifically 
affects those types of MHC class I molecules whose 
surface expression is tapasin-dependent 27. U S6 
blocks peptide transport by TAP and thereby prevents 
the formation of stable trimeric MHC class I 
complexes 28,29. Two other HCMV gene products, U S2 
and U S11, both target MHC class I HCs to the cytosol 
for subsequent proteasomal degradation 30,31.
It is unknown if U S2 and U S11 make use of the 
regular ER quality control pathway for disposal of 
class I molecules. It is also unclear to what extent 
MHC class I molecules have to be folded and 
complexed with 2m and/or peptide before U S2 and 
U S11 can bind to these proteins. These aspects of 
U S2- and U S11-mediated HC degradation are 
investigated in the present study. 
MATERIALS AND METHODS 
Cell lines  
Wild type F O-1 human melanoma cells 32, which have 
a defect in 2m gene expression, and F O-1 cells 
restored for 2m expression 33 were cultured in 
DMEM (Invitrogen, Breda, The Netherlands), 
supplemented with 10%  F CS (Greiner bv, Alphen aan 
den Rijn, The Netherlands), 100 U /ml penicillin and 
100 g/ml streptomycin (Invitrogen, Breda, The 
Netherlands). HLA class I molecules expressed by 
F O-1 cells were genotyped as HLA-A*2501, -B*0801, 
and -Cw*0701 34.
Produ ction of retroviru s and transdu ction 
U S2 and U S11 cDNA fragments, subcloned into the 
pLZ RS-IRE S -EGF P vector were used for transfection 
of amphotropic Phoenix packaging cells to produce 
retrovirus, as described 35-38. Cells were transduced 
with retrovirus using retronectin (Takara Shuzo, Otsu, 
Japan) coated dishes. Transduced cells were sorted 
for EGF P expression using a F ACS Vantage flow 
cytometer. 
A ntibodies 
The following antisera were used for immuno-
precipitations: W6/32 (anti-MHC I complex; 39), HC10 
(anti-MHC I free HC’s; 40), H68.4 (transferrin receptor; 
Z ymed Laboratories, San F rancisco, CA), U S2(N2) 
(anti-U S2; 41), and U S11(N2) (anti-U S11; 42).
Metabolic labeling, cell lysis, immu noprecipitation and 
S DS -PA G E
Metabolic labeling, immunoprecipitations and SDS-
PAGE were performed as described 43. Where 
indicated, media were supplemented with the 
proteasome inhibitor carboxybenzyl-leucyl-leucyl-
leucinal (Z L3H). F or the experiments described in 
F igure 1, 1mM N-ethylmaleimide (NEM; Sigma-
Aldrich, Z wijndrecht, the Netherlands) was added to 
the lysis mix to prevent post-lysis formation of 
disulfide bonds. Peptide-N-glycosidase F  (PNGase F ; 
Roche Diagnostics, Mannheim, Germany) was used 
according to the manufacturer's protocol. F or 
experiments described in figures 2 and 3, immuno-
precipitations were performed on denatured lysates. 
Cells were lysed in a smaller volume of Nonidet-P40 
lysis mix (100 µ l /5x106 cells), and after centrifugation, 
supernatants were transferred to a new tube with 1/10 
volume of 10%  SDS and 1/10 volume of 0.1 M DTT. 
Samples were boiled for 5 min to further denature 
proteins. Next, the volume was increased 10 times 
with non-denaturing buffer (1%  Triton X-100, 50 mM 
Tris HCl pH 7.4, 300 mM EDTA, 0.02% NaN3)
supplemented with protease inhibitors and 10 mM 
iodoacetic acid. Immuno-precipitates were taken up in 
sample buffer with (F igure 2 and 3) or without -
mercaptoethanol (F igure 1) and boiled for 5 minutes 
prior to loading onto 12.5 %  SDS-PAGE acrylamide 
gels. Gels were screened with a Bio-Rad Personal 
Molecular Imager F X and analysed with Q uantity One 
software. 
RESULTS
It is unclear at what stage of folding and assembly of 
newly synthesized MHC class I HCs U S2 and U S11 
come into play to redirect these molecules back to the 
cytosol for subsequent proteasomal degradation. We 
evaluated if U S2 and U S11 can target heavy chains 
for degradation in an early stage, namely when they 
are still unassembled. A 2m-negative cell line was 
used to address this question.  
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A report by Furman et al. indicated that the redox 
status influences degradation of class I heavy chains 
by US2 and US11 44. Mature and fully assembled 
MHC class I complexes contain 3 disulfide bonds: one 
within the 2m light chain and two within the heavy 
chain. The disulfide bonds in the heavy chain are 
located in the membrane-proximal 3 domain and in 
the 2 domain, the latter of which forms part of the 
peptide binding groove. Pulse chase experiments with 
wild type and mutant (C203S+ C259S) HLA-A2 
revealed that formation of a disulfide bond in the 3
domain of class I was essential for US2-mediated 
degradation, but not for degradation mediated by 
US11 45. Besides this, several studies indicated that 
the presence of 2m supports disulfide bond 
formation in MHC class I HCs 46,47. In the absence of 
2m class I HCs cycle between (fully) oxidized and 
reduced states 48. In our current study we make use of 
the 2m-negative FO-I cell line. Before looking at the 
effect of US2 and US11 expression on degradation of 
class I heavy chains, we first investigated the 
differences in oxidation status of class I HCs in this 
cell line.
Shortly after synthesis, the majority of free class I 
HCs is fully oxidised in the absence or presence 
of 2m
We evaluated the oxidation status of MHC class I 
heavy chains in 2m-negative (FO-I wild type) and 
positive (FO-I +  2m) cell lines over time in pulse 
chase experiments (Figure 1). MHC class I heavy 
chains were recovered from NP40 lysates (supple-
mented with the alkylating agent NEM to prevent post 
lysis formation of disulfide bonds), using either HC10 
or W6/32 MoAbs. Samples were separated by SDS-
PAGE under non-reducing conditions. Under these 
circumstances, three distinct bands can be observed 
of which the intensity and migration patterns differ, 
with increasing concen-trations of the reducing agent 
DTT (Figure 1A). The fastest, middle and slowest 
migrating bands reflect fully oxidized (two disulfide 
bonds), partially reduced (one disulfide bond) and 
completely reduced HCs (no disulfide bonds), 
respectively.
HC10 is specific for free HC’s and recognizes all HCs 
expressed in the 2m negative cells (Figure 1B, lanes 
1-4) and only a fraction of the HC pool, likely those 
still unassembled, in the 2m reconstituted cells 
(lanes 5-8). W6/32 only recognizes HCs associated 
with 2m (lanes 13-16) and does not recognize HCs 
expressed in cells lacking 2m (Figure 1B, upper 
panel, lanes 9-12). To exclude a contribution of 
maturation of the N-linked sugar chain on the 
migration pattern of HC’s, part of the samples were 
treated with PNGase F (Figure 1B, lower panel). In 
the presence of 2m, all W6/32-reactive material was 
fully oxidized (lanes 13-16) as well as the majority of 
F igure 1. Shortly after synthesis, the majority of free class I HC's is fully oxidised in the presence or absence of 2m. A) FO-I cells,
which have a defective 2m gene, and FO-I cells restored for 2m-expression were metabolically labeled with 35S Met/Cys for 60 minutes. Cells
were lysed in NP40 lysis mix (supplemented with NEM) and MHC class I HCs were recovered using MoAbs HC10 (anti-free class I HCs) or
W6/32 (anti-complexed class I HCs). After immunoprecipitation, samples were split and taken up in sample buffer without or with DTT at the
concentrations indicated. Samples were separated by SDS-PAGE (12.5 % gel). B ) Cells were labeled for 5 minutes and chased for the indicated
times. After immunoprecipitation, samples were split and one aliquot was treated with PNGaseF. Samples were taken up in nonreducing sample
buffer. Arrows mark the migration pattern of class I HCs with 0, 1, or 2 disulfide bonds.
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the HC10-reactive material (lanes 5-8). In contrast, a 
small amount of fully and partially reduced HC10-
reactive HCs were observed in the 2m-negative cells 
(lanes 1-4). The relative proportion of reduced, 
partially reduced and oxidized HCs as compared to 
the total pool varied in the course of the chase in the 
2m-negative cells. Right after the pulse and up to 30 
minutes later the majority of HCs are fully oxidized 
(lanes 1-3). After a 60 minutes chase, the total pool of 
MHC class I is reduced. This is consistent with 
previous data showing degradation of free HCs in the 
absence of 2m 49. At this time point, a decrease is 
observed in the amount of fully oxidized HCs, and a 
small increase in the more reduced forms, relative to 
the total amount of HCs (lane 4). The three distinct 
conformations are present in more equal amounts 
after 60 minutes of chase (lane 4).  
Since US2 and US11 are known to act within a 
relatively short time window (minutes after MHC class 
I synthesis), they are likely to encounter fully oxidized 
HCs in both 2m-postive and -negative cells. 
Unassembled HC’s are targeted for degradation 
by US2 and US11.  
Next, we introduced US2 and US11 into the FO-I cell 
lines to evaluate with pulse chase experiments if 
these viral proteins can target MHC class I heavy 
Figure 2. Unassembled HCs are targeted for degradation by US2 and US11. FO-I cells restored for 2m expression (+ 2m, panel A) and wild
type FO-I cells (- 2m, panel B) were transduced with wt-EGFP, US2-EGFP, or US11-EGFP-encoding retrovirus and sorted for EGFP expression.
Cells were metabolically labeled with 35S Met/Cys for 10 minutes and chased for the times indicated. MHC class I HCs, transferrin receptor (TfR),
US2 and US11 were recovered from denatured samples, taken up in reducing sample buffer, separated by SDS-PAGE (12.5 % gel) and visualized
using a phosphor-imager. The amount of precipitated MHC class I HCs, normalized on the basis of TfR levels, is displayed as a percentage of HC
levels found at the onset of chase in wt-EGFP cell lines. Results are based on multiple observations, of which one representative experiment is
shown here.
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chains for degradation in the absence of 2m (Figure 
2). After cell lysis, samples were denatured to ensure 
that HC10 was able to immunoprecipitate all HCs 
present in FO-I (+/- 2m) cell samples. Transferrin 
receptor immunoprecipitates are shown, as an internal 
control for cell labelling and sample loading. For these 
experiments, samples were separated by SDS-PAGE 
under reducing conditions. In FO-I cells reconstituted 
for 2m expression (Figure 2A), MHC class I heavy 
chains remained stable over time in the absence of 
viral proteins (lanes 1-3, 7-9), but are destabilized in 
the presence of US2 (lanes 4-6) or US11 (lanes 10-
12). Note that most of the HCs have already been 
degraded during the ten minutes pulse, while the 
transferrin receptor remained stable. Figure 2B shows 
the effect of US2 and US11 on the stability of HCs in 
the absence of 2m. In the presence of US2 (lanes 
16-18), less HCs could be immunoprecipitated 
compared to the amount recovered from US2-
negative cells, while transferrin receptor levels 
remained the same in both cell lines (lanes 13-15). 
The same was observed in US11-expressing FO-I 
cells (compare lanes 22-24, with 19-21).  
Thus, US2 and US11 can target unassembled HCs for 
degradation, indicating that they can act already at an 
early stage of MHC class I folding and complex forma-
tion. 
Figure 3. US11 can target HCs to the cytosol in the absence of 2m, but this action is severely compromised when proteasomal
activity is blocked. FO-I cells restored for 2m expression (+ 2m, panel A) and wild type FO-I cells (- 2m, panel B) were transduced with wt-
EGFP, US2-EGFP, or US11-EGFP-encoding retrovirus and sorted for EGFP expression. Cells were metabolically labeled with 35S Met/Cys for 10
minutes and chased for the times indicated, all in the presence of proteasome inhibitor. MHC class I HCs, US2 and US11 were recovered from
denatured samples, taken up in reducing sample buffer, separated by SDS-PAGE (12.5 % gel) and visualized using a phosphor-imager. Arrows
indicate migration pattern of proteins +/- glycan (CHO). The amount of MHC class I HCs +CHO or – CHO is given as a percentage of the total of
MHC class I HCs (+ and –  CHO) precipitated from that sample. Results are based on multiple observations, of which one representative
experiment is shown here.
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US11 can target HCs to the cytosol in the absence 
of 2m, but this action is severely compromised 
when proteasomal activity is blocked.
Dislocated MHC class I heavy chains can be 
visualized using proteasome inhibitors. Visualization is 
possible due to the fact that the N-linked glycan is 
removed from retro-translocated HCs by a cytosolic 
N-glycanase, before HCs are degraded by 
proteasomes. These breakdown intermediates are 
characterized by a faster migration pattern in SDS-
PAGE 50,51.
To complement the data shown in Figure 2, 
experiments were performed in the presence of 
proteasome inhibitor ZL3H (Figure 3). Figure 3A 
shows that in 2m expressing cells, HCs remain 
stable in the absence of viral proteins (lanes 1-3). In 
both US2+ (lanes 4-6) and US11+ cells (lanes 7-9), a 
decrease is observed in the amount of glycosylated 
HCs (HC+CHO) and an increase in the amount of 
deglycosylated breakdown intermediates (HC-CHO). 
The results have been quantified and displayed as 
graphics, with HC+CHO in dark gray and HC-CHO in 
light gray. Figure 3B shows the results for the 2m-
negative cells. A similar conversion from glycosylated 
HCs to deglycosylated breakdown intermediates could 
be observed for the US2+ cells (lanes 13-15), 
compared to the 2m+, US2+ cells (lanes 4-6). In 
contrast, only a minor fraction of HC breakdown 
intermediates could be observed in the US11+, 2m–
cells (lanes 16-18) as compared to the US11+, 2m+
cells (lanes 7-9) and the US2+, 2m– cells (lanes 13-
15).
These data again show that US2 can target 
unassembled HCs for degradation and suggest that it 
can do so equally well in the presence or absence of 
2m, with or without proteasome inhibitor. In contrast, 
proteasome inhibition appears to interfere with the 
action of US11 in cells lacking 2m. 
Inhibition of proteasome activity also delays dis-
location of unassembled HCs in 2m negative 
cells in the absence of viral proteins. 
In the absence of 2m, MHC class I HCs become a 
target for ER quality control mechanisms that ensure 
disposal of improperly assembled HCs. This has been 
shown using the 2m-negative Daudi cell line 52.
Pulse chase experiments showed that the dislocation 
Figure 4 . Inhibition of proteasome activity also delays dislocation of unassembled HCs in 2m-negative cells in the absence of viral 
proteins. Wild type FO-I cells (- 2m) were metabolically labeled with 35S Met/Cys for 10 minutes and chased in the presence or absence of 
proteasome inhibitor (+/-ZL3H) for the times indicated. MHC class I HCs were recovered from denatured samples, taken up in reducing sample 
buffer, separated by SDS-PAGE (12.5 % gel) and visualized using a phosphor-imager. Arrows indicate migration pattern of HCs +/- glycan 
(CHO). The amount of MHC class I HCs +CHO precipitated at different timepoints (relative to the total amount of HCs at the onset of the chase) 
is displayed graphically.
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and degradation of MHC class I heavy chains takes 
p lace at a slow er p ace, w ith the first signs of 
dislocation show ing 3 0  m inu tes after a 1 0  m inu te 
lab elling tim e. W e investigated if the dislocation of 
u nassem b led HCs req u ires p roteasom al activity. F or 
this p u rp ose eq u al am ou nts of w ild typ e F O -I cells 
w ere p u lse lab elled and chased u p  to 1 2 0  m inu tes 
either in the ab sence or p resence of p roteasom e 
inhib itor (F igu re 4 ). E q u al am ou nts of glycosylated 
HCs cou ld b e p recip itated at the start. O ver the 
cou rse of the chase, som e decrease in the am ou nt of 
glycosylated HCs w as ob served in cells treated w ith 
p roteasom e inhib itor, accom p anied b y a slight 
increase in the am ou nt of deglycosylated HCs. 
How ever, this decrease of glycosylated HCs w as 
m ore p ronou nced in the ab sence of p roteasom e 
inhib itor.  
T hese resu lts indicate that the q u ality control-
associated dislocation of u nassem b led HCs is less 
efficient w hen p roteasom al activity is b locked. 
DISCUSSION
HCMV  encodes several im m u ne evasion p roteins that 
p revent MHC class I su rface ex p ression. T hese viral 
gene p rodu cts can ob stru ct different step s of the 
folding and assem b ly p athw ay of MHC class I 
m olecu les. W e investigated at w hat stage of the 
assem b ly p rocess MHC class I HCs are redirected to 
the cytosol b y U S 2  and U S 1 1  for p roteasom al 
degradation.  
P reviou s ob servations su ggest that U S 2  p refers 
p rop erly folded and assem b led HCs as target; it can 
b e fou nd in association w ith assem b led MHC class I 
m olecu les (indicated b y its co-p recip itation w ith the 
conform ation-dep endent anti-MHC I com p lex  antib ody 
W 6 /3 2 ) 5 3 . In addition, U S 2  co-crystalliz ed w ith class I 
HC- 2 m -p ep tide com p lex es 5 4 .
In this stu dy, w e evalu ated in p u lse chase 
ex p erim ents if U S 2  and U S 1 1  are cap ab le of targeting 
free HCs for degradation. F or this p u rp ose, w e u sed a 
hu m an m elanom a cell line (F O -I), w hich does not 
ex p ress 2 m  5 5 . 2 m -reconstitu ted F O -I cells served 
as a control. S u rp risingly, U S 2  as w ell as U S 1 1  cou ld 
target free HCs for degradation. Moreover, this 
occu rred w ith an efficiency that ap p eared to b e sim ilar 
to that ob served in cells ex p ressing 2 m  (F igu re 2 ). 
T his show s that U S 2  and U S 1 1  can b oth act at early 
stages of MHC class I assem b ly.  
T hese data are in disagreem ent w ith a p reviou s 
rep ort, w hich su ggested that U S 2 -m ediated dis-
location of MHC class I HCs req u ires assem b ly w ith 
2 m 5 6 . T his conclu sion w as b ased on ex p erim ents 
p erform ed w ith a hu m an astrocytom a cell line (U 3 7 3 -
G M) in w hich R N A  interference (R N A i) w as u sed to 
knock dow n 2 m -ex p ression. U S 2 -m ediated dis-
location of class I HCs w as m u ch less efficient in 
these 2 m -knock ou t cells than in w ild typ e cells, as 
indicated b y a slow er conversion of glycosylated to 
deglycosylated HCs in the p resence of p roteasom e 
inhib itor. O u r data su ggest that another factor than the 
ab sence of 2 m  m ay b e resp onsib le for the slow ed 
dow n U S 2 -m ediated retro-transp ort of HCs in these 
U 3 7 3 -G M 2 m -knock ou t cells. In ou r ex p erim ents, 
w e cou ld see sim ilar am ou nts of deglycosylated 
b reakdow n inter-m ediates for b oth F O -I and 2 m -
reconstitu ted F O -I cells (ex p ressing sim ilar am ou nts 
of U S 2 ), w hen p roteasom e inhib itor w as inclu ded 
(F igu re 3 ). It m ay b e that cell typ e sp ecific factors 
render F O -I cells m ore su itab le to facilitate U S 2 -
m ediated degradation of free HCs than U 3 7 3 -MG  
cells. A lternatively, the R N A i constru ct u sed m ay, 
b esides knocking dow n 2 m -ex p ression, also 
influ ence the ex p ression of other factors im p ortant for 
the efficiency of the dislocation p rocess.
W e show ed that HCs do not req u ire assem b ly w ith 
2 m  in order to b ecom e targets for U S 1 1  either. T he 
efficiency of HC degradation in the p resence of U S 1 1  
is sim ilar in 2 m + and 2 m - F O -I cells (F igu re 2 ). 
Interestingly, the inclu sion of p roteasom e inhib itor 
seriou sly ob stru cted the dislocation efficiency of HCs, 
b u t only for U S 1 1 +, 2 m - cells (F igu re 3 ). T his w as not 
ob served in U S 2 + 2 m +, U S 2 +, 2 m -, nor U S 1 1 +
2 m + cells. W hy w as this ob stru ction for dislocation 
seen only in the p resence of p roteasom e inhib itor, and 
w hy only in cells lacking 2 m -ex p ression?  A nd w hy is 
this ob served in U S 1 1 -p ositive cells, b u t not in cells 
ex p ressing U S 2 ?
In the ab sence of U S 2  or U S 1 1 , incom p letely folded 
or assem b led MHC class I m olecu les are also 
rem oved from  the E R  and transp orted to the cytosol 
w here they are degraded b y p roteasom es 5 7 . W e 
show ed that the dislocation of u nassem b led HCs in 
F O -I cells occu rred w ith low er efficiency in the 
p resence of p roteasom e inhib itors, in the ab sence of 
U S 1 1  (F igu re 4 ). A  sim ilar ob servation has b een 
rep orted for 2 m -negative D au di cells 5 8 . Interestingly, 
treatm ent w ith chem icals that interfere w ith disu lfide 
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bond formation (diamide, NEM), also abrogated 
dislocation of HCs in Daudi cells 59 .
MHC class I HCs expressed in cell lines with or 
without 2m are known to differ for their interaction 
with ER chaperones. Analysis of human 2m-deficient 
cells has shown that the light chain is required for 
correct folding, binding to calreticulin and TAP, 
peptide loading, intracellular transport, and cell 
surface expression of HL A class I heavy chains 60,61.
In the absence of 2m, HCs do not enter the 
secretory pathway, but remain associated for a 
prolonged time with B iP and calnexin 62,63. The exact 
mechanism by which misfolded and unassembled 
molecules are finally removed from the ER remains 
elusive, but there are indications that these ER 
chaperones may play a role in this process. 
B iP is known to retain many misfolded proteins in the 
ER 64, including unassembled MHC class I HC’s 65.
Studies with mutant K ar2p (the yeast homologue of 
B iP) and mutant glycoprotein (CPY * ), have shown an 
association between the ATPase activity of K ar2p with 
release of malfolded proteins into the cytosol 66. In 
another report, studying the release from B iP of a 
soluble nonglycosylated protein, unassembled Ig L  
chain, and its retro-translocation out of the ER, the 
dislocation seemed to be tightly coupled to 
proteasome activity 67.
Calnexin, a lectin chaperone, accompanies many 
glycoproteins during their folding 68,69 . It can also 
contribute to oxidative folding, as it acts in conjunction 
with the oxidoreductase ERp57 70. We showed that in 
the absence of 2m, the majority of HCs is fully 
oxidized shortly after synthesis. When these HCs are 
followed in time, a larger amount, relative to the total 
HC pool at that time, is found in a partially or 
completely reduced state (Figure 1). The total amount 
of HCs gradually becomes less, as unassembled HCs 
are targeted for degradation (Hughes, Hammond, and 
Cresswell 19 9 7, and Figure 4). This conversion of 
HCs to a reduced state may be a prerequisite for 
efficient dislocation. The finding that diamide and 
NEM abrogated dislocation in the 2m-negative Daudi 
cell line supports an influence of protein redox status 
on dislocation 71. There are indications that 
proteasome inhibitors may interfere with CNX /oxido-
reductase interactions 72,73. In cells treated with 
lactacystin, a redistribution of ER chaperones was 
observed: upon proteasome inhibition, CNX , CRT, 
and ER degradation substrates (but not B iP, PDI, 
glucosyltransferase, ERp57) accumulated in a 
pericentriolar quality control compartment derived 
from the ER 74,75.
The fact that we found an abrogation of US11-
mediated dislocation, in the presence of proteasome 
inhibitor only and exclusively in cells lacking 2m-
expression may imply that US11 uses partially similar 
mechanisms for discarding HCs as the endogenous 
pathway used by FO-I cells to dispose of 
unassembled class I molecules (Figure 3).  
All in all, we conclude that US2 and US11 can act on 
MHC class I molecules at an early stage of folding 
and assembly. In addition, our data indicate a link 
between the endogenous pathway for disposal of 
terminally misfolded proteins and US11-mediated 
degradation of MHC class I HCs. More research will 
be required to unravel the exact partners that link up 
these processes. 
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Summary and Discussion 
Summary and discussion 
HCMV encodes several proteins that interfere with 
cross talk  b etween infected host cells and im m u ne 
effector cells. T he viral g ene produ cts can redu ce 
su rface levels of antig en presenting  MHC class I 
m olecu les. S everal aspects m ay  influ ence the deg ree 
of MHC class I down-m odu lation b y  HCMV, and 
thereb y  the su ccess of im m u ne escape b y  the viru s. 
F irst of all, the su ccess of im m u ne evasion is lik ely  to 
b e influ enced b y  the specificity  of MHC class I down-
m odu lation, as a com plete down-reg u lation of MHC 
class I su rface ex pression wou ld render cells 
su sceptib le to N K  cell ly sis. A  selective down-
m odu lation of only  those alleles that present viral 
antig ens to cy totox ic T  cells (m ainly  HL A -A  and – B  
locu s produ cts) cou ld ensu re b oth T  and N K  cell 
escape. 
S everal HCMV-encoded proteins contrib u te to the 
down-reg u lation of MHC class I m olecu les in the 
cou rse of infection. T hey  differ from  each other in 
m echanism  and selectivity  in down-m odu latory  effect 
on the different MHC class I locu s produ cts. U S 3 , an 
im m ediate early  HCMV g ene produ ct, m ainly  affects 
su rface ex pression of tapasin-dependent MHC class I 
alleles 1. B y  b lock ing  T A P , U S 6  prevents peptide 
transport into the ER  and su b seq u ent peptide loading  
at early  and late tim es post infection 2 ,3 . T his affects 
su rface ex pression of all MHC class I alleles. In spite 
of this, su rface ex pression of HL A -E m olecu les can b e 
preserved b y  su pply ing  it with a T A P -independent 
peptide 4 ,5 . U S 2  and U S 11, ex pressed at early  tim es 
post infection, targ et newly  sy nthesiz ed MHC class I 
m olecu les for deg radation 6 ,7 . T he effect of these viral 
g ene produ cts on su rface ex pression of different 
su b sets of MHC class I m olecu les will b e discu ssed 
b elow. 
In the stu dies describ ed in Chapters 2 ,3  and 4 , we 
aim ed to clarify  how, and to what ex tent, U S 2  and 
U S 11 can contrib u te to the efficiency  and specificity  of 
MHC class I down-reg u lation. P reviou s stu dies had 
m ainly  focu ssed on the m echanism  of interference 
with antig en presentation 6 ,8 -11. W ith the cell lines and 
antib odies u sed in these stu dies, it is difficu lt to 
dedu ce effects on individu al MHC class I locu s 
produ cts. T o enab le detection of the effects of 
U S 2 /U S 11 on individu al MHC class I alleles, we 
introdu ced different class I heavy  chain constru cts into 
a m u rine cell line which co-ex presses hu m an 2 m . 
W e evalu ated the effect on MHC class I su rface 
ex pression u sing  flow cy tom etry , as this is m ost 
relevant with respect to N K  and T  cell receptor 
interactions. Moreover, MHC class I m olecu les that 
appear stab le in the presence of U S 2  and U S 11 in 
pu lse-chase ex perim ents, cou ld nevertheless b e 
withheld from  the su rface via other m echanism s than 
deg radation. A s shown in Chapter 2 , U S 11 can cau se 
ER  retention of MHC class I m olecu les that are not 
targ eted for deg radation. 
F low cy tom etry  stu dies showed that U S 2  selectively  
down-m odu lates HL A -A 2 , -B 2 7 , and HL A -G , b u t not 
HL A -B 7 , HL A -Cw3 , or HL A -E (Chapter 3 ). S im ilar 
stu dies with U S 11 showed differences in selectivity , 
with HL A -A 2 , -B 7 , -B 2 7 , -Cw3  b eing  sensitive, and 
HL A -G  and -E b eing  insensitive to U S 11-m ediated 
down-reg u lation (Chapters 2  and 4 ). T hese flow 
cy tom etry  stu dies com plem ented and refined 
previou sly  perform ed pu lse chase ex perim ents 
evalu ating  stab ility  chang es of MHC class I m olecu les 
in the presence of U S 2  or U S 11 9 ,12 ,13 , as well as 
previou sly  perform ed in vitro b inding  stu dies 
perform ed with U S 2  and variou s MHC class I alleles 
14 . N ot all HL A -C m olecu les are insensitive to U S 2 , as 
HL A -Cw7  and -Cw2  were down-reg u lated in its 
presence 15 ; ou r own u npu b lished resu lts).
It is clear that there are sensitivity  differences b etween 
the variou s MHC class I locu s produ cts, b u t also 
b etween g ene produ cts of a sing le locu s su b g rou p, for 
down-m odu lation b y  U S 2  and U S 11. O u r nex t step 
was to u nravel the determ inants for this selectivity . 
T his wou ld allow sensitivity  predictions for a larg er 
variety  of MHC class I m olecu les. 
S e le c tivity  of U S 2 -m e d ia te d  d e g ra d a tion of M H C  c la s s  
I m ole c u le s  
B ased on cry stal stru ctu re data of HL A -A 2 - 2 m -U S 2  
com plex es and seq u ence alig nm ents for the reg ion of 
class I im plicated in U S 2  b inding , we hy pothesiz ed 
that allelic variation in the 2 / 3  ER -lu m enal reg ion 
m ig ht ex plain the resistance of HL A -B 7 , -Cw3  and -E 
as opposed to the sensitivity  of HL A -A 2 , -B 2 7  and -G  
16 ,17 . In Chapter 4 , we investig ated whether we cou ld 
convert the resistance of HL A -B 7  and HL A -E b y  
replacing  those residu es that are assu m ed to prohib it 
an interaction with U S 2 , with the corresponding  
residu es fou nd in U S 2 -sensitive m olecu les. T he 
resu lts from  ex perim ents with HL A -B 7  ET (L )Q  and HL A -
E Q R T D  m u tants showed that residu es in this reg ion are 
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indeed important sensitivity determinants. Even a 
single mutation in HLA-E (H181R) significantly altered 
the sensitivity to down-modulation by US2. 
HLA-Cw3 differs at positions 183 (E) and 184 (H) from 
many US2-sensitive class I molecules (carrying D and 
A/P at positions 183 and 184, respectively). However, 
this variation appeared not to be responsible for its 
resistance, as US2-sensitive HLA-Cw2 and -Cw7 also 
carry E183 and H184 residues. Nonetheless, 
sequence variation at this site may still affect the 
efficiency of down-modulation, as US2-resistant HLA-
Cw3 molecules became somewhat more sensitive 
when E183D, H184P mutations were introduced 
(unpublished results). However, the presence of a 
positively charged lysine residue at position 173 is the 
most likely explanation for the resistance to US2-
mediated down-regulation of HLA-Cw3, since US2-
sensitive alleles, including the majority of HLA-C 
alleles, have a negatively charged glutamic acid at 
position 173. 
The crystal structure data showed which region of the 
ER-lumenal part of HLA-A2 was implicated in US2 
binding, but did not provide insights into possible 
interactions between transmembrane and cytosolic 
regions of class I heavy chains and the US proteins. 
Sequence alignments and studies using chimeras 
derived from US2-sensitive and -insensitive alleles 
make it unlikely that sequence variation outside the 
ER-lumenal part of HLA contributes to sensitivity 
differences to US2-mediated down-regulation 
(Chapter 4). 
Sequence alignments of the region implicated in US2-
binding show that HLA-A2, -B27, -E and -G are 
identical to their locus subgroup consensus 
sequences for this region. This makes it likely that the 
majority of HLA-A, B, -E and -G will be down-
modulated in the presence of US2. However, not all 
HLA-B molecules are affected by US2, as exemplified 
by HLA-B7. Those residues that were shown to be 
responsible for the resistance of HLA-B7 can also be 
found in several other HLA-B alleles, including HLA-
B8, -B40 , -B41, -B42, and –B48. These HLA-B alleles, 
which are relatively common (found in 25-30 %  of the 
Caucasion population; F. Claas, unpublished obser-
vation), are likely to be insensitive to US2-mediated 
down-regulation. 
We did not find any indication that sequence variation 
in the domains located outside the ER-lumenal region 
contributes to sensitivity differences between class I 
locus products for US2 (Chapter 4). The pulse chase 
experiments with HLA-G showed that class I heavy 
chains do not need to be equipped with a full-length 
tail in order to be a target for US2-mediated 
degradation (Chapter 4). However, heavy chains com-
prised of ER-lumenal regions only, are inadequate 
targets for US2, as illustrated by the resistance of the 
soluble HLA-G1 isoform (Chapter 4). 
Requirements for US11-mediated degradation of 
MHC class I
For US11, the only MHC class I locus products that 
appear to be completely insensitive to down-
modulation are HLA-G and HLA-E. Interestingly, all 
that is required to confer sensitivity to these two MHC 
class I locus products, is an extension of their 
cytoplasmic tail. HLA-G molecules naturally have a tail 
of 6 residues, and an extension of this tail with 27 
residues derived from the tail of HLA-A2 resulted in a 
very efficient degradation of these mutants in US11-
positive cells (Chapter 2). Surprisingly, a similar HLA-
G mutant with 25 instead of 27 extra tail residues did 
not show this result. Apparently, the C-terminal lysine 
and valine residues were essential for degradation. 
HLA-E has a cytoplasmic tail that lacks only 4 
residues compared to HLA-A molecules. HLA-E 
required only 2 extra residues (lysine and valine) to 
become sensitive to US11 (Chapter 4). This clearly 
shows that length and amino acid composition of the 
tail can be important determinants for sensitivity 
differences between MHC class I locus products. 
However, lysine and valine residues are not the only 
requirements, nor are they essential in all cases. HLA-
B alleles do not encode for C-terminal lysine and 
valine residues, but are nevertheless down-modulated 
by US11. Likewise, a mutant HLA-A2 with a tail as 
long as that of HLA-B molecules (HLA-A2delCKV) and 
HLA-A2 with the tail of HLA-E were still down-
regulated by US11 (Chapter 4). These KV residues 
may, however, determine the effectiveness or 
threshold for down-modulation, as the mutant 
constructs that lacked these residues appeared to 
require higher levels of US11 than their wild type 
counterparts for a similar down-regulatory effect. 
Besides cytosolic residues, other regions of class I 
also play a role. Studies with HLA-A2/G and HLA-
A2/E chimeras showed that the 1- 3 ER-lumenal 
residues influence sensitivity to US11 (Chapters 2 and 
4). A crystal structure of complexed US11/MHC class 
I would be very helpful to narrow down the exact 
region and residues of class I heavy chains that are 
involved in US11 binding. The studies with HLA-A2/G 
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and HLA-A2/E chimeras did not reveal a role for the 
connecting peptide or trans-membrane regions in 
locus product sensitivity differences (Chapters 2 and 
4).
The results from Chapters 2 and 4 give rise to the 
following model: In principle, all MHC class I 
cytoplasmic domains, with the exception of HLA-G, 
have an amino acid composition that can make them 
targets for US11-mediated degradation. However, a 
minimum of 29 class I tail residues has to go with 
either a favourable ER-lumenal region, or with lysine 
and valine tail residues in order to evoke sufficient 
down-modulation by US11. A favourable ER-lumenal 
region may bypass the function of the KV residues 
through a prolonged and/or stronger interaction with 
US11, thereby increasing the chances of getting 
dislocated to the cytosol for subsequent degradation 
by proteasomes. 
The function of the KV, as well as of the other tail 
residues is still unclear. Addition of ubiquitin moieties 
to degradation substrates may provide a handle for 
extraction of proteins across the ER membrane. 
Enhancement of MHC class I down-regulation by KV 
residues may rely on the lysine, functioning as a 
potential ubiquitination site. 
Using a cell line carrying a temperature-dependent 
defect in the E1 ubiquitin-activating enzyme, we have 
shown that ubiquitination is essential for US11-
mediated dislocation of MHC class I molecules 
(Chapter 5). At the non-permissive temperature, MHC 
class I molecules remained in the ER lumen. These 
data clearly showed the importance of ubiquitination 
for the dislocation of MHC class I molecules induced 
by US11. However, it remains unclear which 
protein(s) need to be ubiquitinated to trigger the 
dislocation process. 
A study by Shamu et al. showed that lysine residues 
in the tail of HLA-A2 are not essential for US11-
mediated degradation. However, elimination of a 
mutant HLA-A2 lacking lysine residues in the 
cytoplasmic tail appeared to be retarded compared to 
wild type HLA-A2 18.
Alternatively, the KV residues may merely facilitate 
access of components of the dislocation and 
degradation machinery to essential residues residing 
within another region of the tail. Phosphorylation can 
be an important signal for docking of E3 ligases, 
which in turn can ubiquitinate their substrates 19. The 
tail of MHC class I molecules encodes several 
potential as well as acknowledged phosphorylation 
sites 20-25. Substitutions of the known Y 321 and S335 
phosphorylation sites did not alter the sensitivity to 
US11-associated degradation (Chapter 2 and un-
published results). More research will be required to 
unravel why the tail is essential for US11-mediated 
dislocation of MHC class I molecules. 
Clearly, sequence variation in MHC class I molecules 
is an important determinant for their sensitivity to 
down-modulation by several of the US proteins. At 
present, it is unknown whether the sequence of the 
US region of laboratory HCMV strains differs from that 
in strains circulating in the population. 
Besides the specificity, the degree of MHC class I 
down-regulation is likely important for a successful 
immune escape of HCMV. In vivo, MHC class I 
expression is upregulated in the presence of 
cytokines. When the expression of MHC class I was 
elevated in vitro, higher levels of US proteins were 
required for a sufficient down-modulatory effect 
(Chapter 3). Also, cells infected with a higher HCMV 
copy number show a higher degree of MHC class I 
down-regulation, compared to cells infected with lower 
copy numbers 26.
Why would HCMV encode for so many proteins with 
the same purpose, namely to prevent immune 
detection through down-modulation of MHC class I 
molecules?  In part, this may reflect the fact that these 
proteins show temporal expression patterns. 
Moreover, expression of more than one immune 
evasion gene at a given time during infection could 
ensure a more efficient down-modulation of one 
particular MHC class I locus product. A concerted 
action of US proteins could also affect a broader 
range of MHC class I locus products. Moreover, by 
using different mechanisms, an exhaustion of one 
particular route can be prevented. 
Two of the HCMV-encoded proteins, US2 and US11, 
show similar temporal expression patterns, and seem 
to act very similarly. We evaluated the need for 
expression of both these proteins. 
D ifferences b etw een US2 and US11 
Whereas specificity of US2-mediated down-
modulation seems to rely mostly on a region at the 
junction of the 2/ 3 domain, our data indicate that 
the conditions are different and more complicated for 
US11. Although ER-lumenal residues of HLA class I 
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do play a role, replacement of residues LHLE in the 
HLA-E 2/3 region by QRTD did not affect its 
sensitivity to US11 (unpublished results). Association 
of US2 and US11 with distinct domains of class I 
molecules may contribute to a broader defense of 
HCMV. Together, US2 and US11 could attack a wider 
variety of MHC I molecules. 
Whereas US2 does not require MHC class I tail 
residues, US11-mediated down-modulation depends 
largely on this region. Interestingly, the opposite has 
been observed for US2 and US11 deletion mutants. 
When US2 was deprived of its tail residues it was no 
longer functional, while tailless US11 could still target 
class I molecules for degradation 27,28.
Whereas US2 accompanies its targets to the cytosol, 
US11 seems to remain behind in the ER 7,29. This is 
accompanied by a prolonged stability of US11, 
compared to US2. In the presence of proteasome 
inhibitors, a deglycosylated cytosolic intermediate can 
be observed for US2. 
At present, several proteins and protein complexes 
have been identified that could form a link between 
the dislocation process and proteasomal degradation 
of ER lumenal proteins in general, and MHC class I 
molecules in particular. The cytosolic ATPase p97 
(also called VCP or Cdc48 in yeast) and its cofactor, a 
dimer of Ufd1 and Npl14, have been implicated in the 
retrograde transport of ER substrates 30,31.
Recently, a new protein has been identified, which 
interacts with the transmembrane region of US11 32,33.
This protein, named Derlin-1, is a homologue of yeast 
Der1, which was shown to be required for degradation 
of misfolded lumenal ER proteins 34. Derlin-1 is 
predicted to have 4 transmembrane regions and 
cytosolic N- and C-termini. Derlin-1 is essential for 
US11-mediated dislocation of class I molecules, but 
not for dislocation of class I heavy chains induced by 
US2. Interestingly, dislocation of US2 itself is derlin-1 
dependent 35.
Derlin-1 interacts with another protein called VCP-
interacting membrane protein (VIMP). VIMP is 
predicted to have a single transmembrane spanning 
domain, a short ER lumenal domain and a relatively 
long (~ 132 aa) cytosolic region. The cytoplasmic 
region of VIMP links the p97/VCP complex to the ER 
membrane 36. The p97-Ufd1-Npl4 complex can 
recognize poly-ubiquitin chains, and ATP hydrolysis 
by p97 could provide the driving force to finally pull the 
substrate into the cytosol 37.
It is unknown if other ER-localized proteins facilitate 
the disposal of US2 and US11 targets. It is tempting to 
speculate on US2 and US11 making use of proteins 
normally engaged in quality control and disposal of 
misfolded ER proteins. It is known that in the absence 
of other complex components, e.g. the 2m light 
chain or peptides, free class I heavy chains cannot 
meet the quality standards in the ER and are targeted 
for degradation 38. Different ER chaperones are 
assisting different stages of the folding and assembly 
of MHC class I molecules. In Chapter 6, we 
investigated if US2 and US11 can act at relatively 
early stages of MHC class I folding and complex 
formation, i.e. before association with 2m. We found 
that both US2 and US11 can target free HCs for 
degradation, as evaluated in a 2m-negative cell line. 
They did so equally well, in cells lacking 2m and in 
2m-reconstituted cells. 
Interestingly, the presence of the proteasome inhibitor 
Z L3H severely decreased the efficiency of heavy chain 
dislocation, but only when mediated by US11 and only 
in cells lacking 2m. This was not observed with a 
similar experimental set-up including US2, nor in the 
absence of proteasome inhibitor, nor in US11+, 2m+
cells supplemented with Z L3H.
The ER chaperones that are generally found in 
association with free class I HCs are BiP, calnexin, 
and the oxidoreductase ERp57. BiP is known to retain 
many misfolded proteins in the ER 39. Studies with 
mutant Kar2p (the yeast homologue of BiP), have 
shown an association between the ATPase activity of 
Kar2p with release of malfolded proteins into the 
cytosol 40. In another report, in which the release of 
misfolded immunoglobulin light chains from BiP was 
studied, the dislocation seemed to be tightly coupled 
to proteasome activity 41.
Calnexin serves as a chaperone for many 
glycoproteins 42,43. It may also contribute to oxidative 
folding, as it acts in conjunction with the oxido-
reductase ERp57 44. It is possible that class I heavy 
chains require a more reduced oxidation status for 
efficient dislocation. There are indications that 
proteasome inhibitors may interfere with calnexin / 
oxidoreductase interactions 45,46. In cells treated with 
lactacystin, a redistribution of ER chaperones was 
observed. Upon proteasome inhibition, CNX , CRT, 
and ER degradation substrates (but not BiP, PDI, 
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glucosyltransferase, or ERp57) accumulated in a 
pericentriolar quality control compartment derived 
from the ER 45,46.
The fact that we found an abrogation of US11-
mediated dislocation in the presence of proteasome 
inhibitor and exclusively in cells lacking 2m-
expression may imply that US11 uses partially similar 
mechanisms for discarding HCs as the endogenous 
pathway used by FO-I cells to dispose of 
unassembled class I molecules. It also implies that it 
uses a mechanism distinct from that used by US2. 
More research will be required to elucidate the exact 
pathways of protein disposal. 
References
 1.  Park, B., Y. Kim, J . Shin, S. Lee, K. Cho, K. Fruh, S. Lee, and 
K. Ahn. 2004. Human cytomegalovirus inhibits tapasin-
dependent peptide loading and optimization of the MHC class I 
peptide cargo for immune evasion. Immunity. 20:71-85. 
 2.  Ahn, K., A. Gruhler, B. Galocha, T. R. J ones, E. J . Wiertz, H. 
L. Ploegh, P. A. Peterson, Y. Yang, and K. Fruh. 1997. The 
ER-luminal domain of the HCMV glycoprotein US6 inhibits 
peptide translocation by TAP. Immunity. 6:613-621. 
 3.  Hengel, H., J . O. Koopmann, T. Flohr, W. Muranyi, E. Goulmy, 
G. J . Hammerling, U. H. Koszinowski, and F. Momburg. 1997. 
A viral ER-resident glycoprotein inactivates the MHC-encoded 
peptide transporter. Immunity. 6:623-632. 
 4.  Tomasec, P., V. M. Braud, C. Rickards, M. B. Powell, B. P. 
McSharry, S. Gadola, V. Cerundolo, L. K. Borysiewicz, A. J . 
McMichael, and G. W. Wilkinson. 2000. Surface expression of 
HLA-E, an inhibitor of natural killer cells, enhanced by human 
cytomegalovirus gpUL40. Science 287:1031. 
 5.  Ulbrecht, M., V. Hofmeister, G. Yuksekdag, J . W. Ellwart, H. 
Hengel, F. Momburg, S. Martinozzi, M. Reboul, M. Pla, and E. 
H. Weiss. 2003. HCMV glycoprotein US6 mediated inhibition 
of TAP does not affect HLA-E dependent protection of K-562 
cells from NK cell lysis. Hum.Immunol. 64:231-237. 
 6.  J ones, T. R. and L. Sun. 1997. Human cytomegalovirus US2 
destabilizes major histocompatibility complex class I heavy 
chains. J .V irol. 71:2970-2979. 
 7.  Wiertz, E. J ., T. R. J ones, L. Sun, M. Bogyo, H. J . Geuze, and 
H. L. Ploegh. 1996. The human cytomegalovirus US11 gene 
product dislocates MHC class I heavy chains from the 
endoplasmic reticulum to the cytosol. Cell 84:769-779. 
 8.  Rehm, A., A. Engelsberg, D. Tortorella, I. J . Korner, I. 
Lehmann, H. L. Ploegh, and U. E. Hopken. 2002. Human 
cytomegalovirus gene products US2 and US11 differ in their 
ability to attack major histocompatibility class I heavy chains in 
dendritic cells. J .V irol. 76:5043-5050. 
 9.  Story, C. M., M. H. Furman, and H. L. Ploegh. 1999. The 
cytosolic tail of class I MHC heavy chain is required for its 
dislocation by the human cytomegalovirus US2 and US11 
gene products. P roc.N atl.A cad.Sci.U.S.A  96:8516-8521. 
 10.  Wiertz, E. J ., D. Tortorella, M. Bogyo, J . Yu, W. Mothes, T. R. 
J ones, T. A. Rapoport, and H. L. Ploegh. 1996. Sec61-
mediated transfer of a membrane protein from the 
endoplasmic reticulum to the proteasome for destruction. 
N ature 384:432-438. 
 11.  Chevalier, M. S., G. M. Daniels, and D. C. J ohnson. 2002. 
Binding of human cytomegalovirus US2 to major 
histocompatibility complex class I and II proteins is not 
sufficient for their degradation. J .V irol. 76:8265-8275. 
 12.  Furman, M. H., H. L. Ploegh, and D. J . Schust. 2000. Can 
viruses help us to understand and classify the MHC class I 
molecules at the maternal-fetal interface? Hum.Immunol.
61:1169-1176. 
 13.  Schust, D. J ., D. Tortorella, J . Seebach, C. Phan, and H. L. 
Ploegh. 1998. Trophoblast class I major histocompatibility 
complex (MHC) products are resistant to rapid degradation 
imposed by the human cytomegalovirus (HCMV) gene 
products US2 and US11. J .E x p .Med. 188:497-503. 
 14.  Gewurz, B. E., E. W. Wang, D. Tortorella, D. J . Schust, and H. 
L. Ploegh. 2001. Human cytomegalovirus US2 endoplasmic 
reticulum-lumenal domain dictates association with major 
histocompatibility complex class I in a locus-specific manner. 
J .V irol. 75:5197-5204. 
 15.  Llano, M., M. Guma, M. Ortega, A. Angulo, and M. Lopez-
Botet. 2003. Differential effects of US2, US6 and US11 human 
cytomegalovirus proteins on HLA class Ia and HLA-E 
expression: impact on target susceptibility to NK cell subsets. 
E ur.J .Immunol. 33:2744-2754. 
 16.  Gewurz, B. E., R. Gaudet, D. Tortorella, E. W. Wang, H. L. 
Ploegh, and D. C. Wiley. 2001. Antigen presentation 
subverted: Structure of the human cytomegalovirus protein 
US2 bound to the class I molecule HLA-A2. 
P roc.N atl.A cad.Sci.U.S.A  98:6794-6799. 
 17.  Robinson, J ., M. J . Waller, P. Parham, N. de Groot, R. 
Bontrop, L. J . Kennedy, P. Stoehr, and S. G. Marsh. 2003. 
IMGT/HLA and IMGT/MHC: sequence databases for the study 
of the major histocompatibility complex. N ucleic A cids Res.
31:311-314. 
 18.  Shamu, C. E., C. M. Story, T. A. Rapoport, and H. L. Ploegh. 
1999. The pathway of US11-dependent degradation of MHC 
class I heavy chains involves a ubiquitin-conjugated 
intermediate. J .Cell B iol. 147:45-58. 
 19.  Kile, B. T., B. A. Schulman, W. S. Alexander, N. A. Nicola, H. 
M. Martin, and D. J . Hilton. 2002. The SOCS box: a tale of 
destruction and degradation. T rends B ioch em.Sci. 27:235-241. 
 20.  Blom, N., S. Gammeltoft, and S. Brunak. 1999. Sequence and 
structure-based prediction of eukaryotic protein 
phosphorylation sites. J .Mol.B iol. 294:1351-1362. 
 21.  Paulson, E., C. Tran, K. Collins, and K. Fruh. 2001. KSHV-K5 
inhibits phosphorylation of the major histocompatibility 
complex class I cytoplasmic tail. V irology 288:369-378. 
 22.  Guild, B. C., R. L. Erikson, and J . L. Strominger. 1983. HLA-A2 
and HLA-B7 antigens are phosphorylated in vitro by rous 
sarcoma virus kinase (pp60v-src) at a tyrosine residue 
encoded in a highly conserved exon of the intracellular 
domain. P roc.N atl.A cad.Sci.U.S.A  80:2894-2898. 
 23.  Santos, S. G., S. J . Powis, and F. A. Arosa. 2004. Misfolding 
of major histocompatibility complex class I molecules in 
activated T cells allows cis-interactions with receptors and 
signaling molecules and is associated with tyrosine 
phosphorylation. J .B iol.Ch em. 279:53062-53070. 
 24.  Guild, B. C. and J . L. Strominger. 1984. Human and murine 
class I MHC antigens share conserved serine 335, the site of 
HLA phosphorylation in vivo. J .B iol.Ch em. 259:9235-9240. 
 26.  Pizzato, N., B. Garmy-Susini, P. Le Bouteiller, and F. Lenfant. 
2004. Differential down-modulation of HLA-G and HLA-A2 or -
A3 cell surface expression following human cytomegalovirus 
infection. J .Rep rod.Immunol. 62:3-15. 
 27.  Chevalier, M. S., G. M. Daniels, and D. C. J ohnson. 2002. 
Binding of human cytomegalovirus US2 to major 
histocompatibility complex class I and II proteins is not 
sufficient for their degradation. J .V irol. 76:8265-8275. 
 28.  Furman, M. H., H. L. Ploegh, and D. Tortorella. 2002. 
Membrane-specific, host-derived factors are required for US2- 
and US11-mediated degradation of major histocompatibility 
complex class I molecules. J .B iol.Ch em. 277:3258-3267. 
105
 29.  Tortorella, D., C. M. Story, J. B. Huppa, E. J. Wiertz, T. R. 
Jon es , I. Bac ik , J. R. Ben n in k , J. W. Y ew d ell, an d  H. L . 
P loeg h . 1 998 . Dis loc ation  of type I m em b ran e protein s  from  
th e ER to th e c ytos ol is  s en s itiv e to c h an g es  in  red ox  poten tial. 
J.Cell Biol. 1 4 2:3 6 5 -3 7 6 . 
 3 0 .  Meyer, H. H., J. G . Sh orter, J. Seem an n , D. P appin , an d  G . 
Warren . 20 0 0 . A  c om plex  of m am m alian  ufd 1  an d  n pl4  lin k s  
th e A A A -A TP as e, p97 , to ub iq uitin  an d  n uc lear tran s port 
path w ays . E M BO  J. 1 9:21 8 1 -21 92. 
 3 1 .  Y e, Y ., H. H. Meyer, an d  T. A . Rapoport. 20 0 1 . Th e A A A  
A TP as e Cd c 4 8 /p97  an d  its  partn ers  tran s port protein s  from  
th e ER in to th e c ytos ol. N a tu re 4 1 4 :6 5 2-6 5 6 . 
 3 2.  L illey, B. N . an d  H. L . P loeg h . 20 0 4 . A  m em b ran e protein  
req uired  for d is loc ation  of m is fold ed  protein s  from  th e ER. 
N a tu re 4 29:8 3 4 -8 4 0 . 
 3 3 .  Y e, Y ., Y . Sh ib ata, C. Y un , D. Ron , an d  T. A . Rapoport. 20 0 4 . 
A  m em b ran e protein  c om plex  m ed iates  retro-tran s loc ation  
from  th e ER lum en  in to th e c ytos ol. N a tu re 4 29:8 4 1 -8 4 7 . 
 3 4 .  K n op, M., A . F in g er, T. Braun , K . Hellm uth , an d  D. H. Wolf. 
1 996 . Der1 , a n ov el protein  s pec ific ally req uired  for 
en d oplas m ic  retic ulum  d eg rad ation  in  yeas t. E M BO  J. 1 5 :7 5 3 -
7 6 3 . 
 3 5 .  L illey, B. N . an d  H. L . P loeg h . 20 0 4 . A  m em b ran e protein  
req uired  for d is loc ation  of m is fold ed  protein s  from  th e ER. 
N a tu re 4 29:8 3 4 -8 4 0 . 
 3 6 .  Y e, Y ., Y . Sh ib ata, C. Y un , D. Ron , an d  T. A . Rapoport. 20 0 4 . 
A  m em b ran e protein  c om plex  m ed iates  retro-tran s loc ation  
from  th e ER lum en  in to th e c ytos ol. N a tu re 4 29:8 4 1 -8 4 7 . 
 3 7 .  Y e, Y ., H. H. Meyer, an d  T. A . Rapoport. 20 0 3 . F un c tion  of th e 
p97 -U fd 1 -N pl4  c om plex  in  retrotran s loc ation  from  th e ER to 
th e c ytos ol: d ual rec og n ition  of n on ub iq uitin ated  polypeptid e 
s eg m en ts  an d  polyub iq uitin  c h ain s . J.Cell Biol. 1 6 2:7 1 -8 4 . 
 3 8 .  Hug h es , E. A ., C. Ham m on d , an d  P . Cres s w ell. 1 997 . 
Mis fold ed  m ajor h is toc om patib ility c om plex  c las s  I h eav y 
c h ain s  are tran s loc ated  in to th e c ytoplas m  an d  d eg rad ed  b y 
th e proteas om e. P roc .N a tl.A c a d .S c i.U .S .A  94 :1 8 96 -1 90 1 . 
 3 9.  Ham m on d , C. an d  A . Helen ius . 1 995 . Q uality c on trol in  th e 
s ec retory path w ay. Cu rr.O p in .Cell Biol. 7 :5 23 -5 29. 
 4 0 .  P lem per, R. K ., S. Boh m ler, J. Bord allo, T. Som m er, an d  D. H. 
Wolf. 1 997 . Mutan t an alys is  lin k s  th e tran s loc on  an d  BiP  to 
retrog rad e protein  tran s port for ER d eg rad ation . N a tu re
3 8 8 :8 91 -8 95 . 
 4 1 .  Ch illaron , J. an d  I. G . Haas . 20 0 0 . Dis s oc iation  from  BiP  an d  
retrotran s loc ation  of un as s em b led  im m un og lob ulin  lig h t c h ain s  
are tig h tly c oupled  to proteas om e ac tiv ity. M ol.Biol.Cell
1 1 :21 7 -226 . 
 4 2.  Ham m on d , C., I. Braak m an , an d  A . Helen ius . 1 994 . Role of N -
lin k ed  olig os ac c h arid e rec og n ition , g luc os e trim m in g , an d  
c aln ex in  in  g lyc oprotein  fold in g  an d  q uality c on trol. 
P roc .N a tl.A c a d .S c i.U .S .A  91 :91 3 -91 7 . 
 4 3 .  O u, W. J., P . H. Cam eron , D. Y . Th om as , an d  J. J. Berg eron . 
1 993 . A s s oc iation  of fold in g  in term ed iates  of g lyc oprotein s  
w ith  c aln ex in  d urin g  protein  m aturation . N a tu re 3 6 4 :7 7 1 -7 7 6 . 
 4 4 .  O liv er, J. D., F . J. v an  d er Wal, N . J. Bulleid , an d  S. Hig h . 
1 997 . In terac tion  of th e th iol-d epen d en t red uc tas e ERp5 7  w ith  
n as c en t g lyc oprotein s . S c ien c e 27 5 :8 6 -8 8 . 
 4 5 .  F ren k el, Z ., M. Sh en k m an , M. K on d ratyev , an d  G . Z . 
L ed erk rem er. 20 0 4 . Separate roles  an d  d ifferen t routin g  of 
c aln ex in  an d  ERp5 7  in  en d oplas m ic  retic ulum  q uality c on trol 
rev ealed  b y in terac tion s  w ith  as ialog lyc oprotein  rec eptor 
c h ain s . M ol.Biol.Cell 1 5 :21 3 3 -21 4 2. 
 4 6 .  K am h i-N es h er, S., M. Sh en k m an , S. Tolc h in s k y, S. V . F rom m , 
R. Eh rlic h , an d  G . Z . L ed erk rem er. 20 0 1 . A  n ov el q uality 
c on trol c om partm en t d eriv ed  from  th e en d oplas m ic  retic ulum . 
M ol.Biol.Cell 1 2:1 7 1 1 -1 7 23 . 
106
Nederlandse samenvatting
Het menselijk lichaam wordt voortdurend blootgesteld 
aan allerlei virussen. E r bestaan meerdere 
afweermechanismen die bescherming kunnen bieden 
tegen ongewenste indringers. D e eerste afweerlinie 
wordt gevormd door barriè res als huid, slijmvliez en en 
een z ure omgeving (z oals in de maag). A ls 
virusdeeltjes de gastheer toch weten binnen te 
dringen, treden meer geavanceerde afweermechanis-
men in werking die de detectie en eliminatie van het 
virus p roberen te bewerkstelligen.  
E en virus kan z ichz elf niet vermenigvuldigen en is 
afhankelijk van z ijn gastheer voor de p roductie van 
nageslacht. Het z al een gastheercel moeten binnen-
dringen om daar nieuwe virusdeeltjes te laten maken. 
V oordat een virusdeeltje een cel heeft geïnfecteerd, 
kan het echter worden ontdekt door een sp ecifieke tak 
van het immuunsy steem, namelijk B  cellen. D ez e B  
cellen p roduceren antilichamen die structuren aan de 
buitenkant van het virus kunnen herkennen. D oor aan 
het virusdeeltje te binden kunnen antilichamen het 
virus markeren om te worden op geruimd door het 
immuunsy steem. D e antlichaamp roducerende B  
cellen ontwikkelen ook een geheugen z odat z e bij een 
volgende ontmoeting met een z elfde virus sneller 
kunnen reageren. 
A ls een virusdeeltje toch een cel is binnengedrongen, 
komt een nieuwe tak van het immuunsy steem in 
werking, namelijk de T  cellen. D ez e afweercellen 
kunnen lichaamsvreemde structuren (antigenen) aan 
de buitenkant van een geïnfecteerde cel detecteren. 
G eïnfecteerde cellen dragen kleine fragmentjes van 
het virus op  het celop p ervlak. D ez e antigenen liggen 
ingebed in moleculen die worden gecodeerd door het 
z ogeheten M ajor Histocomp atibility  C omp lex  (M HC ).  
M HC  moleculen z ijn onder te verdelen in twee 
klassen, die elk op  verschillende celty p en voorkomen 
en ook gebruik maken van andere bronnen voor hun 
antigeen-fragmenten. M HC  klasse I moleculen z ijn op  
nagenoeg alle celty p en te vinden en p resenteren over 
het algemeen fragmenten van eiwitten die in de eigen 
cel z ijn gemaakt. M HC  klasse II moleculen komen 
alleen voor op  sp eciale antigeenp resenterende cel-
ty p en (B -cellen, macrofagen en dendritische cellen) 
en binden voornamelijk fragmenten die van buitenaf 
z ijn op genomen.  
C y totox ische T  cellen kunnen de lichaamsvreemde 
virus fragmentjes ontdekken op  M HC  klasse I 
moleculen van geïnfecteerde cellen en vervolgens 
overgaan tot de aanval om dez e cellen te doden. Z ij 
doen dit met hulp  van een andere categorie T  cellen, 
z ogenaamde help er T  cellen, die gesp ecialiseerd z ijn 
in de herkenning van antigenen op  M HC  klasse II 
moleculen. A ls de aanwez igheid van een virus op  
dez e manier is gedetecteerd en de geïnfecteerde 
cellen z ijn op geruimd, wordt daarmee gelijk de 
p roductie van nieuwe virusdeeltjes stop  gez et. 
Het virus waarover dit p roefschrift gaat, is het humane 
cy tomegalovirus (HC M V ). E en groot deel van de 
wereldbevolking is met dit virus geïnfecteerd. Het 
vormt geen bedreiging voor gez onde mensen, maar 
mensen met een onderontwikkeld of verz wakt 
immuunsy steem (oa. A ID S  p atië nten of mensen die 
een transp lantatie hebben ondergaan en immuniteit-
onderdrukkende middelen krijgen toegediend) kunnen 
er ernstig z iek van worden en er z elfs door overlijden. 
Het humaan cy tomegalovirus kan ook aangeboren 
afwijkingen veroorz aken als een moeder tijdens de 
z wangerschap  voor het eerst een infectie met het 
virus op loop t. Z elfs een goedwerkend immuun-
sy steem is niet in staat het virus te elimineren, 
waardoor de gastheer de rest van het leven drager 
blijft van dit virus. Het virus verkeert overigens het 
merendeel van de tijd slechts in een soort 
sluimertoestand (latente infectie) en wordt maar nu en 
dan actief.  
T ijdens de actieve infectiefase gebruikt het virus een 
aantal mechanismen waarmee het tracht te ontkomen 
aan detectie door het immuunsy steem van z ijn 
gastheer. Het z orgt er onder andere voor dat er in 
geïnfecteerde cellen virale eiwitten worden aan-
gemaakt die verhinderen dat M HC  klasse I moleculen 
virusfragmentjes naar het celop p ervlak kunnen 
brengen. T ijdens hun insp ectieronde z ullen T  cellen 
op  dez e manier niet door hebben dat er een virus in 
de cel aanwez ig is en de cel met rust laten. E chter, 
cellen die helemaal geen M HC  klasse I moleculen 
meer op  hun celop p ervlak hebben z ijn ook verdacht. 
Z ogeheten N atural K iller (N K ) cellen kunnen z o’n cel 
alsnog doden. 
E r z ijn meerdere soorten M HC  klasse I moleculen, 
waaronder HL A -A , -B , -C , -E , en -G . V an HL A -A , -B  
en -C  kunnen vele varianten voorkomen in de 
p op ulatie, terwijl HL A -G  en-E  moleculen in bijna ieder 
individu hetz elfde z ijn. D e HL A -A , -B , -C , -E , en -G  
subgroep en verschillen ook in de mate waarin, en het 
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celtype waarop ze voorkomen, evenals in hun 
vermogen om een (grote) variatie aan antigeen 
fragmentjes te presenteren. Met name de HLA-A en -
B moleculen zijn belangrijk voor de presentatie van 
lichaamsvreemde antigenen aan T cellen. De andere 
HLA moleculen zijn tot op zekere hoogte ook in staat 
om antigenen te presenteren, maar spelen 
vermoedelijk een belangrijkere rol bij het in toom 
houden van de NK cellen.  
Nagenoeg alle cellen hebben HLA-A, -B, -C, en -E 
moleculen op hun celoppervlak. HLA-G komt voor-
namelijk voor op cellen gelegen op het grensvlak 
tussen moeder en foetus, in de placenta. O p deze 
cellen bevinden zich naast HLA-G ook HLA-C en -E, 
maar geen HLA-A of -B moleculen. Aangezien de 
HLA-A en -B moleculen in de foetale cellen voor een 
deel anders zullen zijn dan die van de moeder, kan 
hun afwezigheid hier beschermen tegen eventuele 
aanvallen van maternale immuuncellen. 
Voordat een MHC klasse I molecuul zich vanaf het 
celoppervlak kan presenteren aan immuuncellen, is er 
eerst nog een heel assemblage- en keuringsproces 
aan voorafgegaan. In de celvloeistof (het cytosol) ligt 
een netwerk van membranen, het endoplasmatisch 
reticulum (ER ), dat betrokken is bij de bouw en het 
transport van eiwitten. Nieuwe MHC klasse I 
moleculen worden vanuit het cytosol in het ER  
aangeleverd in een soort bouwpakket bestaande uit 
drie losse onderdelen. Het grootste onderdeel (de 
zware keten, HLA-“X ”) zit in het membraan verankerd, 
met een klein staartje in het cytosol en met een groter 
gedeelte in het ER . Aan dit ER -deel wordt allereerst 
een lichte keten ( 2 m) bevestigd en vervolgens een 
antigeen fragment (peptide). Deze assemblage wordt 
ondersteund door verschillende chaperonne-eiwitten 
die ervoor zorgen dat de verschillende losse onder-
delen de juiste conformatie kunnen aannemen en 
nauwkeurig in elkaar passen. Daarnaast vinden er 
ook kwaliteitscontroles plaats. Misvormde en 
ongeassembleerde MHC klasse I moleculen worden 
eruit gepikt en vernietigd in het cytosol. Alleen 
'goedgekeurde' MHC klasse I moleculen worden 
uiteindelijk op transport gezet naar het celoppervlak.  
De studies in dit proefschrift zijn gericht op de eiwitten 
U S2  en U S1 1 , die tijdens een infectie met humaan 
cytomegalovirus worden gemaakt. Deze twee virus-
eiwitten bevinden zich in het endoplasmatisch 
reticulum en binden daar aan nieuw aangemaakte 
MHC klasse I moleculen. U S2  en U S1 1  zorgen ervoor 
dat deze MHC moleculen voor vernietiging naar het 
cytosol worden gedirigeerd.  
In Hoofdstukken 2, 3 en 4 van dit proefschrift is 
beschreven welke typen HLA moleculen doelwit zijn 
van de acties van U S2  en U S1 1 . Hiervoor is gekeken 
naar het effect van deze virale eiwitten op een aantal 
afzonderlijke MHC klasse I moleculen. De resultaten 
laten zien dat er veel minder HLA-A2 , HLA-B2 7  en 
HLA-G moleculen op het celoppervlak voorkomen in 
U S2 -positieve cellen, terwijl het aantal HLA-B7 , HLA-
Cw3  en HLA-E moleculen gelijk blijft. In aanwezigheid 
van U S1 1  daarentegen, is er geen effect te zien op 
HLA-G of HLA-E, maar worden er veel minder HLA-B 
moleculen (B7  en B2 7 ) en HLA-Cw3  en HLA-A2  
moleculen op het celoppervlak gevonden. Deze 
studies geven aan dat U S2  en U S1 1  ieder een 
verschillend pakket van MHC klasse I moleculen als 
doelwit hebben. O ok is duidelijk geworden dat een 
deel van de MHC klasse I moleculen aan de acties 
van U S2  en U S1 1  kunnen ontsnappen. Dit laatste zou 
wel eens voordelig kunnen zijn voor het virus, omdat 
het hierdoor ook een aanval van Natural Killer cellen 
kan voorkomen. 
Van HLA-G en HLA-E zijn heel weinig varianten te 
vinden in de populatie, van HLA-C redelijk veel en van 
HLA-A en HLA-B nog veel meer. Een ander doel van 
de experimenten was erop gericht een indruk te 
krijgen hoe representatief de geteste HLA moleculen 
nu eigenlijk zijn voor hun subgroep. O m voorspel-
lingen te kunnen doen over de gevoeligheid van 
andere HLA moleculen voor U S2  en U S1 1 , is het 
belangrijk om meer te weten over de interactie van 
deze virale eiwitten met hun doelwit. Daarom is er 
gekeken welke domeinen van MHC klasse I 
moleculen precies betrokken zijn bij herkenning door 
U S2  en U S1 1 . Voor dit doel is een hele serie MHC 
klasse I moleculen gemaakt waarin telkens een ander 
domein is uitgewisseld tussen U S2  of U S1 1 -gevoelige 
en ongevoelig MHC klasse I moleculen. Naast deze 
zogenaamde MHC klasse I chimeren zijn er nog een 
aantal mutanten gemaakt waarin slechts enkele 
bouwstenen (aminozuurresiduen) zijn veranderd. 
De resultaten beschreven in Hoofdstuk 2 en 4 laten 
duidelijk zien dat de cytoplasmatische staart van MHC 
klasse I bepalend kan zijn voor de gevoeligheid voor 
U S1 1 . Veranderingen in de staarten van de 
ongevoelige HLA-G en HLA-E moleculen zijn genoeg 
om ze volledig gevoelig te maken voor U S1 1 . De aan- 
of afwezigheid van een paar specifieke bouwstenen 
maakt hier een enorm verschil. Bij andere HLA- 
subgroepen levert dit een minder duidelijk beeld op. 
Zo blijkt uit proeven met HLA-A2 -mutanten dat de 
samenstelling van de staart wel effect heeft op de 
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mate waarin de mutanten gevoelig zijn voor US11, 
maar dat dit niet de enige bepalende factor is voor 
deze gevoeligheid. Afhankelijk van de bouwsteen-
samenstelling kunnen de in het ER gelegen domeinen 
van de zware ketens ook interacties met US11 
aangaan. W elke individuele bouwstenen hierbij 
betrokken zijn moet nog nader worden bepaald. 
Van US2 is er een kristalstructuur bekend, die in 
belangrijke mate laat zien hoe US2 een interactie 
aangaat met HLA-A2. Voor deze kristalstructuur is 
echter gebruik gemaakt van onvolledige versies van 
US2 en HLA-A2, die geen informatie bieden over 
eventuele interacties tussen de membraan-
verankerde, of in het cytosol gelegen onderdelen van 
deze eiwitten. Om een goede indruk te krijgen welke 
domeinen in de zware ketens van klasse I moleculen 
bepalend zijn voor de effectiviteit van US2, is 
onderzocht of de staart- en membraandomeinen ook 
een bijdrage leveren.  
Van HLA-G bestaat een variant waarin de 
transmembraan- en cytoplasmatische domeinen 
ontbreken. Deze oplosbare vorm van HLA-G wordt 
uiteindelijk door de cellen uitgescheiden. De 
resultaten in Hoofdstuk 3 laten zien dat US2 deze 
HLA-G variant, in tegenstelling tot de membraan-
gebonden vorm van HLA-G, niet kan afbreken. Naast 
de in het ER gelegen delen van de zware keten zijn er 
dus duidelijk ook andere domeinen essentieel voor 
een US2-gemedieerde afbraak. Maar zijn deze 
domeinen dan ook verantwoordelijk voor onderlinge 
verschillen in de mate waarin US2 de migratie van 
zware ketens naar het celoppervlak kan verhinderen?  
De studies in Hoofdstuk 3 en 4 met verschillende 
MHC klasse I chimeren duiden erop dat dit niet het 
geval is: alleen de bouwsteensamenstelling van de in 
het ER gelegen delen van de zware ketens zijn 
uiteindelijk bepalend voor de mate waarin hun 
expressie op het celoppervlak door US2 wordt 
verhinderd.
De volgende stap was om te kijken of de gebieden die 
in HLA-A2 belangrijk zijn voor de interactie met US2, 
ook een rol spelen bij de selectie van andere HLA-
typen die onder invloed van US2 kunnen worden 
afgebroken. Als de aminozuurseq uenties van diverse 
klasse I moleculen naast elkaar worden gelegd valt op 
dat er inderdaad verschillende residuen op deze 
posities kunnen voorkomen. Door precies deze 
aminozuren te veranderen in de US2-ongevoelige 
HLA-B7 en HLA-E moleculen, kon er met het in 
Hoofdstuk 4 beschreven onderzoek worden aan-
getoond, dat een verandering van slechts 1-4  
residuen al een enorme invloed heeft op de 
oppervlakte-expressie van deze HLA moleculen in 
US2-positieve cellen. Op basis van gegevens uit een 
databank met MHC klasse I seq uenties (bouw-
tekeningen) kan er zo voor een groot deel van hen 
voorspeld worden of ze gevoelig zullen zijn voor US2. 
In aanwezigheid van US2 of US11 worden MHC 
klasse I moleculen uit het ER membraan verwijderd 
en in het cytosol afgebroken. Het is nog steeds 
onduidelijk hoe dit proces verloopt. Het is wel bekend 
dat eiwitten die afgebroken dienen te worden  eerst 
een soort etiket (ubiq uitine) opgeplakt krijgen. Eiwitten 
die met een keten van deze ubiq uitine moleculen zijn 
uitgerust worden vervolgens herkend door de eiwit-
afbraakmachinerie in de cel, het proteasoom. In 
Hoofdstuk 5  is beschreven in welke mate ubiq uiti-
nering een rol speelt bij het naar het cytosol trans-
porteren van MHC klasse I moleculen in cellen waarin 
US11 actief is. De resultaten laten zien dat er in cellen 
met een defect 'etiketteerapparaat' geen transport van 
MHC klasse I moleculen uit het ER naar het cytosol 
plaats vindt. Ubiq uitinering is dus erg belangrijk voor 
een goed verloop van het door US11 gemedieerde 
afbraakproces van MHC klasse I moleculen.
Het is onwaarschijnlijk dat US2 en US11 volledig 
zelfstandig te werk gaan; het is aannemelijker dat ze 
voor een belangrijk deel gebruik maken van 
bestaande cellulaire systemen. Zoals eerder vermeld 
worden MHC klasse I moleculen die niet aan de 
kwaliteitseisen voldoen ook de afbraakroute inge-
stuurd (bijvoorbeeld omdat de assemblage met de 
lichte keten of antigeen fragmenten niet goed 
verloopt). Vernietiging van de MHC moleculen vindt in 
dit geval pas na een half uur tot een uur plaats, terwijl 
dit in cellen met US2 of US11 al binnen enkele 
minuten gebeurd.  
Het is bekend welke chaperonne eiwitten de speci-
fieke stappen van het assemblage proces van MHC 
klasse I faciliteren en het lijkt erop dat sommige van 
hen ook betrokken zijn bij de afbraak van deze 
moleculen. Om meer inzicht te krijgen in de manier 
waarop US2 en US11 te werk gaan, is onderzocht op 
welk moment US2 en US11 precies aangrijpen in dit 
assemblageproces. Voor dit in Hoofdstuk 6
beschreven onderzoek is gebruik gemaakt van een 
cellijn waarin de lichte keten ontbreekt. Zonder deze 
lichte keten stopt het assemblage proces al in een 
vroeg stadium. De resultaten laten zien dat de virale 
eiwitten de zware ketens zowel in aan- als 
afwezigheid van de lichte keten prima kunnen laten 
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afbreken. De virale eiwitten kunnen dus in een heel 
vroeg stadium van het assemblage proces aangrijpen, 
op een moment waarop de chaperonne-eiwitten BiP , 
calnexin en Erp5 7 nog bij het assemblageproces zijn 
betrokken.  
Een interessante bevinding werd gedaan toen de 
proeven werden uitgevoerd in aanwezigheid van een 
stof die het proteasoom (de al eerder genoemde 
afbraakmachine in het cytosol) blokkeert. Onder deze 
omstandigheden slaagt US11 er nauwelijks meer in 
om de zware ketens naar het cytosol te krijgen in de 
cellen zonder lichte ketens. Er is echter geen 
probleem als de lichte ketens normaal aanwezig zijn. 
US2 heeft onder geen van deze omstandigheden 
problemen om de afbraak van MHC klasse I 
moleculen in gang te zetten. 
De transportroute naar het cytosol wordt ook geremd 
als de proteasomen geblokkeerd worden in de cellen 
waarin de vrije zware ketens op US2 / US11-
onafhankelijke wijze worden afgebroken, bijvoorbeeld 
omdat zij niet aan de kwaliteitseisen voldoen doordat 
de lichte keten ontbreekt. Deze resultaten geven aan 
dat de zware ketens in US2- en US11-positive cellen 
op verschillende manieren naar de proteasomen 
worden gevoerd. Tevens lijkt er een overlap te 
bestaan in de route die gewoonlijk doorlopen wordt 
door afgekeurde MHC klasse I ketens en de route die 
door US11 in gang wordt gezet. 
Al met al hebben de studies in dit proefschrift 
bijgedragen tot een beter inzicht in het type HLA 
moleculen dat onder invloed van US2 en US11 
worden afgebroken, wat belangrijk is voor een juiste 
interpretatie van de effecten op de functie van T cellen 
en NK cellen. Daarnaast hebben de studies meer 
informatie verschaft over de mechanismen die door 
US2 en US11 gebruikt worden om klasse I moleculen 
vanuit het ER naar het cytosol te dirigeren, waar zij 
vervolgens worden afgebroken.  
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